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Abstract 
Enhancement of CHO bioreactor performance has typically been derived from optimization of media 
formulations and feeding strategies, with advances in clone selection systems and cell engineering 
also playing an essential role. However, these breakthroughs in media development are usually not 
disclosed by the biopharmaceutical industry or media vendors due to commercial considerations. As 
a result, optimisation of CHO culture performance from the research sector is thus limited and time-
consuming with undesired and/or unexpected effects in essential steps (e. g. transfection) also 
observed. To address this deficit in information, in-house serum-free and chemically-defined media 
(SFM and CDM) were developed as working tools to study the effects of media additives in culture 
performance. Investigating the titer-enhancing effects of zinc, the specific productivity of DP12 and 
rCHO-K1 cell lines could be significantly increased. A correlated effect was also observed at 
transcriptional level, with increased oxidative respiration metabolism also associated with the zinc-
supplemented, higher-producing cultures. Building on from the knowledge gained, further 
investigation on essential additives for CHO survival was then performed, identifying putrescine as 
a vital supplement. Based on this phenotype, a novel auxotrophic-based selection system was 
designed. The method offers a drug-free, easy-to-apply and cost-effective system for cell line 
development, observed to successfully isolate hEPO- and GFP-expressing clones with stable 
production profiles for at least 42 generations. Further characterisation of the polyamine-dependent 
phenotype of CHO by gene expression microarray (Affymetrix) was then performed, suggesting an 
association between cessation of growth and increased G1/S transition but arrest at M/G1 checkpoint. 
Finally, to highlight the essential implications of media additives in other key steps for bioprocess 
optimisation, the effect of media additives in transfection was investigated. Assessing the efficiencies 
of liposome-, lipopolyplexes- and polymer-mediated transfections, an inhibitory role of ferric 
ammonium citrate was identified and a novel strategy to circumvent this inhibition was 
recommended. 
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Introduction 
Background on biopharmaceutical production 
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In 1982, the first recombinant human DNA therapeutic, insulin (Humulin, Eli Lilly & Co.) was 
released to the market (Quianzon et al. 2012). Since then, over 316 biopharmaceuticals have been 
licensed in U.S. and Europe, with monoclonal antibodies (mAbs) the most predominantly approved 
drug (Fig. 1a) (Walsh 2018). Over the past five years, the rate of biopharmaceuticals approval has 
been observed to increase for the first time since 1995, with a total of 112 products licensed since 
2014 – a 2-fold increase (Fig. 1b) (Walsh 2018). In 2017, total sales of up to $188 billion were 
recorded (Walsh 2018). The emergence of the biopharmaceutical patent cliff, with many 
"blockbuster" drugs coming off patent, is a main driver of this effect over the past number of years, 
resulting in a surge of biosimilar approvals and subsequent increase in competitiveness in the market. 
Several production platforms have been investigated and modified to generate therapeutics on an 
industrial scale. While some smaller proteins not requiring complex folding and post-translational 
modification - such as insulin and Hepatitis B vaccine - can be produced in E. coli or yeast, most 
complex therapeutics, such as monoclonal antibodies, are most efficiently produced in an active form 
by using mammalian platforms (Walsh, 2014) and for this reason mammalian cells are the dominant 
production platform (Walsh 2018) (Fig. 2). Bacterial expression systems lack glycosylation 
machinery and recombinant proteins produced by yeast display altered mannose patterns, so these 
platforms are thus limited to the production of non-glycosylated proteins (Lalonde and Durocher, 
2017a). Similarly, other non-mammalian production platforms, including plant-derived systems (such 
as root carrot-derived cell lines), insect cells (such as Sf9) and transgenic animals (such as goat and 
rabbit) also include altered glycosylation patterns, resulting in only a few biopharmaceuticals and 
vaccines successfully approved for commercialisation with these platforms (see list in Dumont et al., 
2016). 
 
a) 
b) 
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Fig. 1 a) Annual product approval over the indicated period. b) monoclonal antibody approval as a 
percentage of total approvals. Figure obtained from Walsh 2018. 
 
Among mammalian-based expression platforms, Chinese Hamster Ovary (CHO) cells have remained 
the leading cellular system, involved in the production of nearly 70% of biopharmaceutical proteins 
(Butler and Spearman, 2014; Lalonde and Durocher, 2017b). As the first mammalian cell line to be 
used for the production of a commercial therapeutic back in 1986 (tissue plasminogen activator; t-
PA), CHO cells have an extensive safety record and widespread regulatory acceptance (Kim, Kim 
and Lee, 2012). Several advantageous features include lack of human virus entry machinery, which 
increases the biosafety of therapeutic production, and high cell densities in serum-free and 
chemically-defined formulations at large-scale culture. Over the last few years, the development of 
amplification systems for this cell line have resulted in high specific productivities, with yields at the 
gram per litre levels reported (Butler and Spearman, 2014; Dumont et al., 2016; Lalonde and 
Durocher, 2017b). Importantly, recombinant proteins produced in CHO cells include post-
translational modifications resulting in bioactive, stable and compatible human therapeutics. 
Differing glycosylation patterns are sometimes observed between human and CHO products, 
although more humanised biopharmaceuticals can be obtained from several glycoengineering 
approaches, alteration of culture conditions and medium formulation strategies (Zhu, 2012; Butler 
and Spearman, 2014). Human-derived cell lines such as HEK293, PER.C6, HKB-11 and CAP have 
also been utilised over the past few years, with few therapeutic proteins developed from these 
platforms approved for the market in 2015 (e. g. rFVIIIFc, Dulaglutide and Velaglucerase alfa) (Zhu, 
2012). Although human cell lines can facilitate acceptable glycosylation patterns for therapeutic 
activity, clear disadvantages are observed with these lines, such as the risk of pathogen contamination 
and the reported ability of the cells to produce Sialyl-Lewisx modifications that could perturb 
bioavailability of the therapeutic (Kim, Kim and Lee, 2012). As a consequence of all the above, CHO 
cell lines are still the main workhorse for biopharmaceutical production. 
 
Fig. 2 Relative use of mammalian compared to nonmammalian-production system for the 
manufacture of biopharmaceuticals approved over the period of times indicated. Figure obtained from 
Walsh 2018. 
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The production of therapeutic proteins is time-consuming and laborious, consisting of the following 
stages: drug discovery, pre-clinical and clinical testing and approval, development and isolation of 
the producer clonal cell line, bioprocess culture and downstream purification. Targeted improvement 
of any of the stages will result in more efficient processes for the pharmaceutical industry. Given the 
vital role CHO cells play in the industry, enhancement of the culture performance profiles of this cell 
line (growth rate, viability, specific productivity, product quality, metabolite production, etc.) is a key 
goal of the biopharmaceutical sector. Three common strategies employed to improve the production 
process are: (i) media development and feeding strategies, (ii) bioprocess optimisation through 
bioreactor design, continuous bioreactor monitoring tools (e.g. pH, oxygen, temperature, glucose, 
lactate levels) and/or bioreactor culturing strategies (fed-batch, batch, perfusion) and (ii) generation 
of more productive cell lines by genetic engineering, clonal selection and amplification (Butler and 
Meneses-Acosta, 2012; Fischer, Handrick and Otte, 2015). These are briefly discussed below. 
 
1. Media optimisation for improved growth and productivity  
When CHO were first used for production of therapeutics (1986), yields of up to 100mg/L were 
reported (De Jesus and Wurm, 2011). Over the past three decades, this has increased almost 50-fold, 
with reported titers now between 3 - 10g/L - this has been achieved mainly from optimisation of 
feeding composition and bioprocess culture systems (Butler and Meneses-Acosta, 2012; Kelley, Kiss 
and Laird, 2018). Media formulations for biopharmaceutical cell culture have been developed to 
ensure sufficient nutrient availability to support healthy cell proliferation and high production 
profiles, while decreasing accumulation of toxic by-products derived from cell metabolism. 
Formulations are also expected to have minimal negative effects on end-product quality, such as 
increased aggregation of proteins or improper glycosylation patterns. Optimisation and research on 
media formulations and feeding compositions are continuously reviewed and updated in order to 
achieve enhanced bioprocessing. Metabolomics studies have become powerful tools in this area, 
identifying key parameters for efficient cell proliferation and product yield to be used for the 
improvement of bioprocesses (Dickson, 2014; Pereira, Kildegaard and Andersen, 2018).  
 
1.1. Removal of serum: Serum-free and chemically-defined media development 
Producer CHO cell lines used during biopharmaceutical production are clonally-expanded colonies 
isolated from a mixed population by using single-cell cloning assays to increase product 
reproducibility. However, these cells grow slowly or often fail to grow when cultured at low cell 
densities, resulting in poor culture performance (Zhu et al., 2012). For this reason, further 
supplements are required in order to sustain cell growth. Fetal bovine serum (FBS) is a rich 
supplement obtained from foetal calves and contains a mixture of all the essential compounds required 
to promote cell proliferation in vitro (van der Valk et al., 2018). Consequently, it was a widely-used 
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additive for CHO culture, consisting of a complex mixture of biomolecules which participate in the 
stimulation of cell proliferation due to the high content of growth factors and hormones (e.g. insulin, 
insulin-like growth factor 1 and 2, fibroblast growth factor, epidermal growth factor). It also acts as 
a source of large amounts of binding proteins which can act as carriers of trace elements, vitamins 
and lipids (e.g. transferrin, albumin). Moreover, these proteins also play a role in the detoxification 
of accumulated by-products, thereby reducing cell death. Proteins, peptides, minerals and cell 
adherence proteins, such as laminin or fibronectin are found in varying concentrations in FBS (van 
der Valk et al., 2004, 2018).  
Despite the advantages provided by this supplement, industrial production of therapeutics for human 
consumption demands the use of serum-free media formulations, mainly due to safety concerns 
arising from serum’s animal-derived origin; these risks include possible viral, mycoplasma and/or 
prion contamination. Additionally, seasonal and continental variability leads to differences between 
batch-to-batch productions that may cause inconsistencies and impact batch productions of the 
eventual therapeutics (Gstraunthaler, 2003; van der Valk et al., 2004). Moreover, serum’s ill-defined 
composition may lead to the inclusion of additional downstream purification steps in order to remove 
contaminating animal proteins (David W Jayme and Smith, 2000). There are also ethical 
considerations with the use of FBS, as blood is extracted directly from the foetal bovine heart and 
processed to produce the serum (van der Valk et al., 2004, 2018). As a consequence of the above, 
several approaches to reduce and replace serum supplementation have been pursued over the years, 
resulting in the development of a range of formulations that can be classified in four types: 1) Serum-
reduced media, the result of initial attempts of serum-free media development which still requires 
low levels of FBS, along with additional supplements to ensure healthy cell growth; 2) Serum-free 
media (SFM), in which serum supplementation is replaced with growth factors and proteins (derived 
or not from animals); 3) Protein-free media (PFM), characterized by the complete removal of high 
molecular weight proteins. However, it may contain small peptides and/or protein hydrolysates; 4) 
Chemically-defined media (CDM), composed by well-defined supplements, which may or may not 
contain recombinant proteins. Additionally, media can be further defined by the term “animal-derived 
component-free media”, indicating an absolute lack of animal-derived supplements (Fig. 3) (David 
W. Jayme and Smith, 2000; Van Der Valk et al., 2010). 
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Fig. 3 Schematic of serum-removed media classification. A serum-free media might be also described 
as chemically-defined media if there is absence of undefined additives (such as hydrolysates) and 
contains recombinant proteins. A medium can be also defined as protein-free and serum-free if the 
formulation has no proteins. Finally, a third media definition includes lack of proteins and undefined 
peptides being then described as serum-free, chemically-defined and protein-free. Moreover, each of 
the formulations used for biopharmaceutical industry tend to avoid the use of animal-derived 
components. Thus, all three can be further classified as animal-derived component-free media.  
 
1.1.1. Basal media 
Media formulations lacking serum supplementation typically differ considerably depending on the 
nutritional requirements of the cell line, the recombinant product generated and the culture system. 
However, the development of a new formulation usually follows the same workflow: selection of the 
most suitable basal media and enrichment of the composition with essential nutritional supplements.  
Historically, the first successful attempt of in vitro tissue culture was based on a mixture of salts 
developed by Ringer and Buxton (named Ringer's solution), who successfully maintained functional 
frogs heart tissue for short periods of time (Yao and Asayama, 2017). Nonetheless, for the culture of 
cells and tissues for longer periods of time, additional supplementation with nutrients and pH 
buffering components was required to complete the formulation (Yao and Asayama, 2017). In 1955, 
Henry Eagle modified the saline solutions being used up until then by adding changing concentrations 
of L-aminoacids, vitamins, cofactors, carbohydrates and salts and tested them on two mammalian cell 
lines, HeLa and L-fibroblasts (Eagle, 1955). With this approach, essential compounds required for 
prolonged cell maintenance were identified, leading to the generation of the Eagle’s Minimal 
Essential Medium (MEM), developed as a base media still requiring low percentages of serum 
CDM
PFMSFM        
No proteins, no 
undefined additives 
Recombinant defined 
proteins with no hydrolysates 
and undefined additives 
Hydrolysates with no 
proteins 
Animal-derived 
component-free 
 10 
 
addition (Eagle, 1955; Van Der Valk et al., 2010). MEM was well-defined and the removal of any of 
the components resulted in cell death. From this basic approach, a chemically-defined formulation 
was sought. In 1963, serum supplemented to media was replaced by a combination of albumin and 
fetuin serum proteins, resulting in the development of Ham’s F10 formulation. This medium was 
described as one of the first to successfully support isolation of single CHO cells in serum-free 
conditions (Yao and Asayama, 2017;  Evans et al. 1956). Further investigations led to the 
development of a completely defined medium by replacing albumin and fetuin for linoleic acid and 
putrescine, resulting in (the still currently used) Ham’s F12 medium (Ham, 1963b, 1963a; Ham, 
1965). Variations of these formulations have since been designed, with DMEM (Dulbecco's Modified 
Eagle's Medium) being one of the most widely used formulas for cell culture. DMEM has a 4-fold 
increase in the quantity of vitamins and amino acid which supports the culture of a broad range of 
mammalian cell lines. Nutrient enrichment was achieved by combinations of these media, resulting 
in the development of the currently commercially-available DMEM-F12. This new formulation has 
been extensively used as a baseline medium for the development of serum-free formulations for 
several CHO cell lines (Van Der Valk et al., 2010; van der Valk et al., 2018). For instance, Huang et 
al. (2017) reported the development and optimisation of a chemically-defined and protein-free 
DMEM-F12-based media for the growth of an autocrine CHO cell line (Super-CHO), reaching up to 
2.6x106 cells/ml (Huang, Marquis and Gray, 2007). Similarly, DMEM-F12 was used as a basal SFM 
for the study of growth promoting agents, identifying insulin-like growth factor 1 (IGF-1) as an 
important growth-stimulating factor for DG44 cells (Chun et al., 2003). Other basal media have been 
studied less extensively, such as alpha-MEM and IMDM. In 1998, a study to develop a producing 
medium for DG44 cells was performed using alpha-MEM. The final product reached maximal viable 
cell numbers of 5.6x105 cells/ml, similar to the densities observed with 5 % FBS-supplemented media 
(Eun Jung Kim, Kim and Lee, 1998). IMDM (Iscove's Modified Dulbecco's Medium) is another 
popular baseline medium, which was derived from MEM (minimal essential medium) by replacing 
iron with potassium nitrate. For this reason, transferrin or protein-free iron chelator, like ferric citrate, 
must be added to support cell proliferation (Lee et al., 1999; Kim et al., 2006).  
In order to generate further enriched formulations, combinations of two or more basal media have 
been also reported in the literature. For instance, Parampalli et al. published a SFM formulation based 
on a mixture of IMDM:Ham’s F12 (1:1) where the concentration of the supplements was optimized, 
resulting in a final 1.4-fold increased viable cell density compared to the control (1.45x106cells/ml) 
(Parampalli et al., 2007). In 2012, a combination of DMEM-F12:RPMI1640 (2:1:1) supplemented 
with amino acids, insulin, putrescine, ferric ammonium citrate and other components was developed 
for GS-CHO cells, reaching a maxim viable cell density of 3.7x106cells/ml in a 5-day culture; similar 
to that achieved in control EX-CELL 302 commercial medium. Moreover, scaling-up the cultures to 
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2L bioreactors displayed reproducible viable cell density profiles when compared to 125ml shake 
flasks (Zhang et al., 2013). 
 
1.1.2. Additives 
Basal media such as DMEM-F12 provides a mixture of organic and inorganic salts, amino acids, trace 
elements, vitamins, carbohydrates, putrescine, lipids and buffering agents essential for basic growth, 
but fails to support cell proliferation at high cell densities. In 1982, Murakami et al. identified insulin, 
ethanolamine, transferrin and selenium (ITES) as four vital additives to support mouse hybridoma 
cell lines in serum-free conditions (Murakami et al., 1982). During early stages of serum-free and 
chemically-defined media, ITES became extensively popular for the growth of mammalian cell lines, 
resulting in a commercially available supplement for SFM development. Further investigations have 
led to the discovery of more chemically-defined additives that promote cell proliferation for long 
periods of time. In the following section, the most widely used supplements for CHO serum-deprived 
media are outlined. 
 
1.1.2.1.  Hormones and growth factors 
Serum is rich in growth factors and hormones which participate in the activation of antiapoptotic and 
cell proliferation signals (Gospodarowicz and Moran, 1976). For this reason, initial attempts to 
sustain cell cultures in serum-free conditions focused on the supplementation of these proteins 
(Hayashi and Sato, 1976). Insulin has been defined as essential to sustain serum-deprived CHO 
cultures when supplemented at supraphysiological levels (1-20 µg/ml), inducing mitogenic signalling 
pathways with the activation of insulin like growth factor 1 (IGF-1) receptor (Keenan, Pearson and 
Clynes, 2006; Van Der Valk et al., 2010; Ritacco, Wu and Khetan, 2018a). Supplementation of IGF-
1 and its analogue LongR3 IGF-1 (Repligen) have been also explored, reporting similar or even 
increased viability profiles when compared to insulin, at lower supplemented concentrations than 
insulin (Morris and Schmid, 2000; Sunstrom et al., 2000). Additional growth factors have been 
identified from a study of conditioned media samples, identifying fibroblast growth factor 8 (FGF8), 
hepatocyte growth factor (HGF) and vascular endothelial growth factor-c (Vegf-c) as growth 
promoting agents (Lim et al., 2013). However, compared to serum and insulin, their growth 
promoting effects are less effective than those reported for insulin.  
To obtain protein-free formulations, the mitogenic effects of zinc and aurintricarboxylic acid (ATA) 
supplementation have been exploited. Insulin-mediated growth-stimulatory effects mimicked by 
zinc-supplementation have been described in several cell lines (Tang and Shay, 2001; V. V. T. Wong 
et al., 2006) including CHO (at 1.5mg/L Zn), although growth in insulin-replaced media was only 
observed with one of the two CHO cell lines tested (Wong, Ho and Yap, 2004). The role of zinc as 
an insulin-mimic has been associated with the activation of phosphoinositide 3-kinase/Akt pathway, 
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with no interaction with the insulin receptor (Ezaki, 1989; Tang and Shay, 2001). Alternatively, the 
antiapoptotic factor ATA has been previously reported as a growth-stimulation factor in PFM for 
CHO cells (Liu, Chu and Hwang, 2001a; Miki and Takagi, 2015). ATA has been described to induce 
its mitogenic activity through the activation of IGF-1 receptor response in a similar manner as insulin 
(Beery et al., 2001). 
 
1.1.2.2. Carbon sources 
In most serum-free media, glucose is the main source of carbon and energy supplement for CHO 
cells. Industrial media compositions contain amounts at a range from 25 - 35mM. Variations of these 
glucose concentrations over or below the typical limits described have been shown to have an impact 
on the specific growth rate, productivity, nutrient consumption and product quality of CHO cells 
(Altamirano et al., 2000; Wong et al., 2005). From metabolic studies, it is widely known that CHO 
cultures in exponential phase consume glucose in large quantities which is converted to lactate 
through glycolysis, even in the presence of oxygen (Warburg effect) (Dickson, 2014). Limiting-
glucose feeding approaches have been described to elongate the viabilities of the cultures though the 
reduction of lactate accumulation and without changing the transcriptomic expression of the cells 
(Wong et al., 2005; Gowtham, Saski and Harcum, 2017). However, low specific growth and 
productivities are usually displayed as a result. Alternatively, glucose supplementation above 40 mM 
has been reported to increase specific productivity but to cause an accumulation of lactate that results 
in decreased specific cell growth (Lee et al., 2015). For this reason, levels of glucose supplementation 
are usually maintained at 30 mM in growing cultures (Vergara et al., 2018). 
In order to reduce lactate accumulation, “slow metabolised” sugars, such as galactose, mannose or 
fructose, have been also tested. Complete replacement of glucose for either galactose or fructose has 
been reported to reduce cell growth and/or productivity, while mannose-containing cultures achieved 
similar specific growth rates compared to cultures in glucose-supplemented medium (Altamirano et 
al., 2000).  
L-glutamine is an important nutritional component of culture media, playing an essential role as a 
protein precursor as well as an important alternative energy source to glucose (Van Der Valk et al., 
2010). However, L-glutamine represents the main source of ammonia by-product, released for either 
its spontaneous breakdown or metabolism (Jagušić et al., 2016). In order to overcome the lack of 
stability of this essential amino acid, dipeptides of L-alanine‐glutamine (commercially available as 
Glutamax) or glycyl‐glutamine have been developed, increasing the stability of the amino acid 
(Imamoto et al., 2013; Ha and Lee, 2015). Alternative sources such as glutamate or pyruvate have 
been also used as replacements for glutamine, reporting substantial reduction in ammonium secretion 
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(Genzel et al., 2008) and increased productivity profiles compared to non-supplemented cultures 
(Hong, Cho and Yoon, 2010). 
 
1.1.2.3. Iron sources 
Iron is essential for cell cycle progression, growth and division due to its involvement with many 
proteins and enzymes that participate in cell replication. Lack of iron supplementation results in G1/S 
phase arrest, reduction of cell growth and eventual cell death (Yu, Kovacevic and Richardson, 2007). 
However, excessive supplementation also may have detrimental effects. In media, free iron ions are 
highly reactive and may produce ROS species by Fenton redox-cycle reaction, damaging the cells 
(Graham, Bhatia and Yoon, 2019). For this reason, transferrin, the natural iron-chelating protein is 
supplemented in serum-free media formulations (Butler M. et al. 2015). Alternatively, in chemically-
defined and protein-free media, iron has been delivered in the form of ferric citrate, ferric ammonium 
citrate, ferric sulphate, ferric ammonium sulphate or ferric gluconate (Zhang, Robinson and Salmon, 
2006; Bai et al., 2011; Zhang et al., 2013). Sodium selenite has been also described as an effective 
iron-carrier, reporting final cell densities of 10x106 cells/ml and mAb yields of 3 g/L in a 14-day fed-
batch (Zhang, Robinson and Salmon, 2006). Another example is the iron chelating agent tropolone, 
which has not been extensively used in CHO due to patent protection (Zhang, Robinson and Salmon, 
2006). It is noteworthy that, due to the essential nature of this micronutrient, basal media are routinely 
supplemented with traces of iron sources, such as DMEM-F12. However, as described above, 
additional supplementation to PFM and CDM has been observed necessary in order to improve 
cellular proliferation. 
 
1.1.2.4.  Trace elements 
Most trace metals are already part of basal media formulations, such as DMEM-F12. It is noteworthy 
that, even though supplemented at very low levels, metals are essential to sustain healthy cell growth 
in vitro, being involved in many roles: regulatory factors, cellular respiration control, protection 
against oxidative stress and anti-apoptotic agents, among many others (Tan et al., 1984; Gong et al., 
2001; Piret et al., 2004; Chaderjian et al., 2008a; Yuk et al., 2014; Kim and Park, 2016).  
Importantly, analysis of the composition of trace metals between two lots of SFM, revealed significant 
variations in copper, zinc, selenium and cobalt levels (Keenan et al., 2018). These fluctuations have 
been associated with variations in the source and batch of raw materials used for the development of 
SFM formulations, such as hydrolysates (presence of iron salts) and insulin (zinc sometimes used as 
stabiliser). Metals leaching from glass and stainless steel vessels have also been reported, causing 
variability in media composition (reviewed in Graham, Bhatia and Yoon, 2019). Due to the vital 
involvement of metals in key cellular processes, alterations in culture performance may be observed 
in SFM as a consequence of small variations on the levels of these trace elements. 
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The most widely used trace metals for SFM development are copper, zinc and selenium, present as 
traces in basal media formulations. Supplementation of manganese, cobalt and other trace metals such 
as molybdenum and vanadium have been also reported with lower impact. Details on the role of these 
micronutrients are given below. It is also worth noting that further information and strategies for 
media optimisation based on trace metals addition are described in the next section. 
 
1.1.2.4.1. Copper 
Copper is an essential micronutrient for cell growth, being related to oxidative respiration and shift 
to lactate consumption during the stationary phase, thus elongating cell culture (Chaderjian et al., 
2008b; Luo and Pierce, 2012; Yuk et al., 2014; Yuk, Russell, Tang, W. T. Hsu, et al., 2015; Xu, 
Hoshan and Chen, 2016). Copper plays an essential role in the electron transport chain, being a 
cofactor of the cytochrome c oxidase subunit of complex IV (Kang et al., 2014a). Low levels of this 
metal in media have been associated with a reduced number of complex IV (Kang et al., 2014a) and 
increased lactate dehydrogenase function, thus accumulating lactate in the medium (Zagari et al., 
2013a; Kang et al., 2014a; Nargund, Qiu and Goudar, 2015a). Following supplementation of copper 
concentrations above a defined threshold (13nM), induction of a metabolic shift to lactate 
consumption has been reported (Yuk, Russell, Tang, W.-T. Hsu, et al., 2015), resulting in improved 
viable cell density, viability and productivity profiles (Luo et al., 2012). However, reduced viabilities 
(82-90 %) have been observed in DUX-B11 cells cultured in serum-free conditions with 
concentrations of 50-100 µM Cu (Chaderjian et al., 2005). In fact, increased production of reactive 
oxygen species (ROS) are associated with high copper concentrations in culture (Camakaris et al., 
1995). 
 
1.1.2.4.2. Zinc 
Being involved on the activation and function of more than 300 enzymes and transcription factors, 
supplementation with sufficient zinc concentrations is required for proper cell proliferation. The 
importance of this micronutrient in CHO cell growth was reported by Xu et al. Using design of 
experiments (DoE), ZnS04 (at 1mg/L) was identified as one of three most significant supplements 
inducing growth-promoting effects in CHO-K1 cultures in a CDM (Xu et al., 2014). Zinc has been 
described as a powerful antioxidant in culture (Marreiro et al., 2017), acting as a co-factor of 
superoxide dismutase, inducing the expression of glutathione, activating the metal transcription factor 
1 – which plays an important role in regulating oxidative stress – and protecting from lipid 
peroxidation (Marreiro et al., 2017). Zinc has been also observed to display anti-apoptotic properties 
in bioreactor-relevant conditions (Cotter and Al-Rubeai, 1995) and to stimulate glucose uptake 
(Ezaki, 1989). Zinc involvement in mRNA stability has been also reported, mediated by the 
interaction of zinc-finger proteins with nucleic acids (Taylor and Blackshear, 1995; Buchner et al., 
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2015), while a beneficial effect on product titer in CHO has been also described following 
supplementation of zinc at high concentrations (Kim and Park, 2016).  
 
1.1.2.4.3. Selenium 
Selenium has been identified as an essential supplement for mammalian cell culture as well as in 
serum-deprived conditions, enhancing the healthy growth of cells (Mckeehan, Hamilton and Ham, 
1976; Lebkowski, Schain and Okarma, 1995). It is extensively used for serum-free media 
development, with concentrations as low as 20 µg/L commonly supplemented (E J Kim, Kim and 
Lee, 1998; Kim, Kim and Lee, 1999; Lee et al., 1999; Schröder, Matischak and Friedl, 2004). 
Selenium has been described to participate in oxidative-stress protection, constituting selenocysteine-
containing proteins such as glutathione peroxidase and glutathione synthetase (Köhrle et al., 2000; 
Schomburg, Schweizer and Köhrle, 2004). Detoxification of peroxide oxygen radicals by the 
activation of anti-apoptotic pathways has been also observed, promoting longevity of the cultures and 
improved growth profiles (Yoon et al., 2002). Moreover, selenium has been described to play an 
essential role in MAPK pathway and therefore to induce mitogenic growth effects (Zeng and Combs, 
2008).  
 
1.1.2.4.4. Cobalt 
Supplementation of cobalt to culture media has been shown to induce hypoxia-like conditions, 
resulting in the stimulation of glucose uptake and glycolytic pathways. Moreover, antiapoptotic 
protection following serum-deprivation has been also observed in HepG2 cells (Gong et al., 2001; 
Piret et al., 2002, 2004; Torii et al., 2011). In 2014, cobalt was reported to modify the galactosylation 
patterns of a mAb for two CHO cell lines. However, this effect was substantially lower compared to 
manganese supplementation and each cell line presented different sensitivities to the metal, with 
decreased product titer observed at concentrations above 50 µM for cell line 1, but a similar 
phenotypic threshold concentration for cell line 2 was observed at just 5 µM (Hossler and Racicot, 
2015).  
 
1.1.2.4.5. Manganese 
Manganese has been described as an antioxidant, acting as a cofactor of manganese superoxide 
dismutase (Mn-SOD) – a mitochondrial enzyme that eliminates reactive oxygen species by 
conversion into oxygen and hydrogen peroxide (Kaewpila et al., 2008). Manganese plays an 
important role in the regulation of galactosylation and glycosylation processes and for this reason, 
this metal is usually supplemented in serum-free media formulations to enhance product 
glycosylation patterns (Kaufman, Swaroop and Murtha-Riel, 1994; Crowell et al., 2007; Hossler, 
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Khattak and Li, 2009; Graham, Bhatia and Yoon, 2019). However, no effects on cell growth were 
observed in a separate study with supplementations up to 100 µM (Gawlitzek et al., 2009a).  
 
Other trace metals, such as vanadium has also been described to increase cell growth (Ritacco, Wu 
and Khetan, 2018b). 
 
1.1.2.5. Amino acids 
As the starting building blocks for the construction of proteins, amino acids are required for cell 
proliferation and productivity. In response to amino acid-limiting conditions, activation of several 
pathways is observed to decrease the overall cellular translation and induce ER-stress (Kilberg et al., 
2005). Nonetheless, excessive amino acid addition increases media osmolarity and accumulation of 
by-products such as ammonia, therefore resulting in reduced cell growth (González-Leal et al., 2011). 
For this reason, to achieve healthy CHO cell cultures, most amino acid levels have to be maintained 
within specific ranges. Moreover, optimal amino acid supplementation levels vary between cell lines, 
culture systems and compositions of the recombinant protein being produced (Fomina-Yadlin & 
McGrew, 2014). Several studies have demonstrated the effectiveness of adjusting amino acid 
supplementation to achieve high titer and viable cell densities. For example, threonine has been 
reported to alleviate stressing conditions such as high ammonium, dissolved CO2 and osmolality 
effects, resulting in increased VCD and titer profiles (Chen and Harcum, 2005).  
Some amino acids have relatively low solubility and stability, such as tryptophan, glutamine, cysteine 
and tyrosine. To improve their properties and to avoid accumulation of toxic substances derived from 
their breakage, storage of media protected from light participated in maintaining tryptophan levels 
(Mcelearney et al., 2016). The replacement of such amino acids for derivatives has been also 
performed, such as tyrosine-containing dipeptides to improve tyrosine solubility (Kang et al., 2012) 
or s-sulfocysteine, reported to replace cysteine and act as an anti-oxidant in CHO culture media 
(Hecklau et al., 2016). 
 
1.1.2.6. Lipids 
Lipids are an essential constituent of membrane structure acting as cellular stabilizers. Moreover, 
lipids can serve as an energy supply and roles in cellular transport and signalling have also been 
previously described (Ritacco, Wu and Khetan, 2018b). Exogenous addition of lipid is not essential 
for CHO culture. However, increased viable cell density and viability profiles are achieved with the 
addition of the mitogenic lipid lysophosphatidic acid, in the absence of growth factors (Miki and 
Takagi, 2015). Supplementation with ethanolamine phospholipids, major constituents of the cellular 
membrane, has been described to enhance cell proliferation of CHO cells in serum-free media 
formulations (Zhang et al., 2013). Increased CHO growth has been also reported with the 
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supplementation of phosphatidylcholine in serum-free formulations (Sung et al., 2004; Kim and Lee, 
2009), which may have an important role in maintaining the integrity of the cellular membrane 
(Castro et al., 1996). Addition of linoleic acid has been previously reported to stimulate growth of 
CHO cells and supporting cultures for a minimum of 4 subcultures (Eun Jung Kim, Kim and Lee, 
1998). However, linoleic acid is typically supplemented bound to BSA in most of the publications 
(Liu, Chu and Hwang, 2001b; Liu and Chang, 2006). Addition of fatty acids and cholesterol can be 
also performed by using soluble derivates or including small amounts of ethanol. However, high 
concentrations may induce lipotoxicity in CHO cells (Ritacco, Wu and Khetan, 2018b).  
 
1.1.2.7. Vitamins 
Vitamins are essential media additives required in small amounts for cell culture. Vitamins have been 
described to act as enzyme cofactors, biological antioxidants, prosthetic groups or even as hormones 
(Schnellbaecher et al., 2019). Due to their vital roles, vitamins are normally supplemented in basal 
media formulations, such as DMEM-F12, DMEM or RPMI 1640 (Van Der Valk et al., 2010). More 
interestingly, modification in vitamin content has been also reported to enhance growth and titer of 
CHO cell lines (Kim et al., 2005; Zhang et al., 2013).  
Importantly, several factors such as light, heat, oxygen, or reactive oxygen species (ROS) can 
compromise the stability of some vitamins. For this reason, protection of media from the light and 
heat are essential considerations for the proper maintenance of media (Schnellbaecher et al., 2019). 
 
1.1.2.8. Surfactants 
In suspension, CHO-derived cell lines can spontaneously aggregate forming large clumps of cells. 
This effect causes detrimental effects due to the limited availability of oxygen and nutrients for the 
inner cells of the clump (Jing et al., 2016). As a result, several anti-clumping agents have been 
described in the literature which seek to inhibit cell clumping in serum-deprived conditions. Several 
mechanisms of cellular aggregation in suspension culture have been described: DNA released from 
apoptotic cells (Renner et al., 1993), extracellular cell adhesion molecules such as NCAM (neural 
cell adhesion molecule) (Zanghi et al., 1998; Yamamoto et al., 2000) and high amounts of calcium 
(Peshwa et al., 1993). Some examples of the most commonly used additives include Pluronic F68, 
poly vinyl alcohol (PVA), dextran sulphate and suramin (Michaels and Papoutsakis, 1991; Zanghi et 
al., 2000; Jing et al., 2016). Pluronic F68 has been also reported to improve CHO cell growth, 
viability and productivity (Clincke et al., 2011).  
 
1.1.2.9. Polyamines 
The polyamines spermine, spermidine and putrescine are vital for cell growth and cell cycle 
progression and also participate in pathway signalling and apoptosis protection (Igarashi and 
 18 
 
Kashiwagi, 2019). Intracellularly, polyamines are found interacting mainly with RNA but also with 
DNA, participating in the regulation of gene expression and protein transcription (Igarashi and 
Kashiwagi, 2019). In mammalian cells, polyamine production starts with arginase, an enzyme 
catalysing the conversion of L-arginine to L-ornithine, which is the substrate for ornithine 
decarboxylase to generate putrescine (Fig. 4). The latter is then used for the synthesis of spermine 
and spermidine. In CHO, supplementation of putrescine to serum-free formulations is essential to 
sustain healthy cell growth due to the lack of expression of arginase (Hölttä and Pohjanpelto, 1982). 
It is also worth noting that further investigation by Hölttä and Pohjanpelto (1982) revealed arginase 
activity in several sources of serum, masking the vital requirement of polyamines for culture 
progression.  
 
Fig. 4. Schematic of the initial stages of polyamine biosynthesis: arginase and ornithine 
decarboxylase. 
 
Some basal media such as DMEM-F12 already contain traces of putrescine. However, the level is not 
sufficient to support CHO growth, requiring further supplementation (Hölttä and Pohjanpelto, 1982). 
Spermine and spermidine have been also shown to enhance growth rate and viability of CHO cells 
(Spearman et al., 2016). However, high intracellular polyamine content increases activation of 
catabolism pathways, accumulating toxic by-products that can trigger endoplasmic reticulum stress 
and eventually apoptosis (Zahedi et al., 2017; Dever and Ivanov, 2018). Consequently, polyamine 
content in media has to be controlled below toxic levels (at least, lower than 1mM) (Pastorian and 
Byus, 1997).  
 
1.2. Media additives strategies for CHO optimisation 
Optimisation of media formulation has been a key strategy over many years to enhance CHO 
performance. Some of the strategies to improve CHO viable cell densities, titer and specific 
productivities include the use of peptones and hydrolysates, alternative carbon sources, 
supplementations at increased concentrations or the addition of small molecules and epigenetic 
modifiers (Table 1). In the following section, some of these approaches are further detailed. 
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 Table 1. Some media strategies reported to enhance CHO performance in terms of growth, viability 
and/or productivity. 
Supplementation 
strategy 
Cell Line Phenotype Reference 
Peptones and 
hydrolysates 
   
Yeast hydrolysates DUKX-B11 expressing 
human thrombopoietin 
Increased specific productivity 
rate, extended culture longevity, 
higher viability 
Y. H. Sung, 
Chung, Lee, & 
Lim, 2004 
Soy protein 
hydrolysates 
DG44 Enhanced cell growth and 
viability 
hun, Kim, Lee, 
& Chung, 2006 
Wheat peptones rCHO-K1 expressing 
human interferon-γ 
Improved cell growth and 
productivity 
Burteau et al., 
2003 
Combinations of 
wheat, soy and casein 
peptones 
DG44 expressing an 
IgG mAb 
Increased volumetric productivity 
and cell number 
Davami, Baldi, 
Rajendra, & M 
Wurm, 2014 
Yeast extract rCHO-K1 expressing 
Fc-fusion protein 
Increased specific productivity Hu et al., 2015 
Combinations of 
yeastolate, soy and 
wheat gluten 
hydrolysates 
DG44 and DUKX-B11 
expressing mAbs 
Increased cell growth (soy and 
wheat) or specific productivity 
(yestolate) 
S. H. Kim & 
Lee, 2009 
Yeast peptones CHO-AMW expressing 
mAb 
Increased cell growth rate, high 
cell densities and improved 
production 
Mosser et al., 
2013 
Small molecules    
Sodium butyrate 
(NaBu) 
rCHO expressing 
recombinant human 
thryrotropin 
Increased volumetric productivity Damiani, 
Almeida, 
Oliveira, 
Bartolini, & 
Ribela, 2013 
Lithium chloride (LiCl) DUKX-B11 expressing 
Fc-fusion protein 
Increased specific productivity Ha, Kim, & Lee, 
2014 
Aurintricarboxylic acid 
(ATA) 
rCHO expressing Fc-
fusion protein 
Induced proliferation under 
insulin-free conditions 
Liu, Chu, & 
Hwang, 2001 
Valeric acid rCHO-K1 expressing 
mAb 
Increased culture longevity and 
specific productivity 
Park, Noh, Woo, 
Kim, & Lee, 
2016 
Valproic acid DHFR-derived CHO 
cell line expressing a 
mAb 
Increased titer Yang et al., 2014 
Trace metals    
Iron Citrate rCHO expressing a 
mAb 
Enhanced titer Bai et al., 2011 
Copper DXB11 expressing a 
mAb 
Increased product titers, shift to 
lactate consumption 
Yuk et al., 2015 
Copper rCHO expressing a 
mAb 
Increased VCD and titer, shift to 
lactate consumption 
Qian et al., 2011 
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Copper and iron DG44 expressing a 
mAb 
Increased VCD, viability and titer Qian et al., 2014 
Manganese CHOK1SV and 
DUXK-B11 expressing 
mAb 
Galactosylation patterns Grainger & 
James, 2013 
Pacis, Yu, 
Autsen, Bayer, 
& Li, 2011 
Copper and manganese rCHO expressing a 
mAb 
Increased product quality 
(reduced tryptophan oxidation) 
Hazeltine et al., 
2016 
Zinc and manganese DG44 expressing a 
mAb 
Galactosylation patterns Prabhu, Gadre 
and Gadgil, 
2018 
Zinc DG44 expressing a 
mAb 
Increased titer B. G. Kim & 
Park, 2016 
Alternative carbon 
sources 
   
Combinations of 
glucose, galactose 
and/or glutamate 
rCHO Tissue 
plasminogen activator 
Increased viability and 
productivity 
Altamirano et 
al., 2000, 2004 
Glucose and galactose DHFR-derived 
expressing a mAb 
Increased viable cell density and 
specific productivity 
Sun et al., 2013 
Others    
Rapamycin rCHO-K1 and DG44 
expressing a mAb 
Extended viability profiles and 
increase mAb titer 
Lee and Lee, 
2012; 
Dadehbeigi and 
Dickson, 2015 
Dichloroacetate (DCA) rCHO-K1 expressing a 
mAb 
Extended lifespan, increased titer 
and viable cell density 
Buchsteiner et 
al., 2018 
 
1.2.1. Peptones 
Enhancement of growth and productivity profiles has been pursued with a range of feed/media 
additives. Plant peptones and hydrolysates derived from sources such as rice, wheat, soy, pea and 
yeast hydrolysates have been added to serum-free media (SFM) in CHO cell lines, demonstrating 
subsequent enhancement of viable cell density (Chun et al., 2006), as well as specific-productivity 
and/or final titer of recombinant proteins such as IFN-γ (Burteau et al., 2003), human thrombopoietin 
(Sung et al., 2004) and a range of mAbs (Kim and Lee, 2009; Mosser et al., 2013; Davami et al., 
2014; Hu et al., 2015). However, supplementation with these products introduces undefined elements 
to the media, leading to possible batch-to-batch variability that may affect cellular performance in the 
bioreactor (McGillicuddy et al., 2018).  
 
1.2.2. Small molecules 
A more “chemically-defined” approach has seen the use of chemical reagents, including the 
extensively reviewed sodium butyrate (NaBu) as well as several other reagents (valeric acid, valproic 
acid (VPA), lithium chloride, dimethyl sulphoxide (DMSO)) (Liu, Chu and Hwang, 2001a; Damiani 
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et al., 2013; Ha, Kim and Lee, 2014; Yang et al., 2014; Park et al., 2016), with the aim of improving 
titer of several therapeutically-relevant proteins in CHO cultures. However, the specific productivity 
effects observed with most of these chemicals (NaBu, DMSO, VPA) is frequently associated with 
cytotoxic effects resulting in reduced cellular growth (Sung, Hwang and Lee, 2005; Park et al., 2016). 
 
1.2.3. Trace metals 
Supplementation of media with certain metals has revealed great potential to induce beneficial CHO 
performance features such as improved growth, specific productivity and viability profiles in culture. 
Increased mAb titers have been reported in CHO supplemented with iron-citrate (Bai et al., 2011), 
while supplementation with copper has been extensively reported to increase product titer and to 
extend the lifespan of CHO cultures due to a shift to lactate consumption (Luo et al., 2012; Zagari et 
al., 2013b; Kang et al., 2014b; Nargund, Qiu and Goudar, 2015b; Yuk, Russell, Tang, W.-T. Hsu, et 
al., 2015). Co-supplementation of copper and iron during the scale-up stage has been observed to 
improve cell growth, viability and IgG productivity of CHO cultures. This effect was a consequence 
of the upregulated expression of hypoxia-inducible factor 1 alpha induced by copper (Qian et al., 
2014). Manganese supplementation has been used to modulate the glycosylation patterns of mAb 
(Gawlitzek et al., 2009b; Pacis et al., 2011; Grainger and James, 2013). Reduced tryptophan oxidation 
by manganese and copper supplementation in an IgG4-biopharmaceutical producing CHO culture 
(with no effects on titer or VCD) has also been reported (Hazeltine et al., 2016). Moreover, high zinc 
supplementation to a DG44 culture growing in an in-house and commercial PFM and CDM media 
has been reported to induce up to 6.5-fold increased mAb titer (Kim and Park, 2016). However, a 
suitable ratio between zinc and manganese concentrations has to be achieved in order to obtain proper 
galactosylation patterns (Prabhu, Gadre and Gadgil, 2018). 
 
1.2.4. Reducing by-product accumulation 
As described in the previous sections, accumulation of toxic by-products – primarily lactate and 
ammonium from glucose and glutamine metabolism - is detrimental for CHO cultures (Lao and Toth, 
1997) and approaches to reduce their production have been thus pursued. Combination of the slowly-
metabolised carbon source galactose with glutamate have been reported to dramatically reduce lactate 
and ammonia accumulation, but at a cost of decreased CHO viable cell density profiles (Altamirano 
et al., 2000; Altamirano, Cairó and Gòdia, 2001). In a follow-up study, alternation of the carbon 
source between glucose and galactose alongside the replacement of glutamine by glutamate was 
observed to increase viability, longevity and t-PA production (Altamirano et al., 2004). Similarly, 
Sun et al. reported increased cell density, specific productivity and a lactate switch following glucose-
galactose feeding (Sun et al., 2013). Indirect increased expression of pyruvate dehydrogenase using 
the inhibitor dichloroacetate (DCA) was reported to result in increased viable cell density, culture 
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length and final mAb yield, which was observed to be as a consequence of decreased lactate 
production and glucose consumption profiles (Buchsteiner et al., 2018).  
 
2. Culture strategies 
As biopharmaceutical manufacturing culturing strategies developed, batch was the first and the 
easiest mode of operation; where cells are cultured until the available nutrients are exhausted, closely 
followed by cell viability and growth drops, when product is harvested and purified through 
downstream processes (Bielser et al., 2018). A second system is fed-batch. This mode of operation is 
currently the main workhorse in the biopharmaceutical industry, with feeding strategies targeting the 
control of by-product accumulation (such as lactate or ammonia) and supplementation of nutrient 
levels to suffice cell metabolic requirements (Kelley, Kiss and Laird, 2018; Mellahi et al. 2019). 
Consequently, typical fed-batch culture duration is longer than in batch mode and consequently 
reaches higher product yields at similar volumes. A third system (continuous/perfusion) is described 
by constant feed of media and removal of bioreactor content, with a retention of cells into the 
bioreactor (Bielser et al., 2018). A recent combinatorial approach of perfusion and fed-batch systems 
has also been described, with sustained increased viable cell densities leading to almost 2-fold higher 
titers compared to fed-batch production, which was tested in five mAb-producer CHO cell lines 
(Hiller et al., 2017). Recently, perfusion culture system has shown potential achieving increased cell 
densities and high volumetric productivities compared to fed-batch production (Bielser et al., 2018). 
This intensified culture performance is so dramatic that it can result in the design of smaller 
production plants for similar output levels (Bielser et al., 2018). Moreover, continuous removal of 
recombinant protein from the culture vessel can also help increase the stability of the products 
(Kelley, Kiss and Laird, 2018). However, possible technical issues (such as microbial contamination 
and technical failure), difficulties in mixing high cell density vessels and downstream train 
bottlenecks are still issues that need to be fully addressed to facilitate the successful application of 
continuous production systems (reviewed in Bielser et al., 2018; Kelley, Kiss and Laird, 2018). 
 
2.1. Culture parameters 
CHO cells are very robust, adapting easily to changes in pH, temperature, osmolality, oxygen and 
pressure. This has allowed development of strategies to increase titre and cell growth by altering some 
of the parameters described above (Gagnon et al., 2011; Nasseri et al., 2014). One of the most 
extensively-studied strategies consists of the use of mild hypothermia (30 - 350C) or “cold-shock” at 
advanced stages of the culture in order to induce increased specific productivities (Becerra et al., 
2012; Bedoya-López et al., 2016; Zhou et al., 2018). However, variability in product quality attributes 
such as glycosylation and charge heterogeneity have been reported in low temperature cultures, which 
must be considered when applying this approach (Zheng et al., 2018). Additionally, induction of 
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metabolic switch to lactate consumption has been related to increased productivity profiles (Le et al., 
2012). A pH – glucose feeding strategy has also been developed, generally resulting in higher peak 
viable cell densities and process productivity (Gagnon et al., 2011). The method, named as HiPDOG 
(Hi‐end pH delivery of glucose), involves the continuous monitoring and control of glucose 
concentrations at very low levels based on changes in pH (Gagnon et al., 2011). Enhancing CHO 
performance through various culture strategies has been facilitated by the development of process 
analytical technologies providing in situ adjustment of the essential parameters (pH, CO2, oxygen) 
(Teixeira et al., 2009), enabling more controlled production processes. 
 
3. Cell line development  
In the biopharmaceutical industry, production of therapeutics relies on the generation of stable cell 
lines following two main technologies: dihydrofolate dehydrogenase (DHFR) and glutamine 
synthetase (GS). The DHFR-deficient DG44 and DUXB11 cell lines are commonly used for DHFR-
selection system, while the GS system can be equally used in GS-deficient or parental CHO cells 
(Dumont et al., 2016), in which case methionine sulfoximine (MSX) selection pressure is applied. To 
achieve high producing populations, the use of methotrexate (MTX), a DHFR inhibitor, is included 
to increase the stringency of the selection. Similarly, for the GS system, MSX inhibitor is 
supplemented. However, several rounds of incrementing MTX concentrations are usually required, 
resulting in a 5-6 months selecting process (Goh and Ng, 2018). Compared to DHFR, the GS system, 
selection in glutamine-free medium reduces the accumulation of ammonia in the medium and thus is 
advantageous in maintaining healthy cultures (Edmonds et al., 2006).  
The process begins with the design of an expression vector encoding for the recombinant protein and 
the complimentary marker (DHFR or GS) (Fig. 5). Selection of transfected populations is then 
performed in media depleted of either thymidine, hypoxanthine (DHFR system) or glutamine (for GS 
system), resulting in only the survival of the transfected population. An amplification step is then 
performed in order to obtain high producer populations, using the enzyme inhibitors MTX or MSX. 
In order to survive, cells suffer multiple genomic rearrangements, resulting in increased copy number 
of DHFR or GS (depending on the system used) and also of the heterologous protein. Consequently, 
an heterogeneous pool of cells expressing at different levels and rates is obtained and clonal isolation 
is then performed. Hundreds of clones are screened and only the ones displaying the highest specific 
productivity and growth rates are selected to be expanded. Clonal-derived populations are then 
cultured for several passages and re-assessed for growth and productivity to finally select the best 
performing cell line for large scale production (Lai, Yang and Ng, 2013; Le et al., 2015). 
Development of stable cell lines is a laborious, time-consuming and costly process, generally lasting 
between 6 to 12 months (Gutiérrez-Granados et al., 2018).  
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Fig. 5 Stable cell line development. Image obtained from (Lai, Yang and Ng, 2013). 
 
Advances in cell line development technologies are mainly focused on reducing the timeline of the 
process. Random transgene integration into transcriptionally active loci is one of the major 
challenges. To enhance the expression of heterologous protein, several approaches have been 
developed. For example, site-directed integration into productive chromosomal spots (“hot spots”) 
(using e. g. CRISPR-cas or Cre/Lox systems) (Le et al., 2015; Kelley, Kiss and Laird, 2018) or 
inclusion of chromosomal elements results in an enhancement of transgene transcription (e. g. matrix 
attachment regions (MARS) and ubiquitous chromatin opening elements (UCOEs)) (Lai, Yang and 
Ng, 2013). Other strategies focus on increasing the stringency of the selection process in order to 
increase gene copy number, using attenuated selection markers or controlling the expression of the 
selection marker by an internal ribosome entry site (IRES) (Le et al., 2015; Zhu and Hatton 2018).  
Assurance of clonal-derived cell lines is demanded by regulatory agencies to ensure reproducibility 
over the production process of product quality attributes. For this reason, several rounds of limiting-
dilution cloning or validating the use of a single cell by image analysis are common strategies during 
the single-cell cloning step (Kelley, Kiss and Laird, 2018; Welch and Arden, 2019). Automated high-
throughput platforms have been also developed, enabling the screening of large numbers of plates 
(Priola et al., 2016).  
Large amounts of recombinant protein (at gram level) can be also produced by transient gene 
expression (TGE). This approach consists on the transfection of an exogenous recombinant protein 
with no subsequent selection, resulting in very short production processes with recombinant protein 
expressed after 7-14 days. However, lack of selection pressure leads to an eventual loss of vector 
expression. Currently, TGE technology plays an important role during the early stages of 
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biopharmaceutical development, but still presents some limitations for large scale production (such 
as regulatory acceptance, media suitable for transfection and production, large quantities of DNA 
required) (Zhu, 2012). 
3.1. Cell line engineering – tools and strategies  
Some of the genetic engineering strategies for the enhancement of CHO culture performance have 
focused on the modification of pathways related to cell growth and protein production. For instance, 
overexpression of genes involved in cell proliferation, cell cycle, anti-apoptotic responses or the 
mTORC1 pathway have resulted in increased lifespan of cultures, increased growth and final product 
yields (D. C. F. Wong et al., 2006; Kuystermans and Al-Rubeai, 2009; Dreesen and Fussenegger, 
2011). A major bottleneck for CHO recombinant protein production is protein processing and 
secretion, suggested from the lack of correlation between gene copy number and final protein titer 
reported. Thus, modifications in the unfolded protein response, endoplasmic reticulum chaperones 
and vesicle transporters have also been extensively studied in CHO (reviewed in (Zhou et al., 2018)). 
Metabolomic engineering has been also employed in an attempt to decrease toxic by-product 
accumulation. For example, strategies to decrease lactate production have been achieved by the 
overexpression of fructose transporter (GLUT5) a component of the malate-aspartate shuttle 
(Aralar1) or pyruvate carboxylate (PYC2) (reviewed in Pereira, Kildegaard and Andersen, 2018). 
Over the past few years, enormous advances in genome-editing technologies have been achieved, 
facilitating the generation of modified producer CHO cell lines. These include miRNAs and sponge 
tools, CRISPR/cas9 and RNAi knock-out technologies, zinc fingers nucleases (ZFN) and 
transcription activator-like effector nucleases (TALENs) (reviewed in Fischer, Handrick and Otte, 
2015). Together with the availability of the CHO-K1 and Chinese hamster genome sequences 
(Brinkrolf et al., 2013; Lewis et al., 2013; Xu et al., 2011), these advances in the field have provided 
new opportunities for further genetic improvement of these cell lines. 
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Preface to the Chapters 
In-house serum-free media development 
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Over several years, CHO product yields and culture performance have remarkably improved 
following directed development efforts by the biopharmaceutical industry. A key strategy driving 
these improvements has been the development and optimisation of media formulations. However, 
due to commercial sensitivities around disclosing formulations, industry knowledge regarding the 
efficacy of particular additives or combinations have remained confidential and progress in this area 
is typically not disclosed. Consequently, knowledge of media additives routinely used in commercial 
media is limited in the research sector, reducing efficiency during investigation of media additives 
for CHO culture enhancement or product quality and resulting in potentially repetitive, time-
consuming processes. Moreover, the addition of certain media supplements can negatively impact 
basic culture techniques, such as  transfection efficiencies or affect proteomic sample analysis in mass 
spectrometry and these negative impacts tend to be unknown to wider research community. For these 
reasons, a substantial portion of my research focused on the study of media development for CHO 
and the growth- and production-enhancing effects of selected additives.  
During the initial steps of my research project, development of an in-house serum-free medium for 
CHO cell growth was performed following two approaches described in Fig. 6 and 7. The CHO-K1 
parental cell line was chosen as a model cell line and growth was analysed in 5 ml working volume 
cultures in batch conditions. Cultures were adapted to each testing media prior to cell growth and 
viability assessment (2 to 3 passages), to ensure reproducibility of the results.  
 
 
Fig. 6. Workflow for the development of an in-house serum-free medium (SFM) for growth. The 
process was divided into 4 stages: 1. Basal media; 2. Initial media; 3. Iron Sources; 4. Trace Elements 
(Preliminary tests). The following abbreviations are indicated: basic additives (BA), 
lipids/polyamines (LP), anticlumping agents (AC), ferric ammonium sulphate (FAS), ferric 
ammonium citrate (FAC), ferric citrate (FC), alternative anti-clumping (alternative AC). 
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1. Approach 1 –Addition - SFM development  
Following a thorough literature survey focusing on serum-free, protein-free and chemically-defined 
media development for CHO, an in-house SFM was designed. DMEM-F12 medium was used as basal 
medium (J Van Der Valk et al. 2010; C.-H. Liu and Wu 2009; Egorova-Zachernyuk, Bosman, and 
DeGrip 2011) and eight commonly used supplements (D. Y. Kim et al. 2006; G. M. Lee et al. 1999; 
H. Zhang et al. 2013) were added in three different groups (Fig. 6 - Stage 2): (i) basic additives (BA) 
– considered essential to support cell growth – comprising NEAA, glutamine, rhInsulin and NaSe, 
and (ii) lipids/polyamines (LP) – common additives reported in the literature – comprising linoleic 
acid, ethanolamine, putrescine and phosphatidylcholine. Supplementation with anti-clumping agents 
(AC) was also assessed comparing the widely used pluronic F68 with polyvinyl alcohol (PVA) 
(Costello et al. 2017; Michaels and Papoutsakis 1991; Clincke et al. 2011). Formulation SFM-1, 
containing both BA, LP and the anticlumping agent PVA was identified as the “best performing” 
medium (Fig. 8). 
At stage 3, supplementation of iron sources was performed (Fig. 6 – stage 3). Three iron sources were 
compared: Ferric Ammonium Citrate (FAC), Ferric Citrate (FC) and Ferric Ammonium Sulphate  (S. 
H. Kim and Lee 2009b; Schröder, Matischak, and Friedl 2004b; H. Zhang et al. 2013; Rodrigues et 
al. 2013; Bai et al. 2011; Y. H. Sung, Lim, et al. 2004), resulting in a 2.5-fold increased VCD with 
the addition of FAC. This formulation was named SFM-7 (Fig. 8).  
Finally - at stage 4 – individual supplementation with a set of four trace metals (cobalt, copper, zinc, 
manganese) was performed (Yuk et al. 2014; Chaderjian et al. 2008b; Gong, Hu, Stewart, Ellerbe, 
Figueroa, Blank, et al. 2001; J.-P. Piret et al. 2004; B. G. Kim and Park 2016; Tan et al. 1984), but 
no significant changes were observed in CHO-K1 growth. For this reason, addition of these trace 
metals was not performed.  
This process led us with a final in-house serum-free formulation (SFM-7) that sustained the growth 
of CHO-K1 cultures for 6 days with viabilities over 90% during that period of time (Fig. 8). 
 
2. Approach 2 - Removal – media simplification and cost reduction 
At this stage, we aimed to simplify the formulation in order to obtain a cost-effective product for 
possible commercialisation while identifying essential additives for CHO-K1 growth (Fig. 7). The 
cost of production of 1L of SFM-7 (€32.15) was mainly derived from three components: DMEM-
F12, rhInsulin and phosphatidylcholine. DMEM-F12 medium was the basal medium used for the 
SFM-7 formulation and we did not consider that a cheaper substitute was feasible. However, the more 
expensive phosphatidylcholine and rhInsulin additives had been supplemented in the medium in 
groups of supplements (BA, LP – Fig. 6 -stage 2), indicating that the essentiality of each of these 
individual supplements in our medium had not yet been proven. The removal of phosphatidylcholine 
induced a rapid but shorter growth profile that nevertheless resulted in similar peak VCD to that 
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obtained for SFM-7 (Fig. 8). As the phosphatidylcholine supplement comprised 25 % of the total cost 
of formulating SFM-7 (and considering the similar peak obtained between SFM-7 and 
phosphatidylcholine-removed medium), it was decided (for cost reasons solely) to eliminate this 
supplement from the medium (SFM-8, referred as BCR-F12 in Chapter 4). This formulation was 
further simplified with the removal of linoleic acid (no changes in VCD), resulting in SFM-9. 
Development of a chemically-defined and protein-free formulation was then approached with the 
removal of rhInsulin and replacement with two cost-effective mitogenic agents, zinc and 
aurintricarboxylic acid (ATA) (V. V. T. Wong, Ho, and Yap 2004a; C.-H. Liu, Chu, and Hwang 
2001b; Miki and Takagi 2015). Supplementation with either ATA (15 - 30mg/L) or zinc (0.5 – 
2.5mg/L) resulted in an enhanced VCD and viability profiles compared to SFM-9 (referred as SFM-
F12 in Chapter 2 and 3), resulting in two new CDM products: CDM-ATA (referred as CDM-A in 
Chapter 1) and CDM-Zn, respectively. A peak VCD of 4x106 cells/ml was observed with ATA, while 
a maximal VCD of 3.5x106 cells/ml was displayed in zinc-supplemented medium (Fig. 8).  
 
Fig. 7 Workflow for the simplification of SFM-7 formulation and development of CDM products.  
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Fig. 8. Viable cell density (VCD) (a) and viability (%) (b) of CHO-K1 cells in the SFM and CDM 
developed: SFM-1 (stage 1 product), SFM-7 (stage 2 product), SFM-8 (phosphatidylcholine removal, 
referred as BCR-F12 in Chapter 4), SFM-9 (linoleic acid removal, referred as SFM-F12 in Chapter 2 
and 3), CDM-ATA (ATA-supplemented, referred as CDM-A in Chapter 1), CDM-Zn (zinc-
supplemented). The commercial CHO-S SFM-II was also added as comparison.  
 
Table 2. Media formulations developed 
Additive Concentration SFM-8 SFM-9 CDM-ATA CDM-Zn 
NEAA 1.75X x x x x 
L-glutamine 4mM x x x x 
rhInsulin 10mg/l x x   
NaSe 6.7µg/l x x x x 
Linoleic acid 0.08mg/l x    
Ethanolamine 2.5mg/l x x x x 
Putrescine 1mg/l x x x x 
PVA 2% x x x x 
ATA 30mg/l   x  
Zinc Sulphate 2.5mg/l    x 
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CHAPTER 1 
Zinc supplementation increases protein titer of recombinant CHO cells 
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Preface to the paper – zinc as a titer-enhancer for CHO cells 
During the initial stages of this research project, a chemically-defined medium was developed on the 
basis of CHO-K1 cell growth (described in section 2). In CDM containing aurintricarboxylic acid 
(ATA), cultures displayed the highest VCD and viability profiles among the SFM and CDM 
formulations developed. However, assessment of recombinant protein production of two CHO cell 
lines, an IgG-producing DP12 cell line and an in-house EPO-secreting rCHO-K1 (named SK15), 
revealed low final titers (15 mg/L IgG and 3 mg/L EPO, respectively). For this reason, we aimed to 
increase the productivity of the cells by supplementing with media additives to increase the expression 
of recombinant protein. Several additives have been described in the literature to increase specific 
productivity of CHO cultures, such as the use of peptones and hydrolysates (S. H. Kim and Lee 2009a; 
Mosser et al. 2013; Hu et al. 2015; Davami et al. 2014) and small molecules such as sodium butyrate 
(NaBu) or valproic acid (Damiani, Almeida, Oliveira, Bartolini, & Ribela, 2013; Ha, Kim, & Lee, 
2014; Liu, Chu, & Hwang, 2001). However, the variable and non-specific composition when 
hydrolysates are used and the cytotoxic effects reported with NaBu led us to investigate a different 
approach. In 2016, titer-enhancing effects following zinc supplementation were reported in DG44 
cells (B. G. Kim and Park 2016). At the same time, insulin-mimicking effects by zinc-
supplementation have been described in several mammalian and some CHO cell lines (at 1.5mg/L 
Zn) (Wong, Ho, & Yap, 2004;Tang & Shay, 2001; Wong et al., 2006). Considering these two features, 
supplementation of high zinc concentrations was pursued, resulting in subsequent increased IgG and 
EPO titers. As we had full knowledge of the formulation of our in-house medium, the specific 
productivity of both cell lines could be further enhanced by removing a selected additive - ATA - 
from the zinc-supplemented cultures. Moreover, we could further identify that the productivity-
enhancing effects of zinc was also related to an increase in the mRNA levels of both recombinant 
proteins, indicating a possible effect at transcriptional level. Finally, indirect assessment of the 
metabolic potential of the cells revealed a connection between cultures displaying enhanced titers, 
due to the presence of high zinc concentrations, and increased oxidative respiration metabolism. 
Whether this effect is a consequence of the high productivity profiles or because of the presence of 
zinc needs further investigation. At high levels of intracellular zinc, localisation of this metal into the 
mitochondria has been reported (Lu et al. 2016). However, divergence observations into the 
stimulation of oxidative respiration have been reported in different cell types (Masayoshi, Masatsugu, 
and Shoji 1982; Dineley, Votyakova, and Reynolds 2003; Dakubo et al. 2006). 
Zinc is an essential micronutrient that interacts with hundreds of proteins, being involved in several 
functions. This trace metal is essential to form the secondary structures of zinc finger motifs, 
participating in their stabilisation. In this conformation, these proteins are reported to have high 
affinity for DNA, playing an important role in transcription regulation (Cummings and Kovacic 
2009). Moreover, zinc finger proteins have been also described to participate in mRNAs decay, with 
 48 
 
reported stabilization of some mRNAs, such as c-fos and Glut4 (Buchner et al. 2015; Taylor and 
Blackshear 1995). At the same time, zinc has been described as a powerful antioxidant agent, 
protecting against ROS species produced during cellular respiration due to its structural role in Cu/Zn-
superoxide dismutase (Marreiro et al. 2017). Altogether this array of effects on diverse cellular 
processes indicates that zinc is a vital media additive for supporting CHO cell culture. 
 
In parallel, the extensively studied metal, copper, was also assessed (Luo et al., 2012; Nargund, Qiu, 
& Goudar, 2015; Yuk et al., 2015), reporting cell line-specific effects in our conditions (Table 3).  
 
Table 3. Summary of copper supplementation effects in SK15 and DP12 compared to CDM+ATA 
without the metal 
Cell line Titer effects VCD and Viability effects 
SK15 60-90% increase No changes 
DP12 20% decrease 
2-25% lower peak and decrease in 
viability by day 4 (above 13.7 mg/L 
Cu) 
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ABSTRACT 
In order to study the impact of zinc and copper on the titer levels of mAb and recombinant protein in 
CHO cells, the IgG-expressing (DP12) and EPO-expressing (SK15) cell lines were cultured in 
chemically-defined media with increasing concentrations of either metal. Supplementation with 25 
mg/L in CDM media resulted in a significant increase in EPO (1.7-fold) and IgG (2.6-fold) titers 
compared to control (no added zinc). Titers at this Zn concentration in CDM containing the insulin 
replacing agent aurintricarboxylic acid (ATA) (CDM+A), showed a 1.8-fold (EPO) and 1.2-fold 
(IgG) titers increase compared to control. ATA appeared to also reduce the specific productivity (Qp) 
enhancement induced by Zn-25, with up to 4.9-fold (DP12) and 1.9-fold (SK15) Qp increase in CDM 
compared to the 1.6-fold (DP12) and 1.5-fold (SK15) Qp increase observed in CDM+A. A 31 % 
reduced Viable Cell Density (VCD) in DP12 was observed in both Zn-supplemented media (3x106 
cells/ml vs 4.2x106 cells/ml, day 5), whereas SK15 Zn-25 cultures displayed a 24 % lower peak only 
in CDM+A (2.2x106 cells/ml vs 3.2x106 cells/ml, day 5). Supplementation with copper at 13.7-20 
mg/L resulted in less significant cell line/product-type dependent effects on titer, VCD and Viability. 
Analysis of the energetic phenotype of both cell lines in 25 mg/L Zn-supplemented CDM medium 
revealed a 2-fold increase in the oxygen consumption rate (OCR) compared to non-supplemented 
cells. Together, these data suggest that high zinc supplementation may induce an increase in oxidative 
respiration metabolism that results in increased Qp and titers in suspension CHO cultures.  
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1. Introduction  
Enhancement of Chinese Hamster Ovary (CHO) culture performance profiles (titer, specific 
productivity (Qp), peak cell density, Viability) is a key goal of the biopharmaceutical sector. 
Industrial production of human therapeutics requires the use of serum-free formulations, mainly 
protein-free and chemically-defined media, due to biosafety concerns (Gstraunthaler, 2003) and to 
facilitate downstream processing. Consequently, in order to improve CHO performance in serum-free 
culture, a range of additives have been evaluated in basal serum-free formulations to optimise growth 
and productivity profiles. 
Supplementations with chemical reagents such as sodium butyrate or valeric acid (Damiani et al., 
2013; Park et al., 2016) have been extensively tested, offering a chemically-defined additive 
alternative for improving specific productivity of several therapeutically-relevant proteins in CHO 
cultures. However, the specific productivity effects observed with some of these chemicals (sodium 
butyrate, lithium chloride, valproic acid) have also been frequently associated with apoptosis (NaBu, 
reviewed by Kim et al., 2013) and/or low growth profiles (Park et al., 2016). 
More recently, metal supplementation has shown substantial potential in improving CHO 
performance features in serum-free culture. For instance, supplementation with iron-citrate has been 
observed to increase mAb titer by 30-40 % (Bai et al. 2011), while extended lifespan of CHO cultures 
and increased product titer have been reported following copper supplementation (Yuk et al., 2015; 
Luo et al., 2012). Additionally, manganese supplementation has been related to the modulation of 
glycoforms patterns of several recombinant products, including mAb (Grainger & James, 2013). 
More recently, Kim and Park (2016) reported the titer-associated benefits of high zinc 
supplementation of a DG44 culture growing in an in-house and commercial media, with up to 6.5-
fold increase in mAb titer observed (Kim & Park, 2016). 
In this study, we aimed to examine the effects of supplementation of a chemically-defined medium 
with copper or zinc on the titer, VCD and Viability profiles of two CHO cell lines producing different 
products in serum-free suspension culture: an IgG-expressing (DP12) and an EPO-expressing CHO-
K1 (SK15).  
 
2. Materials and Methods 
 
2.1. In-house chemically-defined media development 
As commercially prepared media products frequently do not disclose their exact components, two 
chemically-defined media (CDM+A and CDM) were developed based on an in-house serum-free 
medium formulation: DMEM-F12 (D3487) supplemented with sodium selenite (S5261), recombinant 
insulin (I9279), ethanolamine (E0135), ammonium iron (III) citrate (F5879), poly vinyl alcohol, L-
glutamine (Gibco (Dublin, Ireland), 25030024), NEAA (Gibco (Dublin, Ireland), 11140035) and 
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putrescine dihydrochloride (P7505). For the development of chemically-defined and protein-free 
formulation, insulin was replaced with 30 mg/L aurintricarboxylic acid (ATA) (CDM+A medium). 
Due to the chelating nature of ATA, which might mask the effects of the supplemented metals, ATA-
removed medium (CDM) was evaluated. All supplements were purchased from Sigma Aldrich 
(Wicklow, Ireland) unless otherwise stated. 
 
2.2.  Cell culture 
Over the course of this study, two suspension producer CHO cell lines were used: CHO-DP12 (a 
recombinant human anti-IL-8 producer, ATCC CRL-12445 clone#1934) and SK15 (an in-house 
CHO-K1 (ATCC CCL-61) derived cell line, expressing recombinant human erythropoietin (EPO) in 
a pcDNA3.1 vector (Invitrogen) modified with puromycin resistance as selection system) (Costello 
et al., 2019). Both cell lines were maintained in in-house protein-free chemically-defined medium 
supplemented with increasing concentrations of zinc sulphate heptahydrate (1, 10, 15, 25 and 30 
mg/L) or copper sulphate pentahydrate (1, 7.5, 13.7 and 20 mg/L) (added to the basal levels found in 
DMEM-F12: 0.432 mg/L Zn and 1.3 µg/L Cu). Cells were routinely split and re-seeded at 2x105 
cells/ml in 5 ml working volume. At least 2 passages were allowed for adaptation before each test. 
DP12 and SK15 cells were pulsed every second passage with 200 nM MTX (Sigma, M8407) (DP12) 
or 10 µg/ml puromycin (Gibco, A11138-03) (SK15). Viable Cell Density (VCD) and Viability were 
analysed in triplicate using the ViaCount on a Guava easyCyte HT benchtop cytometer (Merck 
Millipore, UK). 
 
2.3. Enzyme Linked Immunosorbent Assay (ELISA) 
Enzyme Linked Immunosorbent assay (ELISA) was performed in order to determine the levels of 
mAb and EPO. For mAb detection, the protocol described in the Human IgG ELISA Quantitation Set 
from Bethyl Laboratories Inc. (E80-104) was followed. For EPO detection, the protocol previously 
described by Costello et al. (2019) was followed, including modifications on incubation times for 
both samples (1.5 h) and capture antibody (overnight). Statistical analysis of the average of each 
biological triplicate of ELISA data obtained was performed in Microsoft excel software using 
Fischer’s Exact Test to determine variance and the two-tailed T-test tools to generate p-values. Cell 
specific productivity (Qp; pg protein/cell/day) was determined as per Clarke et al. (2011).  
 
2.4. RNA isolation 
RNA samples from SK15 and DP12 cultures in Zn-25 and CDM control media were collected at day 
5 from 30ml cultures in shake flasks. Between 1-5x106 cells were collected, centrifuged at 1000rpm 
for 5min and resuspended in 1ml Trizol reagent (Thermo Scientific). RNA was extracted following 
the Trizol protocol as per manufacturer’s instructions. Quantity and quality of the extracted samples 
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were analysed by Nanodrop (Thermo Scientific). To remove potential genomic DNA contamination, 
DNaseI treatment (Sigma Aldrich) was applied as per manufacturer’s protocol. 
 
2.5. RT-qPCR 
The High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was followed as per 
manufacturer’s protocol to generate cDNA from total RNA samples. cDNA was used for mRNA 
level quantification by qPCR using Fast SYBR Green Master Mix (Applied Biosystems) in a 7500 
(Applied Biosystems). 2XSYBR master mix was prepared with 400nM primers, 200ng cDNA and 
nuclease-free water made up to 20µL per reaction well. Relative quantification was measured by the 
delta delta Ct method with Gapdh as an endogenous control. Each biological replicate was measured 
in technical triplicate wells. The sequences of the primers used were as follows (5’ -> 3’): IgG-LC 
Fwd – CATGTCCCGCTCACGTTT, IgG-LC Rev – CAGGCACACAACAGAAGCA (Beckmann et 
al. 2012); IgG-HC Fwd – ACGGTGTCGTGGAACTCAG, IgG-HC Rev – 
ACGCTGCTGAGGGAGTAGAG (Haredy et al. 2013); hEPO Fwd – 
GCATGTGGATAAAGCCGTCA, hEPO Rev – GCAGTGATTGTTCGGAGTGG; Gapdh Fwd – 
TGGCTACAGCAACAGAGTGG, Gapdh Rev – GTGAGGGAGATGATCGGTGT. 
 
2.6. Energetic phenotype: Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate 
(ECAR) 
An Agilent Technologies XF96 Analyzer was used to analyse the metabolic potential of both cell 
lines. Suspension cells were immobilised prior to analysis with the XF96 Seahorse using 
the "Immobilization of non-adherent cells with Cell-Tak for Assay on the Seahorse XF/XF96" 
protocol (Agilent Technologies, Technical overview, Publication Part Number: 5991-7153EN, 2016). 
Some modifications were applied (as per Kelly et al. 2019): 20 µL Cell-Tak was used per well and 
plates were placed in a non-CO2 incubator at 37 oC for 1 h. Plates were then washed twice and air-
dried for an hour at room temperature before cell plating. The test used was the Agilent Seahorse XFp 
Cell Energy Phenotype Test Kit (Agilent Technologies, 103275-100) with a final seeding density of 
20,000 cells/well and a final concentration of Carbonyl cyanide 4-(trifluoromethoxy) 
phenylhydrazone (FCCP) and oligomycin of 1 µM, as per manufacturer's instructions. Basal 
(“Baseline levels”) levels of Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate 
(ECAR) were first measured under standard conditions (no inhibitors supplemented). The cells were 
then “Stressed” following injection of oligomycin (ATP synthase inhibitor) and FCCP (potent 
uncoupler of mitochondrial oxidative phosphorylation). This supplementation results in the 
maximum cellular respiration state (maximum Electron Transport System) (“Stressed levels”) which 
corresponds to the OCR and ECAR levels of the cells attempting to restore the proton gradient loss 
from the mitochondrial inhibitors supplemented. Consequently, by the continuous monitoring of 
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oxygen concentration changes in the medium (OCR) and pH (ECAR), the XF96 Seahorse instrument 
allows direct quantification of the mitochondrial respiration and glycolysis of the cells (Plitzko & 
Loesgen 2018). 
In order to avoid interference by dead cells, SK15 and DP12 cells were analysed at day 4. A total of 
2 biological replicates for each cell line, with analysis of 11-21 wells/condition per replicate, were 
performed. 
 
3. Results and Discussion 
 
3.1.  Zinc supplementation of CDM+A results in enhanced IgG titer and Qp but lower peak VCD in 
CHO 
Significantly enhanced EPO and IgG titer profiles were observed at Zn-25 medium (Fig. 1), 
displaying a 40-50 % increase in IgG titer (by day 2-4; Fig. 1b) and a 1.8-fold increase in EPO titer 
(by day 8; Fig. 1a) compared to the non-supplemented CDM+A control. No significant effects on 
titer were observed with any of the lower zinc supplementations at later stages of culture.  
Results for Qp are presented in Table 1. A 1.5-fold (SK15) and 1.6-fold (DP12) significant increase 
in Qp was observed at Zn-25 compared to control medium (Table 1). No positive effects were 
displayed at lower zinc concentrations.  
Decreases in peak VCD in both cell lines were observed at 25 mg/L zinc supplementation; a 31 % 
drop in SK15 and a 24 % drop in DP12 at day 5 (Fig. 1c,d). DP12 VCD was also negatively affected 
in Zn-15 medium, with a 12 % lower peak VCD observed (Fig. 1d). Supplementation at lower zinc 
concentrations did not display any effect on VCD in either cell line. Viability profiles were observed 
to be similar between supplemented and control CDM+A medium at all concentrations (Fig. 1e,f). 
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Fig. 1 Titer (a, b), Viable Cell Density (VCD) (c, d) and Viability (e, f) of SK15 (a, c, e) and DP12 
(b, d, f) cells grown in suspension in in-house chemically-defined medium CDM+A supplemented 
with zinc at: 1 mg/L (Zn-1), 10 mg/L (Zn-10), 15 mg/L (Zn-15) and 25 mg/L (Zn-25). Statistical 
differences of titer data compared to the control (CDM+A) are represented as: p-value <0.05 (*) 
3.2. Copper increases EPO titer in SK15 cells 
Compared to the CDM+A control, supplementation with copper resulted in different effects in the 
two CHO cell lines; with EPO titers increased by 80-90 % (at 13.7 mg/L and 20 mg/L Cu, 
respectively) and 65 % (at 1 mg/L and 7.5 mg/L Cu) media, while IgG final titers decreased by 20 % 
following copper supplementation at all concentrations (Appendix A, Supplementary Figure 1a,b). 
Copper-supplemented SK15 cultures displayed similar VCD and Viability profiles to non-
supplemented control CDM+A media for all concentrations; with peak VCD of 3-3.2x106 cells/ml 
1 
 2 
 3 
Fig. 1 4 
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and Viabilities above 91 % until day 5 observed (Appendix A, Supplementary Figure 1c,e). Similar 
to the results obtained for titer profiles (Appendix A, Supplementary Figure 1a,b), DP12 cells were 
observed to be negatively affected, with peak VCD drops of 2-24 % displayed as the concentrations 
of copper increased (Appendix A, Supplementary Figure1d). While similar Viability profiles (to the 
CDM+A control) were observed with supplementations up to 7.5 mg/L Cu, concentrations above 
13.7 mg/L resulted in detrimental effects, with a 25 % drop in DP12 Viability from day 4 to day 6 
(Appendix A, Supplementary Figure 1f). 
Previous studies have reported enhanced titer and VCD profiles following copper supplementation in 
serum-free CHO culture (Yuk et al., 2015, Xu et al., 2016). However, similar to our observations, 
cell line-dependant outcomes have also been reported by Luo et al (2012), with increased VCD and 
mAb titers in two (of three) DUXKB11 CHO suspension cell lines following high copper 
supplementation in a proprietary CDM, but zero effect on either phenotype in the 3rd subline studied. 
Additionally, previous studies supplementing with copper concentrations equivalent to the higher 
levels tested here reported induced DNA damage and reduced Viabilities of CHO-K1 parental cells 
in a cytotoxic study performed in serum-supplemented media (Grillo et al., 2010), which may explain 
the decreased Viabilities observed in the DP12 results presented here (Appendix A, Supplementary 
Figure 1f). 
Table 1. Specific productivity (Qp)(pg/cell/day) of SK15 and DP12 cell lines (day 0 - day 4) in 
CDM+A and CDM supplemented with zinc at: 0 mg/L (Ctl), 1 mg/L (Zn-1), 10 mg/L (Zn-10), 15 
mg/L (Zn-15), 25 mg/L (Zn-25) and 30 mg/L (Zn-30). Statistical differences of titer data compared 
to the respective control are represented as: p-value <0.05 (*), <0.01 (**), <0.001 (***). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  SK15 DP12 
CDM+A 
Ctl 1.7 ± 0.5 3.5 ± 0.4 
Zn-1 1.1 ± 0.4 3.1 ± 0.6 
Zn-10 1.3 ± 0.3 3.6 ± 0.6 
Zn-15 1.5 ± 0.3 3.6 ± 0.4 
Zn-25 2.4 ± 1.6 5.8 ± 0.4** 
CDM 
Ctl 3.5 ± 0.4 2.2 ± 0.6 
Zn-1 6.1 ± 0.2 1.6 ± 0.7 
Zn-10 8.1 ± 1.9 6 ± 0.5*** 
Zn-25 11.4 ± 1* 10.4 ± 2.7** 
Zn-30 11.7 ± 2* 16 ± 7.4** 
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3.3. Removal of ATA from CDM+A further increases zinc-induced enhancement of titer and Qp 
Similar to zinc, ATA has previously been used as an insulin-replacement additive in the development 
of PFM for CHO cells (Miki & Takagi, 2015) and its molecular structure provides strong metal 
chelating ability (Kumar Sharma et al. 2000), acting by forming a coat on the cell surface interacting 
with IGF-1R (Beery et al. 2001). To avoid possible interference by chelating activity, a medium 
without ATA (CDM) was formulated and used in order to identify (i) whether addition of zinc by 
itself could replace the growth-stimulatory effects of ATA while simultaneously improving titer and 
(ii) if ATA was masking the maximum positive effects of zinc on product titer due to chelating 
interaction. Moreover, an additional 30 mg/L Zn concentration was also included to evaluate the 
potential for further titer enhancement at higher concentrations.  
 
   1 
2 
 3 
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Fig. 2 Titer (a, b) Viable Cell Density (VCD) (c, d) and Viability (e, f) of SK15 (a, c, e) and DP12 (b, 
d, f) cells grown in suspension in in-house chemically-defined medium CDM supplemented with zinc 
at: 1 mg/L (Zn-1), 10 mg/L (Zn-10), 25 mg/L (Zn-25) and 30 mg/L (Zn-30). Statistical differences of 
titer data compared to the control (CDM) are represented as: p-value <0.05 (*), <0.01 (**), <0.001 
(***)  
Removal of ATA resulted in enhanced EPO and IgG titer profiles following Zn supplementation in 
the concentration range of 10-30 mg/L; displaying a maximal increase of 1.7-fold EPO titer (in Zn-
25) and 3.9-fold IgG titer (in Zn-30) compared to the non-supplemented control (Fig. 2a,b). Final IgG 
yield was also increased by 2.6-fold with 25 mg/L zinc supplementation (vs. 7.1 mg/L in CDM 
control) (Fig. 2b).  
Specific productivity of both CHO cell lines increased as the concentration of zinc increased, reaching 
up to 11.4 pg EPO/cell/day (SK15) and 16 pg IgG/cell/day (DP12) at Zn-30 (Table 1). 
Supplementation with 25 mg/L zinc resulted in a 1.9-fold (SK15) and 4.8-fold (DP12) increase in Qp 
compared to non-supplemented medium. 
VCD and Viability results for each Zn concentration tested are displayed in Fig. 2 (c-f). No effects 
on SK15 VCD (relative to CDM control) were observed at 25 mg/L zinc supplementation (Fig. 2c). 
For DP12, negative effects on maximal VCD were observed in Zn-25, causing a drop of 29 % in peak 
VCD (Fig. 2d). At this zinc concentration, both cell lines displayed lower Viability profiles compared 
to the non-supplemented CDM control medium (90-83 % vs. 94-88 %; Fig. 2e,f).  
Interestingly, the beneficial effects of zinc supplementation on titer were also observed at the 
transcriptional level, with a 25.6-fold (heavy chain) and 4.3-fold (light chain) increase in IgG mRNA 
levels in DP12 cells and a 1.8-fold increase in hEPO mRNA levels in SK15 cells, following 
supplementation at 25mg/L (Fig. 3). This result is in accordance with the IgG expression cassette 
used for the development of DP12 cell line, which enhances IgG heavy chain expression relative to 
light chain as a result of MTX selection and amplification, since the DHFR and heavy chain sequences 
share the same promoter (Gonzalez et al. 2000). 
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Fig. 3 Relative quantification (RQ) of (a) heavy and light chain of IgG (anti-IL-8) antibody in DP12 
cells and (b) hEPO mRNA levels in SK15 cells in CDM Zn25 medium normalized to the mRNA 
levels of the cells in CDM control medium. The Gapdh endogenous gene was used to standardize the 
results. RNA samples analysed were collected at day 5 from 30ml cultures. 
 
 Only a few studies have reported beneficial effects of high zinc supplementation on enhancing 
recombinant protein production in CHO. Zuquelis et al. (2006) observed an 8-fold increase of IFN-
β1a titer following supplementation with 150 µM zinc and a lower (2-fold) increase at 25-50 µM Zn 
(both in adherent CHO-K1 cultures grown in 0.5 % FBS) (Zuquelis et al., 2006). More recently, zinc 
supplementation at 30-60 µM in PFM and CDM in-house formulations increased mAb titer by a 
maximum of 6.5-fold and peak VCD by 1.2-fold in DG44 suspension cultures (Kim & Park, 2016). 
Moreover, Kim et. al (2016) also reported enhanced mAb titer at 90 µM Zn supplementation in CDM, 
which was associated with a lower VCD peak, a finding which is similar to the results presented here 
at Zn-25 (equivalent to 86.93 µM Zn). However, supplementation with zinc concentrations above 100 
µM in CHO suspension cultures has been shown to impact final mAb quality (reduction in 
galactosylation patterns), although the effects can be reversed by addition of manganese (Prabhu et 
al., 2018). 
From the results displayed here, strategies involving supplementation of 25mg/L zinc on commercial 
media may be considered as credible approaches focused on increasing titer in suspension CHO 
cultures utilising commercial media. However, it is important to note that the different additives 
present in each formulation may influence the positive effects observed with zinc (as was observed 
here when zinc was co-supplemented in the presence of ATA (Fig. 1a,b)). Interestingly, Kim et. al 
(2016) have shown increases of 1.2 – 1.5-fold in mAb titer with zinc supplementation to a range of 
three commercial media (Power CHO-2CD (Lonza), CDM4CHO (Hyclone) and EXCELL CD CHO 
(SAFC Bioscience)), although the concentrations used (60µM, 17.25mg/L) were lower than the 
optimal concentration described here. Consequently, due to the lack of disclosure on composition of 
 1 
                2 
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commercial media formulations, it may be necessary to deploy several zinc concentration and 
supplementation strategies to achieve titer enhancement in other culture systems. 
 
3.4. Zn-25 increases the oxidative respiration of DP12 and SK15 cells 
Zinc is involved in the folding, stability and/or activity of hundreds of proteins, being essential for 
several cellular functions such as DNA and RNA synthesis, mRNA stability and protection against 
apoptosis. Moreover, it also participates in the activation of glutathione and antioxidant enzymes such 
as, superoxide dismutase and catalase, hence protecting against ROS species produced during cellular 
respiration (Kloubert & Rink, 2015). However, little is known about its function as a possible additive 
for improving production of therapeutic proteins. 
Batch cultures typically display a stationary phase where growth slows and a production profile is 
observed, correlated with a switch to oxidative respiration (Dickson 2014a). A maximum induction 
of Oxygen Consumption Rate (OCR: indicator of mitochondrial respiration) was observed following 
supplementation at Zn-25, displaying a substantial 1.8-fold (SK15) and 2.1-fold (DP12) increased 
oxygen consumption compared to the CDM non-supplemented medium (Fig. 4a,b). OCR levels were 
also affected at lower zinc concentrations, although to a lesser degree; with an increase of 1.2-fold in 
Zn-10-supplemented SK15 and a 1.3-fold (Zn-1) - 1.4-fold (Zn-10) increase in DP12. Cellular 
Extracellular Acidification Rate (ECAR: indicator of glycolysis) levels were not substantially 
affected following Zn supplementation under stressed conditions (Fig. 4c,d). 
 
1 
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Fig. 4 Oxygen Consumption Rate (OCR) (a, b) and Extracellular Acidification Rate (ECAR) (c, d) 
of SK15 (a, c) and DP12 (b, d) cells in CDM supplemented with zinc at: 0mg/L (CDM), 1 mg/L (Zn-
1), 10 mg/L (Zn-10) and 25 mg/L (Zn-25) at day 4.“Baseline” indicates OCR and ECAR levels 
measured under normal growing conditions; “Stressed” indicates OCR and ECAR levels measured 
following supplementation of FCCP and oligomycin, which induces maximum cellular respiration 
state (maximum Electron Transport System) of the cells by blocking mitochondrial function. 
Consecutively the mitochondrial respiration and glycolysis of the cells are quantified by the changes 
on the oxygen consumption and pH in both Baseline and Stressed levels. OCR are indicated as pmol 
Oxygen consumed per min whereas ECAR is indicates as mpH/min. 
 
Disrupted homeostasis by high zinc concentrations results in the sequestration by metallothionein or 
internalization into organelles, including mitochondria (Qiping et al., 2016). Zinc has been observed 
to stimulate oxidative phosphorylation and the electron transport chain (ETC) in rat hepatic 
mitochondria (Masayoshi et al., 1982). Increased ATP production and mitochondrial biogenesis has 
been also displayed in melanocytes after zinc supplementation (Rudolf& Rudolf, 2017). However, 
divergent observations have been also reported in rat neurons and prostate epithelial cells, with 
reduced mitochondrial energy production observed following Zn-supplemented conditions (Dineley 
et al. 2005; Dakubo et al., 2006), which might indicate possible tissue-specific effects. While the role 
of zinc in the regulation of energy metabolism in suspension CHO cells is still unclear, the results 
presented here suggest that zinc supplementation strategies at stationary phases on the cultures might 
be suitable for enhancing CHO final titers due to the increased OCR levels and titers displayed.  
 
4. Conclusions 
We have found that supplementation of protein-free media with zinc at 25 mg/L (86.93 µM) resulted 
in a significant increase of both recombinant EPO and IgG titers in two CHO cell lines; SK15 and 
DP12. Although lower peak VCD was also displayed following supplementation, viabilities were 
maintained above 80 % throughout. Increased oxidative respiration was also observed to correlate 
with the increased titer profiles in both cell lines. Together, these data indicate that zinc 
supplementation strategies may be a viable mechanism for increasing specific productivity in CHO 
cell lines. 
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Preface to the paper – Recombinant protein producer selection  
During the development of the in-house SFM (described in: Research performed – serum-free media 
development and study of media additives section), we aimed to simplify the formulation in order to 
reduce cost of production and identify essential supplements. Individual removal of each additive was 
performed, identifying the polyamine putrescine as a vital supplement. In putrescine-deprived media, 
a dramatic negative effect on cell growth and viability was observed. Even though the commercial 
basal medium DMEM-F12 contains traces of putrescine (81µg/L), this level was revealed to be 
insufficient for survival of CHO cells. Polyamines are essential for cell proliferation, playing key 
roles in several cellular processes, including DNA replication, protein expression, cell cycle 
progression and protection against oxidative stress (Heby, O., 1981, Rhee et al 2007, Pegg, 2016). In 
1981, Pohjanpelto et al reported an inhibition of CHO-K1 growth when cells were cultured in serum-
free media (Pohjanpelto et al. 1981). Further investigation of this phenotype revealed an endogenous 
lack of arginase activity in CHO (Hölttä et al. 1982), first enzyme of the polyamine biosynthesis 
pathway. Consequently, CHO cells display a polyamine-dependent phenotype in serum-free 
formulations deprived of putrescine.  
Currently, generation of biopharmaceutical producing cell lines is mainly focused on two selection 
systems: the dihydrofolate reductase (DHFR) and the glutamine synthetase (GS) (Costa et al. 2010). 
Both systems are based on the essential function of each enzyme for healthy cell proliferation. 
Consequently, selection is performed by combining CHO cell lines deficient in expression of either 
of these enzymes and transfection with a vector co-expressing the gene of interest and the 
complementary essential enzyme. Selection occurs by culturing the cells in the absence of the vital 
supplement (thymidine and hypoxanthine for DHFR-deficient cells and glutamine for the GS system), 
impeding the growth of non-transfected populations (Costa et al. 2010). Gene-amplification can be 
performed in both systems with the use of either methotrexate (MTX), a DHFR inhibitor, or MSX, a 
GS inhibitor, resulting in highly producing cell lines. However, alterations in the desired product may 
be introduced as a consequence of long amplification processes, principally with MTX (Guo et al. 
2010). Moreover, as the number of generations increases, unpredictable drops in specific productivity 
profiles are reported in both GS and DHFR generated cell lines (Kim et al. 2011, Chusainow et al. 
2009, Kim et al. 1998). While not onerous, the limitations of these existing systems highlight the 
commercial relevance of developing alternative selection systems that can circumvent these 
challenges and improve this time-consuming and costly step in upstream CHO cell line development.  
For this reason, we aimed to develop an alternative cytotoxic-free selection system based on the 
arginase-deficiency phenotype of CHO. To achieve this aim, we designed a bicistronic vector co-
expressing GFP or hEPO and arginase and transfected into CHO-K1 cells. Cultures were then placed 
in selecting conditions - low putrescine and putrescine-deprived media. Analysing the expression of 
recombinant protein (GFP or hEPO), producer populations were successfully obtained in both 
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conditions. Single-cell derived populations in in-house selecting medium stably expressed GFP or 
hEPO for a total of 42 generations, with no changes in growth and viability profiles. To further 
characterise the system, hEPO-expressing clones were grown in putrescine-containing medium as 
well as commercial media (BalanCD and CHO-S SFM-II), reporting recombinant protein expression 
for at least nine passages (27 generations), with a minimal decrease in hEPO titer by the end of the 
culture.  
The arginase-based selection system designed offers an alternative, drug-free, cost-effective and easy-
to-apply method for CHO but also other arginase-deficient mammalian cell lines, which may be used 
in conjunction with DHFR or GS methods. Due to the novelty, efficacy and applicability of the system 
designed, intellectual property protection has been filed for the work described in this chapter under 
patent application number 1911023.8 (titled: Transfection selection and polypeptide or RNA 
expression). 
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ABSTRACT  
Polyamines have essential roles in cell proliferation, DNA replication, transcription, and translation 
processes, with intracellular depletion of putrescine, spermidine, and spermine resulting in cellular 
growth arrest and eventual death. Serum-free media for CHO-K1 cells require putrescine 
supplementation, as these cells lack the first enzyme of the polyamine production pathway, arginase. 
On the basis of this phenotype, we developed an arginase-based selection system. We transfected 
CHO-K1 cells with a bicistronic vector co-expressing GFP and arginase and selected cells in media 
devoid of L-ornithine and putrescine, resulting in mixed populations stably expressing GFP. 
Moreover, single clones in these selective media stably expressed GFP for a total of 42 generations. 
Using this polyamine starvation method, we next generated recombinant CHO-K1 cells co-expressing 
arginase and human erythropoietin (EPO), which also displayed stable expression and healthy 
growth. The EPO-expressing clones grew in commercial media, such as BalanCD and CHO-S SFM-
II, as well as in a defined serum-free, putrescine-containing medium for at least nine passages (27 
generations), with a minimal decrease in EPO titer by the end of the culture. We observed lack of 
arginase activity also in several CHO cell strains (CHO-DP12, CHO-S, and DUXB11) and other 
mammalian cell lines, including BHK21, suggesting broader utility of this selection system. In 
conclusion, we have established an easy-to-apply alternative selection system that effectively 
generates mammalian cell clones expressing biopharmaceutically relevant or other recombinant 
proteins without the need for any toxic selective agents. We propose that this system is applicable to 
mammalian cell lines that lack arginase activity.  
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1. Introduction 
The Chinese Hamster Ovary cell line (CHO) is the workhorse for the production of therapeutic 
proteins in the biopharmaceutical industry due to their safety record, ability to grow in large-scale 
suspension cultures and extensive knowledge about their genome, thus facilitating genetic 
manipulation. Moreover, introduction of essential post-translational human-type modifications 
(especially glycosylations) are also achievable with this platform. Media formulations, feed 
strategies, bioprocess development and gene expression modifications have driven significant 
increases in final yields over the past years, reaching titer levels of 5-10g/L (1, 2). However, stable 
cell line development and clonal selection still remain as a costly, labour- and time-consuming step 
(3).  
Development of CHO producer cell lines is mainly based on two selection markers: dihydrofolate 
reductase (DHFR), an enzyme required for nucleotide metabolism, and glutamine synthetase (GS), 
essential for intracellular glutamine production (4). In both systems, selection occurs in the absence 
of a vital supplement (thymidine and hypoxanthine for DHFR-deficient cells and glutamine for the 
GS system), preventing the growth of non-transfected populations. Compared to DHFR selection, the 
GS-system can be equally used to derive parental cells lacking GS activity (such as NS0 myeloma or 
SP2 hybridoma cell lines) or expressing glutamine synthetase (such as CHO cells), in which case 
methionine sulphoximine (MSX) selection pressure is applied. However, more stringent selection 
achieved with GS knock out CHO cells have been reported to double mAb bulk culture productivity 
compared to parental CHO-K1 (5). Similarly, the -/-DHFR DG44 and DUXB11 cell lines are 
commonly used for DHFR-selection system. In both cases, highly producing populations are 
generated by increasing the stringency of the selection process with either methotrexate (MTX), a 
DHFR inhibitor, or MSX, a GS inhibitor, thus inducing transgene co-amplification. However, several 
rounds of incrementing MTX concentrations are usually required, resulting in a 5-6 months selecting 
process (6). To note, increased mutation rates have been reported from the long amplification process 
involving mutagenic chemicals, resulting in occasions in variations in the amino acid sequence of the 
desired product (7). Hence, cell line development and pharmaceutical manufacturing in drug-free 
systems is desirable to satisfy safety concerns and achieve more efficient and cost-effective processes. 
Moreover, removal of selection pressure has to guarantee stable specific productivity of the clones, a 
vital attribute for the pharmaceutical industry. However, several reports have suggested unstable 
specific productivity profiles in both GS and DHFR generated cell lines, exposing the limitations of 
these systems (8, 9, 10).  
Putrescine, spermidine and spermine are essential polyamines for cellular development, playing key 
roles in DNA replication, RNA expression, protein synthesis, protection against oxidative stress, 
regulation of apoptosis and cell differentiation (11, 12, 13). Historically, eukaryotic polyamine 
production has been related to arginase, an enzyme catalysing the conversion of L-arginine to L-
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ornithine, and ornithine decarboxylase, decarboxylating the L-ornithine to finally generate putrescine 
(11). However, in some mammalian tissues (such as ovine conceptuses (14) and rat neurons (15) and 
liver (16)) an alternative pathway, already described in plants and prokaryotes, has been recently 
reported. Polyamine homeostasis is tightly regulated by internal systems (such as antizyme-antizyme 
inhibitor) and membrane transport, enabling the uptake or release of these essential polycations for 
healthy growth development (17). In the early 1980s, putrescine-dependence was first identified in 
CHO-K1 when culturing in polyamine-free and serum-free media, resulted in a detrimental cellular 
growth profile due to disorganization of actin bundles and microfilaments (18). Later characterization 
of the phenotype revealed a lack of arginase activity in CHO cells (19), which was also observed to 
induce an arrest in the S phase of the cell cycle (20). Further investigation of polyamine metabolism 
has resulted from the generation of knock out cell lines and use of enzyme inhibitors (such as α-
difluoromethylornithine (DFMO) and 5'-{[(Z)-4-amino-2-butenyl]methylamino}-5'-deoxyadenosine 
(AbeAdo)), exposing the vital role of these polycations for healthy cell proliferation (21, 22, 23, 24).  
Based on the polyamine-dependence phenotype of CHO cells and due to the limitations still 
remaining for efficient generation of stable cell lines, we aimed to develop an alternative cytotoxic-
free selection system for producer cell lines.  
 
2. Experimental procedures 
 
2.1. Media development 
Two serum-free media (SFM) were developed: a low putrescine (SFM-F12 medium) and a 
putrescine-free formulation (SFM-F10 medium). The commercial DMEM-F12 medium (Sigma-
Aldrich, D8437) was used as a basal medium for SFM-F12 medium. Due to the presence of putrescine 
in DMEM-F12 medium formulation (81µg/L), a mixture of DMEM high glucose (D5671) and 
Nutrient Mixture Ham's F10 (Sigma-Aldrich, N2147) (1:1) was used for SFM-F10 medium. The latter 
was further supplemented with HEPES, linoleic acid (L1376) and glucose in order to mimic DMEM-
F12 formulation. Both basal media were further supplemented with sodium selenite (S5261), 
recombinant insulin (I9279), ethanolamine (E0135), ammonium iron (III) citrate (F5879), poly vinyl 
alcohol, L-glutamine (Gibco, 25030024), NEAA (Gibco, 11140035) and putrescine dihydrochloride 
(P7505) (25). When indicated, 100µM L-ornithine or 1mg/L putrescine was added to each media. All 
media and additives were purchased from Sigma-Aldrich unless otherwise stated. 
 
2.2. Cell Culture 
The parental CHO-K1 cell line (ATTC CCL-61) was cultured in SFM-F12 medium supplemented 
with putrescine. Cells were maintained in suspension culture in an ISF1-X (Climo Shaker) Kuhner 
incubator at 37oC, 170rpm, 5% CO2 and 80% humidity. Cells were routinely split every 3-4 days and 
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re-seeded at 0.2x106 cells/ml in 50ml spin tubes (Sartorius, DF-050MB-SSH) in a 5 ml working 
volume. Biological triplicates were analysed for viable cell density (VCD) and viability using the 
ViaCount on a Guava easyCyte HT benchtop cytometer (Merck Millipore, UK). Measurements were 
performed in technical duplicates (unless stated). 
For arginase activity tests, DUXB11 (kindly donated by Chasin, L., Columbia University) were 
cultured in MEM alpha medium (Thermo Fisher, 12561056) supplemented with 0.5-2% foetal bovine 
serum (FBS) in T-75 flasks; CHO-DP12 (ATCC, clone #1934) and CHO-S cells were cultured in 
BalanCD Growth A medium (Irvine Scientific) supplemented with 8mM L-glutamine (Thermo 
Fisher, 2503008) in 50ml spin tubes (Sartorius, DF-050MB-SSH) in a 5ml working volume; HEK293 
were cultured in MEM (Sigma Aldrich, M5650) supplemented with 2mM L-glutamine (Thermo 
Fisher, 2503008), 0.1mM MEM non-essential amino acid (Biosciences, 11140050), 1mM sodium 
pyruvate (Thermo Fisher, 11360070) and 10% heat-inactivated horse serum in T-75 flasks; SP2 
(Immune Systems) were cultured in DMEM Glutamax (Gibco, 10566-016) supplemented with 10% 
heat inactivated FBS in T-25 flasks; BHK-21 (Flow Laboratories Irvine) were cultured in MEM 
(Sigma Aldrich, M5650) supplemented with 2mM L-glutamine (Thermo Fisher, 2503008), 1% MEM 
non-essential amino acid (Thermo Fisher, 11140050), 1% sodium pyruvate (Thermo Fisher, 
11360070) and 5% fetal calf serum (FCS) in T-25 flasks; the pancreatic cell lines BxPC-3 (ATCC, 
CRL-1687), MiaPaca-2 (ATCC, CRL-1420), PANC-1 (ATCC, CRL-1469), Capan-2 (DSMZ, ACC 
244) were cultured in DMEM high glucose (Sigma-Aldrich, D5671) supplemented with 5% FCS and 
2% L-glutamine (Thermo Fisher, 2503008) in T-75 flasks. 
Isolation of clonal cells was performed by dilution. A volume of 100µl per well was added in a 96-
well plate at 5 cells/ml. Plates were then incubated uninterruptedly at 37oC and 5% CO2 up to day 7-
10, when plates were inspected to identify and mark wells presenting single colonies. Plates were 
then re-incubated at 37oC. At day 14, 60-70% confluence was observed and colonies were picked and 
expanded to larger volumes. First, 1ml cultures were performed in non-adherent suspension 24-well 
plates (Greiner Bio-one, 662102). After 2-3 days, successful clones were then placed in 50ml spin 
tubes (Sartorius, DF-050MB-SSH) in a 5ml working volume for stability tests.  
For stability tests, the doubling time and generation number of each clone was calculated as per (37). 
Clones were assessed for a total of 41-53 generations (for GFP-expressing clones) and 40-51 
generations (hEPO-expressing clones), depending on the clone. For simplicity, a doubling time of 
24h was assumed for data discussion, resulting in a total of 42 generations experiment.  
 
2.3. Vectors 
Phusion High-Fidelity PCR master mix (Thermo Scientific) was used to obtain the mouse arginase 
coding sequence (CDS) from pcDNA3.1-mArg1, an internal ribosome entry site (IRES) sequence 
from pINDUCER10 vector (kindly gifted by Dr. Stephen Elledge, Harvard Medical School Centre of 
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Genetics and Genomics, Boston, U.S.A) and the human erythropoietin (hEPO) CDS from a 
pLenti6.36.3hEPO. The protocol was followed as per manufacturer's recommendations, with 10ng 
vector used in a total of 50µL reaction volume. Both arginase and IRES fragments were first cloned 
downstream of a green fluorescence protein (GFP) from a modified GFP-expressing vector N44-
CSanDI-Hyg (derived from pcDNA5 CMV-d2eGFP (Addgene, 26164), resulting in a GFP-IRES-
Arg bicistronic vector controlled by a CMV promoter. For the hEPO expressing vector, the hEPO 
CDS replaced the GFP in the GFP-IRES-Arg vector, resulting in a hEPO-IRES-Arg bicistronic 
vector.  
The pcDNA3.1-mArg1 was a gift from Peter Murray (Addgene, plasmid #34573), pInducer10-mir-
RUP-PheS was a gift from Stephen Elledge (Addgene plasmid #44011) (38) and pLenti6.3-hEPO 
was a gift from Juan Melero-Martin (Addgene plasmid #50436) (39). 
Proof of concept tests were performed using the pcDNA3.1-mArg1 vector. 
 
2.4. Transfection and selection 
Vector transfections were performed in 1ml suspension cultures in 24-well tissue-untreated plates 
(Greiner Bio-one, 662102) SFM-F12 medium with putrescine. The TransIT PRO transfection agent 
(Mirus Bio, Mir 5740) was used as per manufacturer's recommendations with minimal changes. 
Briefly, cells were counted and re-seeded at 0.5-1x106cells/ml in fresh media 24h prior transfection. 
A total of 500ng vector were mixed with 1µL TransIT PRO and 100µl media and incubated for 10min 
at room temperature. Cells were re-suspended in fresh media at 2x106cells/ml and 900µl were seeded 
per well. A total of 100µl of vector-TransIT PRO complex suspension was then added to each well. 
Plates were parafilmed and incubated at 37oC, 170rpm with 5% CO2 and 80% humidity in an ISF1-
X (Climo Shaker) Kuhner incubator. A negative control for transfection was also included (no vector 
was added during transfection). Biological triplicate were performed per each transfections. Selection 
was performed in putrescine-free SFM-F12 medium. Cells were also placed in putrescine-containing 
SFM-F12 medium as negative controls. 
For the GFP-expressing vector, the efficiency of the process was assessed 24h post-transfection by 
vector Green Fluorescent Protein (GFP) expression using the Express Plus software of GUAVA 
easyCyte HT benchtop cytometer (Merck Millipore, UK). To determine the amount of fluorescent 
cells, negative control cells (zero fluorescence) were gated and these settings were then used to 
identify the GFP-positive populations. Fluorescence of dead cells and debris were excluded to avoid 
false positive results. Viable cell density and viability were also assessed as previously described.  
 
2.5. Arginase activity 
One million cells were collected per sample and centrifuged at 1000 rpm. Pellets were then washed 
with PBS and finally stored at -80°C until assayed. The arginase activity kit (Sigma-Aldrich, 
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MAK112) was used. Pellets were lysed for 10min in 100µl of lysis buffer as per manufacturer’s 
recommendations, with pepstatin A (Sigma Aldrich, P5318) and leupeptin (Sigma Aldrich, L9783). 
To determine arginase activity, manufacturer's protocol was followed. Arginase activity (U) was 
determined with the following equation:  
𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =  
𝐴𝑏𝑠 𝑆𝑝𝑙𝑒 − 𝐴𝑏𝑠 𝐵
𝐴𝑏𝑠 𝑆𝑡𝑑 − 𝐴𝑏𝑠 𝑊
 𝑥 
1𝑚𝑀 𝑥 50 𝑥 1000
𝑆𝑝𝑙𝑒 𝑣𝑜𝑙 𝑥 𝑟𝑒𝑎𝑐𝑡 𝑡𝑖𝑚𝑒
 
Being: 
Abs Sple: absorbance sample at 430nm 
Abs B: absorbance blank at 430nm 
Abs Std: absorbance standard at 430nm 
Abs W: absorbance water at 430nm 
Sple vol: sample volume (µl) 
React time: reaction time (min) 
Where one unit of arginase corresponds to the amount of enzyme that will convert 1µmole of L-
arginine to ornithine and urea per minute at pH 9.5 and 37°C. 
Biological triplicates were analysed per each condition and cell line except for pancreatic cell lines, 
which were assessed in biological duplicates.  
 
2.6. RNA isolation and RT-qPCR performance 
RNA was collected by centrifuging 1-5x106cells at 1000rpm, 4°C for 5min. Pellets were re-suspended 
in 1ml Trizol reagent (Thermo Fisher, 15596018) and stored at -80°C until assayed. Total RNA 
isolation was performed as per manufacturer's recommendations (Thermo Fisher). RNA 
quantification and quality were evaluated by NanoDrop (Thermo Scientific). To remove 
contaminating DNA, RNA samples were treated with DNase I (Sigma Aldrich) as per manufacturer’s 
protocol and stored at -80°C. cDNA was obtained using the High Capacity cDNA Reverse 
Transcription Kits (Applied Biosciences) which was followed as per manufacturer’s 
recommendations. A total of 200ng cDNA per reaction well was used for qRT-PCR using Fast SYBR 
Green Master Mix (Applied Biosystems) and run in a 7500 (Applied Biosystems). The 2XSYBR 
master mix was prepared with 400nM primers and nuclease-free water made up to 16µL per reaction. 
Relative quantification was measured by the ddCt method with Gapdh as an endogenous control. 
Technical triplicate wells were run for each clone sample. The sequences of the primers used are as 
follows (5’->3’): Gapdh-Fw TGGCTACAGCAACAGAGTGG, Gapdh-Rv 
GTGAGGGAGATGATCGGTGT, Arg-Fw ACAAGACAGGGCTCCTTTCA, Arg-Rev 
TGCCGTGTTCACAGTACTCT, hEPO-Fw GCATGTGGATAAAGCCGTCA, hEPO-Rv 
GCAGTGATTGTTCGGAGTGG, d2GFP-Fw GACGACGGCAACTACAAGAC, d2GFP-Rv 
TCCTTGAAGTCGATGCCCTT. 
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2.7. ELISA 
For hEPO detection, the protocol previously described by Costello et al. (2019) (40) was followed 
with overnight incubation for capturing antibody and samples (1.5 h). 
 
3. Results 
 
3.1. CHO-K1 cells require supplementation of putrescine or L-ornithine for healthy growth  
During the development of a serum-free medium for CHO cells (SFM-F12) (25), reduction of 
putrescine supplementation to less than 200µg/L was observed to have a dramatic negative effect on 
cell growth, resulting in a consistent drop on viability to less than 55% at concentrations lower than 
100µg/L. In SFM-F12 with increased putrescine supplementation up to 200µg/L, a substantial 
negative effect in VCD and viabilities was still observed (Appendix B, Fig. S1).  
 
Figure 1. CHO-K1 cells require putrescine or L-ornithine supplementation for healthy growth. CHO-
K1 viable cell density (VCD) (lines) and viability (bars) in SFM-F12 medium (81µg/L putrescine) 
(a, c, e) and SFM-F10 medium (no putrescine) (b, d, f) supplemented with: 1mg/L putrescine (a, b, 
circles), 100µM ornithine (c, d, squares) or without any supplementation (e, f, triangles). VCD and 
viability displayed are per each passage (P). Technical triplicates were performed for each condition 
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except for passage 1 in SFM-F12 which was performed in a single tube. Triplicates were seeded for 
subsequent passages in SFM-F12 and SFM-F10. 
 
Intracellular putrescine production requires the conversion of arginine to L-ornithine, which is then 
decarboxylated to generate putrescine. To assess which of the two reactions was causing the 
putrescine-dependent phenotype observed, CHO-K1 cells were cultured for 4 passages in three 
conditions: (i) SFM-F12 medium lacking putrescine, (ii) SFM-F12 medium supplemented with L-
ornithine (100µM) and (iii) SFM-F12 control medium (containing 1.08mg/L putrescine). Due to the 
presence of traces of putrescine (81µg/L) in the DMEM-F12 formulation (basal medium for SFM-
F12 medium), an SFM-F10 medium (based in DMEM:F10 medium (1:1 v/v) - 0 µg/L putrescine) 
was developed and tested under the same conditions as SFM-F12 to compare effects of media fully 
depleted of putrescine. In SFM-F12 (Fig. 1a, c, e), CHO-K1 cells were observed to display a similar 
growth profile in both L-ornithine- and putrescine- supplemented media with consistent viabilities 
(87-95%) maintained among the 4 passages. In contrast, cultures in non-supplemented SFM-F12 (Fig. 
1e) displayed negligible growth. Similar to the SFM-F12 results, SFM-F10 L-ornithine- and 
putrescine- supplemented cultures displayed similar profiles, with growth observed at each passage 
and viabilities increased from P2 to P4 (Fig 1b, d). Zero growth was observed in CHO-K1 cells in 
SFM-F10 non-supplemented medium, with viability decreasing to 15% by P2 (Fig. 1f). It is 
noteworthy that CHO-K1 cells were grown in SFM-F12 medium supplemented with putrescine prior 
to the start of the SFM-F10 test, with no previous adaptation to SFM-F10 medium. This may explain 
the similar growth profiles observed in all three SFM-F10 testing media at P1 and P2 (Fig. 1b, d, f). 
 
3.2. Replenishment of arginase activity results in healthy growth and can be used to select CHO-K1 
cells  
In 1982, Hölta et al. (19) reported a lack of arginase activity in a CHO-K1 cell line in serum-free 
conditions, resulting in a polyamine-dependent phenotype. In accordance with their findings, it was 
hypothesized that a lack of arginase expression could be also occurring in our parental cell line. Based 
on that and, in order to exploit this phenotype, we designed a selection system for CHO-K1 producer 
cell lines. As a proof of concept, a commercial arginase-expressing vector, pcDNA3.1-mArg 
(Addgene), was first transfected and selected in media lacking putrescine (NoP) compared to media 
with putrescine (P). A negative control, consisting of wild type untransfected cells, was also included.  
CHO-K1 cells transfected and selected in SFM-F12 medium lacking putrescine resumed cellular 
growth by passage 6 (day 20), finally reaching VCD and viability profiles similar to the parental 
control cells in putrescine-containing medium by passage 8 (day 26) (Fig 2a, b). Correspondingly, an 
increase in arginase activity was also detected in the transfected and selected cultures (NoP-Arg) from 
P5 (Fig 2c). In contrast, expected minimal arginase activity levels were detected in parental cells, 
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with a cessation of growth in medium without putrescine (NoP-Neg) from passage 2 (day 9) and 
viabilities of 60-69% observed until the end of the culture. Phenotypic characterization of the selected 
mixed populations (NoP-Arg) over a 7-day culture period revealed almost identical VCD and viability 
profiles as parental cells in SFM-F12 medium with putrescine (Appendix B, Fig. S2). 
 
 
Figure 2. Replenishment of arginase activity in CHO-K1 parental cells enables growth in polyamine-
free media. Viable cell density (VCD) (a), viability (b) and arginase activity (c) of CHO-K1 
transfected with 500ng pcDNA3.1-mArg1 vector (P-Arg, NoP-Arg). A negative control of cells with 
no DNA transfected (P-Neg, NoP-Neg) was included. Transfected and non- transfected cells were 
placed in either SFM-F12 medium supplemented with putrescine (P) or selective SFM-F12 medium 
(without putrescine, NoP). For arginase activity analysis, samples for NoP-Neg could not be collected 
at P3, P4 and P7. Triplicate wells were transfected per each condition. 
 
3.3. GFP-expressing clones successfully selected in low putrescine containing media 
After having demonstrated the ability to select CHO-K1 cells transfected with an arginase expressing 
vector in media lacking putrescine, the next step was to determine whether the system could be 
applied to the selection of cells expressing a gene of interest. To achieve this aim, green fluorescence 
protein (GFP) was selected for initial tests due to the ease traceability during the transfection process. 
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A bicistronic vector expressing GFP and arginase linked by an IRES and under the control of a CMV 
promoter was designed for the purposes of this experiment (Appendix B, Fig. S3). 
In SFM-F12 medium, healthy mixed populations were successfully obtained by passage 8, recovering 
VCD and viability profiles similar to the parental control cells (Fig 3a, b). GFP expression was first 
detected at passage 7, with 14.5% GFP expressing cells observed in mixed population 1, 2.9% in 
mixed population 2 and 8.1% in mixed population 3. Interestingly, the GFP-expressing population 
was observed to increase over each passage, reaching an average of 27.2% cells by the end of the 
experiment (P12) (Fig. 3c). In contrast and as expected from previous results, the VCD and viability 
of the untransfected cultures in SFM-F12 medium without putrescine (NoP-Neg) dropped by passage 
2, displaying an average VCD of 0.3-0.6x106cells/ml and viabilities between 57-64% until the end of 
the culture (NoP-Neg). Variability in the viability of the three replicates for the negative control was 
observed by the end of the experiment (P11 and P12), where replicate 2 and 3 displayed viabilities of 
44-49% but 79% viable cells were detected in replicate 1.  
 
Figure 3. GFP-expressing populations can be isolated in polyamine-free media. Viable cell density 
(VCD) (a), viability (b) and percentage of GFP expressing (c) CHO-K1 cells transfected with 500ng 
GFP-IRES-Arg vector (P-GFP, NoP-GFP). A negative control of cells with no DNA transfected (P-
Neg, NoP-Neg) was included. Transfected and non- transfected cells were placed in either SFM-F12 
medium supplemented with putrescine (P) or selective SMF-F12 medium (without putrescine, NoP). 
Triplicate wells were transfected per each condition.  
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Interestingly, selection performed in parallel in putrescine-depleted SFM-F10 medium displayed 
similar profiles to those performed in SFM-F12, with recovery of mixed populations observed at P8 
(Appendix B, Fig. S 4a, b). In this case, a higher percentage of GFP-expressing populations were 
recovered (reaching on average up to 70% by P9), which may be related to the increased stringency 
of this medium (Appendix B, Fig. S4c). It is noteworthy that mixed population 2 was observed to 
unstably express GFP from P6 to P10, displaying a dramatic drop in the percentage of GFP-expressing 
cells by P11, finally resulting in cellular death (P12). Hence, the large error bars displayed at P10 and 
P11. 
Although SFM-F10 medium was observed to outperform SFM-F12 selective medium in terms of 
percentage of GFP-expressing populations obtained, differences in the composition of both media 
resulted in maximal viabilities of 80-85% in control parental cells cultured in SFM-F10 medium (P-
T, P-Neg) (Appendix B, Fig. S4b), while viabilities over 90% were consistently observed in SFM-
F12 media. For this reason, further testing was performed only on SFM-F12 medium.  
 
Figure 4. Long-term growth and stable expression of isolated GFP-expressing clones in selective 
media. Viable cell density (VCD) (a), viability (b) and mean fluorescence intensity (MFI) (c) of seven 
GFP-expressing clones isolated by limited dilution growing in selective medium (SFM-F12 without 
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putrescine) for 14 passages (42 generations). Each clone was maintained in a single tube. Duplicate 
technical readings were performed for each phenotype.  
 
3.4. Long term stably expressing clones can be generated by polyamine and L-ornithine starvation  
To assess the stability of the GFP-expressing populations generated, seven clones were isolated and 
placed in SFM-F12 medium lacking putrescine in order to monitor their growth (VCD), viability and 
GFP expression in terms of mean fluorescence intensity (MFI) and at a mRNA level (relative 
quantification, RQ) for a total of 42 generations (14 passages).  
Consistent growth and healthy viabilities were displayed over the 42 generations (Fig. 4a, b). Clones 
7 and 16 were observed as low producers while clone 12 displayed remarkably increased MFI levels. 
Nevertheless, GFP expression was detected throughout the 42 generations, with an increase in MFI 
levels relative to passage 1 observed in all clones except clone 11 (Fig. 4c). Stable expression was 
also confirmed at a transcriptional level (Fig. 5). Due to the design of the expression vector, almost 
identical GFP and arginase RQ profiles were observed. Interestingly, from passage 4 (12 generations), 
an increase in the RQ of both GFP and arginase were observed with all clones except clone 11. This 
effect might be related to the transference of clones from putrescine-containing media (during single-
cell cloning) to SFM-F12 medium depleted of putrescine, i.e. increased stringency of selection. 
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Figure 5. Long-term stable GFP and arginase mRNA expression of isolated GFP-expressing clones 
in selective media. Relative quantification (RQ) of GFP and arginase mRNA levels in seven GFP-
expressing clones growing in selective media for 14 passages (42 generations) normalized to the 
mRNA levels in passage 2. The Gapdh endogenous gene was used to standardize the results.  
 
3.5. Single clones stably expressing a therapeutically-relevant recombinant protein can be generated 
in polyamine and L-ornithine-free media 
To confirm whether the selection system designed would support the generation and preferential 
survival of clones expressing pharmaceutically relevant therapeutics, a bicistronic vector expressing 
human erythropoietin (hEPO) was designed and transfected into CHO-K1 cells; cultures were then 
plated in selective medium (putrescine-free).  
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Figure 6. hEPO-expressing populations can be isolated in polyamine-free media. Viable cell density (bars, 
VCD) and viability (lines) (a) and hEPO titer (mg/L) (b) of CHO-K1 cells transfected with 500ng hEPO-IRES-
Arg vector (hEPO, stripes) in selective medium (SFM-F12 without putrescine). A negative control of cells with 
no DNA transfected (Neg, black) was included. Triplicate wells were transfected per each condition.  
 
Successful mixed populations were selected by passage 9, as observed for the detection of hEPO 
(0.26mg/L) and the recovery of VCD and healthy viabilities (Fig. 6). Clones were isolated and seven 
of them were randomly selected to assess stability in selective media for a total of 42 generations (14 
passages). Stable titer expression was confirmed over the 42 generations (Fig. 7c). Assessment of 
hEPO and arginase mRNA expression relative to passage 2 was performed on three phenotypically 
divergent clones: clone 4 (low producer but fast growing), clone 10 (high producer but moderate 
growth) and clone 18 (medium producer with moderate growth). Both clones 10 and 18 were found 
to be stable, displaying levels of expression similar to those in passage 2 for at least 36 generations 
(P12) (Fig. 8). In contrast, the low producer clone 4 displayed a 20% decrease on hEPO mRNA 
expression at 18 generations (P6), dropping to less than 50% relative to the expression at passage 2 
by passage 8. Nonetheless, both hEPO and arginase expression were detected over the 42 generations 
(P14) (Fig. 7).  
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Figure 7. Long-term growth and stable expression of isolated hEPO-expressing clones in selective 
media. Viable cell density (VCD) (a), viability (b) and hEPO titer (mg/L) (c) of seven hEPO-
expressing clones isolated by limited dilution growing in selective media (SFM-F12 without 
putrescine) for 14 passages (42 generations). Each clone was maintained in a single tube. Duplicate 
(VCD, viability) or triplicate (titer) technical readings were performed for each phenotype.  
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Figure 8. Long-term stable hEPO and arginase mRNA expression of isolated hEPO-expressing 
clones in selective media. Relative quantification (RQ) of hEPO and arginase mRNA levels in three 
hEPO-expressing clones growing in selective media for 14 passages (42 generations) normalized to 
the mRNA levels in passage 2. CHO-K1 (K1) parental cells were also assessed as control. The Gapdh 
endogenous gene was used to standardize the results.  
 
In order to determine whether the application of 
this selection system may be limited to CHO-K1 
cells, several mammalian cell lines (HEK293, SP2, 
BHK21, Vero, BxPC-3, Capan-2, MiaPaca-2 and 
PANC-1), including three CHO cell lines CHO-
DP12, CHO-S and DUXB11, were assessed for 
arginase activity (Fig. 9). Neither BHK21 nor any 
of the CHO cell lines tested displayed arginase 
activity, indicating that the system may be 
applicable to several parental CHO cell lines. 
Conversely, the HEK293, Vero lines and the 
pancreatic BxPC-3 and MiaPaca-2 cell lines 
displayed arginase activity levels similar to the 
pcDNA3.1-Arg transfected CHO-K1 cells (Fig. 2c), making these parental cell lines unsuitable for 
the system. Finally, low levels of activity were observed in SP2, Capan-2 and PANC-1. Whether this 
activity is low enough to allow application of the arginase-based selection system requires further 
investigation.  
 
3.6. hEPO clones display stable expression in putrescine-containing media 
Due to the vital role played by polyamines in the culture of CHO cell lines in serum-free media (19), 
commercial and chemically-defined formulations contain putrescine levels sufficient to supply the 
metabolic requirements of CHO cells. To address whether clones generated following our polyamine-
starvation method would maintain expression in non-selective conditions, clone 4, 10 and 18 were 
adapted to SFM-F12 medium containing putrescine as well as two commercially available 
formulations of undisclosed composition: a serum-free medium, CHO-S SFM-II (Gibco), and a 
chemically-defined medium, BalanCD Growth A (Irvine). Clones cultured in SFM-F12 and BalanCD 
media displayed constant VCD and viability profiles (Fig. 10a, b). In contrast, SFM-II medium was 
less supportive of healthy cultures, resulting in a decrease in growth from passage 2 (6 generations) 
in two of the clones, reaching consistent VCDs by passage 6 (2.3x106cells/ml, clone 4) and passage 
5 (1.5x106cells/ml clone 10). Moreover, in this medium, the viability of clone 10 dropped to 70% by 
Figure 9. Arginase activity of mammalian cell 
lines. HEK 293, SP2, BHK21, Vero, DP12, 
CHO-S and DUXB11 cells were analysed in 
triplicate. The pancreatic cell lines BxPC-3, 
Capan-2, MiaPaca-2 and PANC-1 were 
analysed in duplicates. 
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passage 6 and to 60% in clone 18 by passage 7. Stable hEPO expression was observed in BalanCD 
and SFM-F12 medium for clone 10 (up to P9, 27 generations), while decreased (23-30% lower) hEPO 
titers were displayed by passage 8 in clone 18 and clone 4 (40-30% lower) by passage 9 (Fig. 10c). 
In SFM-II medium, both clone 10 and 18 performed similarly to the other two media. However, clone 
4 was less stable, with hEPO titer dropping by 60% at passage 6 but maintaining this level until the 
end of the culture.  
 
Figure 10. Long-term growth and stable expression of isolated hEPO-expressing clones in 
commercial and in-house media containing putrescine. Viability, viable cell density (VCD) and hEPO 
titer (mg/L) of three hEPO-expressing clones isolated by limited dilution growing in SFM-F12 
medium with putrescine (+Put), BalanCD Growth A supplemented with L-glutamine (BCD) and 
CHO-S SFM-II supplemented with PVA (SFM-II) for 10 passages (30 generations). Each clone in 
SFM-II was maintained in a single tube. Duplicate tubes were performed for SFM-F12 and BalanCD. 
Duplicate technical readings were performed for each condition.  
To further characterize the capabilities of the system, all three clones were each cultured in both 
commercial media and SFM-F12 with putrescine for a total of 7 days to allow for high hEPO and, 
consequently, arginase expression. Healthy growth and hEPO expression was supported at different 
levels in all media tested, indicating that an increase in the arginase expression had no detrimental 
effect on CHO cell development (Appendix B, Fig. S5).  
 
4. Discussion 
With the results reported here, we have demonstrated the efficacy of a newly developed auxotrophic 
selection system for CHO cells which exploits an arginase-deficiency phenotype observed in several 
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mammalian cells. The method was shown to sustain the survival and growth of arginase-expressing 
transfected cell pools in a polyamine and L-ornithine-free environment, supporting the isolation of 
GFP and recombinant therapeutic protein (erythropoietin) expressing single-cell derived populations. 
Moreover, initial evidence of clonal stability was observed, with the maintenance of VCD, viability 
and production profiles for at least 42 generations in selective media (14 passages). The clones were 
also observed to express and grow in non-selective commercial media for at least 27 generations. 
The routinely used DHFR and GS expression systems, although being described as auxotrophic 
selection methods, require MTX and MSX drug-selection pressure for the generation and isolation of 
high producer cell lines (4), resulting in time-consuming amplification processes (reaching up to 5-6 
months) mainly for the DHFR system (6), as several rounds are required. Moreover, the DHFR-
expressing system is predominately used with CHO cells lacking DHFR expression, thus enabling 
selection in nucleoside-depleted media (26). On the other hand, despite endogenous expression of 
glutamine synthetase in CHO cells, selection of parental producer colonies have been isolated in 
glutamine-free media by MSX pressure. However, the endogenous GS gene has been suggested to 
display activity at a sufficient levels to allow non-producer CHO cells survival, reducing the 
stringency of the GS system (27). Consequently, use of GS-KO CHO-K1 has been found to be optimal 
(5). In contrast, the arginase-expression system proposed here is a drug-free method applicable, but 
not limited to, CHO-K1 parental cells due to their inherent lack of arginase activity, which has been 
further observed as an intrinsic phenotype of several CHO cell lines and some mammalian cells. 
Interestingly, arginase activity was reported by Hölttä et al (1982) in several sources of serum (19). 
As FBS is still a common supplement used in mammalian cultures, arginase-deficiency may be 
masked in some cell lines, which indicates the possibility of a broader applicability of the system 
described here.  
Development of cell lines with stable production phenotypes is an essential attribute in the 
pharmaceutical industry. Hence, several studies have been focused on the characterization of the two 
predominant selection systems. In 2006, Jun et al. reported decreases of 33-62% in specific 
productivity of GS-derived high producer clones over the first batch, reaching further lower 
expression up to passage 6 (28). Similarly, monoclonal antibody was observed to decrease during the 
30 passages assessment of CHO-GS clones in selective and non-selective media (29), while lower 
titer levels were observed after 20 days in a DHFR-derived cell line (10). Further investigation studies 
have revealed loss of gene copies, epigenetic modifications and inefficient or decreased mRNA 
transcription (8, 9, 30, 21, 32) as the main causes of clonal instability, being observed as a widespread 
issue. Compared to GS and DHFR studies, clones isolated with the arginase system proposed here 
have displayed stable GFP and EPO expression at protein and mRNA levels for over 40-53 
generations (depending on the clone - 14 passages) in drug-free selection media. Other alternative 
drug-free selection systems such as OSCARtm (based on knock out cell lines for hypoxanthine 
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phosphoribosyl transferase (HPRT)), have reported lower stability with a rapid mAb expression decay 
displayed after 3 weeks in culture (33). Although clonal stability monitoring in industry is performed 
for periods over 60 generations, initial evidence for stable production have been described for the 
arginase-expressing method, with further characterization to be performed.  
Due to the essential roles of polyamines in the maintenance of cellular wellbeing, it is not surprising 
to observe regulatory pathways to compensate imbalanced intracellular polyamine content. In 
response to critical levels of spermidine, spermine and putrescine, active transport mechanisms 
participate in the maintenance of polyamine homeostasis. In mammals, polyamine transport systems 
are still poorly understood but three models have been suggested: (1) polyamine uptake by 
unidentified membrane permeases, (2) interaction with heparin sulphate and glypican 1 and (3) 
putrescine uptake by a caveolin-1-dependent endocytosis mechanism, which has been associated to 
SLC3A2 (17). Other solute carrier transporters are also under investigation (reviewed in 41) and a 
diamine exporter (DAX) has been identified to have the ability to export putrescine in CHO (42). In 
plants and microorganisms, putrescine can be alternatively produced by arginine decarboxylase and 
agmatinase. In this pathway, arginine is first decarboxylated to agmatine, which is then used as a 
substrate to generate putrescine (11). Recent evidence of agmatinase activity has been reported in rat 
liver (16) and kidney (34) as well as brain and other tissues of several mammalian species (35) where 
agmatine has been described as a potent biological active substance (e.g. acting as a neurotransmitter 
(15), modulator of nitric oxide synthesis or interacting with several receptors, ion channels or 
membrane transporters (35)). Consequently, agmatine degradation to putrescine has been suggested 
as regulatory system rather than an “alternative” pathway for the production of polyamine (36). In 
2014, ornithine decarboxylase knock-out ovarian conceptuses (ODC-KO) were generated and 
observed to compensate polyamine-deficiency conditions by agmatine production. However, this 
phenotype was only observed in half of the ODC-KO ovarian conceptuses while the other half 
displayed lack of agmatine production resulting in cessation of cellular development (14). Similarly, 
we have here observed that removal of putrescine and L-ornithine from media results in a drop of 
viability and VCD of CHO-K1 parental cells and this altered phenotype is maintained for at least 40-
53 generations (depending on the clone - 14 passages). As a result, investigation of agmatine 
expression was not performed. Further research is necessary to determine whether the agmatine-
derived pathway is active and contributes to polyamine production in CHO cells. 
Similar to the findings reported here, lack of arginase activity and subsequent decreases in cellular 
growth has been previously reported with CHO cells cultured in absence of putrescine, with cellular 
death observed after 8-14 days (18, 19) due to the intracellular depletion of the secondary polyamines 
spermine and spermidine (3). As expected, more stringent conditions obtained in putrescine-depleted 
media were here observed to outperform the selection efficiency of the low putrescine-containing 
media. However, traces of this polyamine in media did not impede isolation of arginase-expressing 
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clones, suggesting potentially easy applicability of this system when paired with common basal 
media, such as DMEM-F12. It is important to note that the use of this medium would require clonal 
isolation in order to remove background populations not expressing the gene of interest (such as cells 
only expressing arginase or non-transfected populations); in any case, this is a step that is commonly 
performed to achieve stable high producer clones. 
In conclusion, we have presented here evidences for an alternative method for the generation of stable 
producer CHO-K1 cell lines using an arginase-expressing system in polyamine- and ornithine-free 
media. We have conclusively demonstrated that arginase-expressing selection is efficient, offering a 
drug-free, cost-effective and easy-to-apply method for a range of parental mammalian cells displaying 
lack of arginase activity. The system may be also used in conjunction with GS or DHFR methods, 
offering an alternative to antibiotic-based selection for the generation of double transfectants avoiding 
possible secondary effects from drug selection. To note, the aim of the investigation presented here 
was to prove the feasibility of the system. Further analysis focused on the isolation of high producing 
clones and improvement of the system with modifications such as using an attenuated arginase gene, 
the use of a weak promoter or knock out of polyamine transporters may lead to a more efficient system 
and will be further investigated.  
 
5. References 
1- Li, F., Vijayasankaran, N., Shen, A. Y., Kiss, R. and Amanullah1, A. (2010) Cell culture processes 
for monoclonal antibody production. mAbs. 2(5), 466-477.  
2- Fan, L., Frye, C. C. and Racher, A. J. (2013) The use of glutamine synthetase as a selection marker: 
recent advances in Chinese hamster ovary cell line generation processes. Pharm. Bioprocess. 1(5), 
487–502.  
3- Wurm, F. M. (2004) Production of recombinant protein therapeutics in cultivated mammalian cells 
Nat. Biotechnol. 22(11), 1393-8.  
4- Costa, A. R., Rodrigues, M. E., Henriques, M., Azeredo, J. and Oliveira, R. (2010) Guidelines to 
cell engineering for monoclonal antibody production. Eur J Pharm Biopharm. 74(2), 127-38.  
5- Fan, L., Kadura, I., Krebs, L. E., Hatfield, C.C., Shaw, M. M. and Frye, C. C. (2012) Improving 
the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells. 
Biotechnol Bioeng. 109(4), 1007-15  
6- Jayapal, K. P., Wlaschin, K. F., Hu, W. S. and Yap, M. C. S. (2007) Recombinant protein 
therapeutics from CHO cells – 20 years and counting. Chem. Engin. Progr. 103 (10), 40–47.  
7- Guo, D., Gao, A., Michels, D. A., Feeney, L., Eng, M., Chan, B., Laird, M. W., Zhang, B., Yu, X. 
C., Joly, J., Snedecor, B. and Shen, A. (2010) Mechanisms of unintended amino acid sequence 
changes in recombinant monoclonal antibodies expressed in Chinese Hamster Ovary (CHO) cells. 
Biotechnol Bioeng. 107(1), 163-71  
 91 
 
8- Kim, M., O'Callaghan, P. M., Droms, K.A. and James, D. C. (2011) A mechanistic understanding 
of production instability in CHO cell lines expressing recombinant monoclonal antibodies. 
Biotechnol Bioeng. 108(10), 2434-46  
9- Chusainow, J., Yang, Y. S., Yeo, J. H., Toh, P. C., Asvadi, P., Wong, N. S. and Yap, M. G. (2009) 
A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer? 
Biotechnol Bioeng. 102(4), 1182-96  
10- Kim, N. S., Kim, S. J. and Lee, G. M. (1998) Clonal variability within dihydrofolate reductase-
mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure 
Biotechnol Bioeng. 60(6), 679-88.    
11- Heby, O. (1981) Role of polyamines in the control of cell proliferation and differentiation. 
Differentiation. 19(1), 1-20.  
12- Rhee, H. J., Kim, E. J. and Lee, J. K. (2007) Physiological polyamines: simple primordial stress 
molecules. J Cell Mol Med. 11(4), 685-703.  
13- Pegg, A. E. (2016) Functions of polyamines in mammals. J Biol Chem. 291(29):14904-12  
14- Wang, X., Ying, W., Dunlap, K. A., Lin, G., Satterfield, M. C., Burghardt, R.C., Wu, G. and 
Bazer, F.W. (2014) Arginine decarboxylase and agmatinase: an alternative pathway for de novo 
biosynthesis of polyamines for development of mammalian conceptuses. Biol Reprod. 90(4), 84  
15- Iyo, A. H., Zhu, M. Y., Ordway, G. A and Regunathan, S. (2006) Expression of arginine 
decarboxylase in brain regions and neuronal cells. J Neurochem. 96(4), 1042–1050.  
16- Horyn, O., Luhovyy, B., Lazarow, A., Daikhin, Y., Nissim, I., Yudkoff, M. and Nissim, I. (2005) 
Biosynthesis of agmatine in isolated mitochondria and perfused rat liver: studies with 15N-labelled 
arginine. Biochemical Journal 388 (2), 419-425  
17- Baea, D-H., Laneb, D. J. R., Janssona, P. J. and Richardson, D. R. (2018) The old and new 
biochemistry of polyamines. Biochim Biophys Acta Gen Subj. 1862(9), 2053-2068. 
18- Pohjanpelto, P., Virtanen, I. and Hölttä, E. (1981) Polyamine starvation causes disappearance of 
actin filaments and microtubules in polyamine-auxotrophic CHO cells. Nature. 293(5832), 475-7.  
19- Hölttä, E. and Pohjanpelto, P. (1982) Polyamine dependence of Chinese hamster ovary cells in 
serum-free culture is due to deficient arginase activity. Biochim Biophys Acta. 721(4), 321-7.  
20- Anehus, S., Pohjanpelto, P., Baldetorp, B., Långström, E. and Heby, O. (1984) Polyamine 
starvation prolongs the S and G2 phases of polyamine-dependent (arginase-deficient) CHO cells. Mol 
Cell Biol. 4(5), 915-22.  
21- Pohjanpelto, P., Hölttä, E. and Jänne, O. A. (1985) Mutant strain of Chinese hamster ovary cells 
with no detectable ornithine decarboxylase activity. Mol Cell Biol. 5(6), 1385-90.  
22- Steglich, C. and Scheffler, I. E. (1982) An ornithine decarboxylase-deficient mutant of Chinese 
hamster ovary cells. J Biol Chem. 257(8), 4603-9.  
 92 
 
23- Byers, T. L., Wechter, R. S., Hu, R. H. and Pegg, A. E. (1994) Effects of the S-
adenosylmethionine decarboxylase inhibitor, 5'-{[(Z)-4-amino-2butenyl]methylamino}-5'-
deoxyadenosine, on cell growth and polyamine metabolism and transport in Chinese hamster ovary 
cell cultures. Biochem J. 303 (Pt 1), 89-96.  
24- Mamont, P. S., Böhlen, P., McCann, P. P., Bey, P., Schuber, F. and Tardif, C. (1976) α-Methyl 
ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat 
hepatoma cells in culture. Proc Natl Acad Sci U S A. 73(5), 1626-30.  
25- Capella Roca, B., Alarcón Miguez, A., Keenan, J., Suda, S., Barron, N., O'Gorman, D. and 
Doolan, P., Clynes, M. (2019) Zinc supplementation increases protein titer of recombinant CHO cells. 
Cytotechnology. doi: 10.1007/s10616-019-00334-1 
26- Cacciatore, J. J., Chasin, L. A. and Leonard, E. F. (2010) Gene amplification and vector 
engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO 
cell selection system. Biotechnol Adv. 28(6), 673-81. 
27- Sanders, P. G. and Wilson, R. H. (1984) Amplification and cloning of the Chinese hamster 
glutamine synthetase gene. EMBO J. 3(1), 65-71. 
28- Jun, S. C., Kim, M. S., Hong, H. J. and Lee, G. M. (2006) Limitations to the development of 
humanized antibody producing Chinese hamster ovary cells using glutamine synthetase mediated 
gene amplification. Biotechnol Prog. 22(3), 770-80. 
29- Noh, S. M., Shin, S. and Lee, G. M. (2018) Comprehensive characterization of glutamine 
synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal 
antibodies. Sci Rep. 8(1), 5361. 
30- Barnes, L. M., Bentley, C. M. and Dickson, A. J. (2004) Molecular Definition of Predictive 
Indicators of Stable Protein Expression in Recombinant NS0 Myeloma Cells. Biotechnol Bioeng. 
85(2), 115-21. 
31- Yang, Y., Mariati, Chusainow, J. and Yap, M. G. (2010) DNA methylation contributes to loss in 
productivity of monoclonal antibody-producing CHO cell lines. J Biotechnol. 147(3-4):180-5. 
32- Brown, M. E., Renner, G., Field, R. P. and Hassell, T. (1992) Process development for the 
production of recombinant antibodies using the glutamine synthetase (GS) system. Cytotechnology. 
9(1-3), 231-6. 
33- Costa, A. R., Rodrigues, M. E., Henriques, M., Melton, D., Cunnah, P., Oliveira, R. and Azeredo, 
J. (2012) Evaluation of the OSCAR system for the production of monoclonal antibodies by CHO-K1 
cells. Int J Pharm. 430(1-2), 42-6. 
34- Lortie, M. J., Novotny, W. F., Peterson, O. W., Vallon, V., Malvey, K., Mendonca, M., Satriano, 
J., Insel, P., Thomson, S. C. and Blantz, R. C. (1996) Agmatine, a bioactive metabolite of arginine. 
Production, degradation, and functional effects in the kidney of the rat. J Clin Invest. 97(2), 413-20. 
 93 
 
35- Piletz, J. E., Aricioglu, F., Cheng, J. T., Fairbanks, C. A., Gilad, V. H., Haenisch, B., Halaris, A., 
Hong, S., Lee, J. E., Li, J., Liu, P., Molderings, G. J., Rodrigues, A. L., Satriano, J., Seong, G. J., 
Wilcox, G., Wu, N. and Gilad, G. M. (2013) Agmatine: clinical applications after 100 years in 
translation. Drug Discov Today. 18(17-18), 880-93. 
36- Peters, D., Berger, J., Langnaese, K., Derst, C., Madai, V. I., Krauss, M., Fischer, K. D., Veh, R. 
W. and Laube, G. (2013) Arginase and arginine decarboxylase – where do the putative gate keepers 
of polyamine synthesis reside in rat brain? PLoS One. 8(6):e66735. 
37- Chida, Y., Takagi, K. and Terada, S. (2013) Establishment of a mammalian cell line suitable for 
industrial production of recombinant protein using mutations induced by high-energy beam radiation. 
Cytotechnology. 65(6), 955–965. 
38– Meerbrey, K. L., Hu, G., Kessler, J. D., Roarty, K., Li, M. Z., Fang, J. E., Herschkowitz, J. I., 
Burrows, A. E., Ciccia, A., Sun, T., Schmitt, E. M., Bernardi, R. J., Fu, X., Bland, C. S., Cooper, T. 
A., Schiff, R., Rosen, J. M., Westbrook, T. F. and Elledge, S. J. (2011) The pINDUCER lentiviral 
toolkit for inducible RNA interference in vitro and in vivo.. Proc Natl Acad Sci U S A. 108(9), 3665-
70.  
39- Lin, R. Z., Dreyzin, A., Aamodt, K., Li, D., Jaminet, S.C., Dudley, A. C., Melero-Martin, J. M. 
(2011) Induction of erythropoiesis using human vascular networks genetically engineered for 
controlled erythropoietin release. Blood. 118(20), 5420-8. 
40- Costello, A., Lao, N.T., Barron, N. and Clynes, M. (2019) Improved yield of rhEPO in CHO cells 
with synthetic 5′ UTR. Biotechnol Lett 41(2), 231–239. 
41- Abdulhussein, A. A. and Wallace, H. M. (2014) Polyamines and membrane transporters. Amino 
Acids 46, 655–660. 
42- Uemura, T., Yerushalmi, H. F., Tsaprailis, G., Stringer, D. E., Pastorian, K. E., Hawel, L., Byus, 
C. V. and Gerner, E. W. (2008) Identification and Characterization of a Diamine Exporter in Colon 
Epithelial Cells. J Biol Chem. 283(39), 26428–26435.  
Chung et al. (2003) Reduction of ammonia accumulation and improvement of cell viability by 
expression of urea cycle enzymes in Chinese Hamster ovary cells. Journal of Microbiology and 
Biotechnology 13(2):217-224 
Claudia Altamirano, C, Berrios, J, Vergara, M and Becerra, S (2013) Advances in improving 
mammalian cells metabolism for recombinant protein production. Electronic Journal of 
Biotechnology doi: 10.2225/vol16-issue3-fulltext-2 
 
 
 
 
 
94 
CHAPTER 3 
Altered gene expression in CHO cells following polyamine starvation 
Berta Capella Roca, Padraig Doolan, Niall Barron, Fiona O’Neill* and Martin Clynes* 
*Both authors contributed equally
Manuscript accepted (subject to reviewer’s comments) in Biotechnology Letters (manuscript 
ID:BILE-D-19-00932) 
 95 
 
Preface to the paper – Polyamine functions 
The design of a selection system for producer CHO cells based on polyamine-dependence, 
highlighted the vital role of these amines in viable cell proliferation in CHO. Intracellularly, 
polyamines are polycations that interact with nucleic acids, ATP and phospholipids, affecting 
multiple cellular processes (Igarashi K et al. 2019). Hence, the function of these amines is not only 
limited to cell proliferation but it is also related to DNA synthesis, RNA expression, protein synthesis, 
cell cycle progression and apoptosis among many other relevant functions. By binding with DNA, 
polyamines can cause chromatin condensation or/and induction of Z-DNA conformation, being 
reported to increase the expression of some genes (Thomas et al. 1995; Dever and Ivanov 2018, Liu 
et al. 2001). Increases on the intracellular polyamine levels have been observed to increase the 
expression of transcription factors, while deprivation of these amines can have an effect on mRNA 
stability (Zou et al. 2006; L. Liu et al. 2009). As a consequence, polyamines regulate the expression 
of multiple genes, being essential for cell survival.  
In CHO, polyamines are an absolute vital supplement due to the lack of endogenous arginase activity 
of these cells, phenotype firstly reported by Höltä et al in 1982 (Hölttä E et al. 1982). Since then, 
studies on the polyamine metabolism in CHO were performed by generating knock out cell lines 
and/or using polyamine biosynthesis enzymes inhibitors (such as α-difluoromethylornithine (DFMO) 
and 5'-{[(Z)-4-amino-2-butenyl]methylamino}-5'-deoxyadenosine (AbeAdo)) (Pohjanpelto, Hölttä  
and Jänne 1985; Steglich  and Scheffler 1982; Byers et al. 1994). However, even though polyamines 
display major roles on key parameters for the biopharmaceutical area (cell proliferation and protein 
expression), little recent investigation has been carried out (Hyvönen 1989; Jan O. Fredlund and 
Oredsson 1997a; Berntsson, Alm and Oredsson 1999; Pastorian, Hawel, and Byus 2000), with last 
reports in polyamines effects in CHO metabolism from 2008 (Uemura et al. 2008). 
Leading on from the described arginase-based selection system for CHO (Chapter 2) and given the 
critical role these compounds play in various cellular pathways, the impact of polyamine-deprivation 
in CHO was investigated. Due to the broad effects of polyamines, the development of -omic 
technologies have provided new tools for the study of these multifunction amines. For this reason, 
changes on gene expression were assessed by using Affymetrix CHO whole transcriptome microarray 
chips. Moreover, based on the polyamine-dependence of CHO cultures, the use of chemical inhibitors 
such as DFMO or AbeAdo was avoided, eliminating possible off-target effects. 
CHO-K1 cells were starved for putrescine for three days, when samples were collected. Phenotypic 
assessment displayed a drop on cell proliferation while analysis of the cell cycle by flow cytometry 
revealed a substantial increase on the S-phase population over the three days culture. At 
transcriptional level, five major pathways revealed changes in the mRNA levels, being cell cycle, 
p53, spliceosome, protein processing in endoplasmic reticulum and Fanconi anaemia pathway. 
 96 
 
Moreover, changes in proteins localised in the cellular membrane were observed to display major 
fold-changes between putrescine-containing and starved cultures.  
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ABSTRACT 
Aim: To investigate the impact of polyamine deprivation on the transcriptome of CHO cells 
Results: Polyamines play a central but poorly-understood role in cell proliferation. Most studies to 
date have utilised chemical inhibitors to probe polyamine function. Here we exploit the fact that CHO 
cells grown in serum-free medium have an absolute requirement for putrescine supplementation due 
to their deficiency in activity of the enzyme arginase. A gene expression microarray (Affymetrix) 
analysis of CHO-K1 cells starved of polyamines for 3 days showed that cessation of growth, 
associated with increased G1/S transition and decreased M/G1 transition, was accompanied by 
increased mRNA levels of mitotic complex checkpoint genes (Mad2l1, Tkk, Bub1b) and of the 
transition of G1- to S-phase (such as Skp2 and Tfdp1). mRNAs associated with DNA homologous 
recombination and repair (including Fanconi’s anaemia-related genes) and with RNA splicing were 
consistently increased. Alterations in mRNA levels for genes related to protein processing in the ER, 
to ER stress, and to p53-related and apoptosis pathways were also observed. mRNAs showing highest 
levels of fold-change included several which code for membrane-localised proteins and receptors 
(Thbs1, Tfrc1, Ackr3, Extl1). 
Conclusions: Growth-arrest induced by polyamine deprivation was associated with significant 
alterations in levels of mRNAs associated with cell cycle progression, DNA repair, RNA splicing, 
ER trafficking and membrane signalling as well as p53 and apoptosis-related pathways. 
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1. Introduction 
The polyamines spermine, spermidine and putrescine play multiple roles in cell growth, survival and 
differentiation, being essential for healthy cell proliferation. Due to their cationic state at 
physiological pH, polyamines mainly exist as polyamine-RNA complexes, being described to induce 
ribosome shunting, displacing translation inhibitors and stabilising RNA structures, suggesting an 
important role in the regulation of protein synthesis (Igarashi and Kashiwagi 2019). DNA structural 
changes are also induced by polyamine interaction, increasing chromosomal condensation or 
inducing B- to Z- DNA conformational changes, thus regulating gene expression (Casero, Murray 
Stewart, and Pegg 2018; Igarashi and Kashiwagi 2019). Activation of transcription factors has been 
also observed to be affected by polyamine levels. Consequently, polyamines have an impact on gene 
expression at transcriptional and translational level, affecting the proliferation and viability of 
mammalian cells. 
In 1982, Hölta et al. reported growth arrest of a CHO-K1 cell line in serum-free and polyamine-free 
media, which was associated with a lack of expression of the first enzyme of polyamine production 
pathway (arginase) (E Hölttä and Pohjanpelto 1982). Since then, several studies focused on 
understanding polyamines essential role were performed by generating mutants or supplementing 
polyamine biosynthesis inhibitors (Anehus et al. 1984; Jan O. Fredlund and Oredsson 1997b). 
However, little investigation has been carried out in CHO since the early 2000s. Recently, we have 
described a novel selection system for the generation of recombinant protein producing CHO cells by 
combining the use of an arginase-expressing vector and selection in putrescine-free media (Capella 
Roca et al. 2019). Lack of arginase activity was further confirmed in a panel of three CHO cell lines 
(CHO-S, DP12 and DUXB11), confirming the importance of putrescine for CHO cells. This unusual 
property of CHO cells provides an interesting opportunity to study the effects at a cellular and 
molecular level of polyamine deprivation, without the need to use chemical inhibitors of polyamine 
biosynthesis which although quite specific may also display off-target effects. Given the critical role 
these compounds play in various cellular pathways we therefore decided to investigate the impact of 
polyamine removal on gene expression in CHO cells using Affymetrix CHO whole transcriptome 
microarray chips 
 
2. Materials and methods 
 
2.1. Cell culture 
A parental CHO-K1 cell line (ATTC CCL-61) was cultured in in-house serum-free SFM-F12 medium 
containing 1mg putrescine/L (Capella Roca et al. 2019). To study the effects of polyamine 
deprivation, cells were cultured both with and without putrescine in another in-house SFM-F10 
medium, which has a similar formulation to SFM-F12 but lacks putrescine (Capella Roca et al. 2019). 
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Biological triplicates were analysed for viable cell density (VCD) and viability using the ViaCount 
on a Guava easyCyte HT benchtop cytometer.  
 
2.2. Cell Cycle analysis 
For cell cycle analysis, samples were prepared using the Guava Cell Cycle reagent containing 
propidium iodide, following manufacturer’s instructions, and read on the Guava easyCyte HT 
benchtop cytometer. Data was analysed using the ModFit LT 3.2 software. 
 
2.3. RNA extraction 
Cell pellets from biological triplicates were collected at day 3 from putrescine-deprived and control 
(putrescine-containing) cultures. They were re-suspended in 1ml Trizol reagent and total RNA was 
then isolated following manufacturer's recommendations. NanoDrop was used to evaluate RNA 
quantification and quality. DNase I treatment was performed as per manufacturer’s protocol and 
samples were stored at – 80 C until assessed.  
 
2.4. Microarrays 
RNA quality was assessed using an Agilent 2100 Bioanalyzer. A total of 300 ng was added to each 
Affymetrix CHOGene 2.0 ST array, as per manufacturer's instructions. Data pre-processing and 
analysis of microarray data was carried out using the Transcriptome Analysis Console (TAC) 4.0.1 
(Applied Biosystems). Only differentially-expressed (DE) genes between putrescine-deprived and 
control cells with a fold-change cut off of 1.5 and a Benjamini-Hochberg FDR p-value ≤ 0.05 were 
considered. Enrichment analysis was carried out for the differentially-expressed mRNAs via the 
DAVID interface (http://david.abcc.ncifcrf.gov ) for two databases (Kyoto Encyclopedia of Genes 
and Genomes (KEGG)). The microarray data files have been deposited at Gene Expression Omnibus 
(GEO). 
 
2.5. RT-qPCR 
Samples were prepared using the High Capacity cDNA Reverse Transcription Kits and Fast SYBR 
Green Master Mix, as per manufacturer’s recommendations. RT-qPCR were performed in an 7500 
(Applied Biosystems) as per Capella et al. 2019. Relative quantification was measured by the 
comparative ddCt method (Livak and Schmittgen 2001). Gapdh was used as endogenous control, as 
it was by Veress et al. (2000) but note that they reported stabilisation of Gapdh mRNA following 
polyamine-inhibition treatment. The Ct values for Gapdh from both cultures (with and without 
putrescine) were observed in between the range of 15-16 Ct. It was then considered that the RQ data 
was obtained was accurate, although our qPCR may underestimate fold change of mRNAs showing 
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differential expression (this does not apply to the microarray results). Technical triplicate wells were 
run per each biological triplicate. The sequences of the primers used are available in Supplementary 
Table 1 (Appendix C).  
 
3. Results and Discussion 
Exploiting the lack of arginase activity of CHO-K1 cells (E Hölttä and Pohjanpelto 1982), the effects 
of polyamine withdrawal in these cells was assessed in serum-free medium. Hence, polyamine 
biosynthesis inhibitors (e. g. α-difluoromethylornithine (DFMO)), commonly used for the study of 
polyamine-deprivation, were not needed, eliminating the danger of possible off-target effects 
(Mamont et al. 1978). Initial assessment of cell proliferation following polyamine starvation revealed 
a decrease in CHO K1 growth, with viability only slightly reduced (Fig. 1a), in agreement with 
previous research (Anehus et al. 1984; E Hölttä and Pohjanpelto 1982; Capella Roca et al. 2019). 
 
 
Fig. 1 (a) Viable cell density (VCD, black lines) and 
viability (dotted lines) of CHO-K1 cells in SFM-F10 
without putrescine (NoPut) and supplemented with 
putrescine (+Put). (b, c, d) Distribution of cell cycle 
population of cultures with putrescine (+Put) and 
without (NoPut) at day 1 (b), day 2 (c) and day 3 (d), 
being populations at G1 (first peak, left) and G2 
(second peak, right) represented in red and S-phase 
cells in stripped lines. Biological triplicates and 
technical duplicates were performed for each 
condition (cell cycle represented corresponds to the 
biological triplicate 3). 
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3.1. Gene expression altered in CHO K1 cells following polyamine-deprivation 
To investigate impact of putrescine deprivation on mRNA levels in CHO cells, RNA samples taken 
at day 3 (when growth arrest had been maintained for 2 days) were hybridised to the Affymetrix 
CHOGene 2.0 ST array. A total of 2,171 mRNAs were found to be differentially-expressed (DE) with 
1,194 mRNAs up- and 977 down-regulated. It should be noted that our methods do not distinguish 
between transcriptional activation of genes and stabilisation of existing mRNAs; in fact as discussed 
by Veress et al (2000) it is likely that polyamine deprivation results in selective stabilisation of certain 
mRNAs since eIF5A, which requires polyamines for an essential posttranslational modification, is 
believed to play a central and selective role in RNA degradation. Our finding that many mRNAs 
involved in RNA splicing are present at higher levels suggests that increased saturation of pre-
mRNAs may also play a role. 
Initial analysis of the data focused on changes in the expression of polyamine metabolism genes in 
order to validate the experiment. An induction of polyamine biosynthesis pathway-related genes 
(ornithine decarboxylase (Odc1) and antizyme inhibitor 1) and down-regulation of genes involved in 
polyamine catabolism (ornithine decarboxylase antizyme 2 and N1-acetyltransferase 1 (Sat1)) was 
observed as expected from the literature (Igarashi and Kashiwagi 2019). These results suggest that 
even though CHO-K1 cells lack endogenous ornithine production pathways (E Hölttä and 
Pohjanpelto 1982; Baumgartner 2000), a response to restore polyamine levels by Odc1overexpression 
is still present in polyamine-deprived CHO cells.  
From a list of 20 mRNAs displaying the largest fold-changes in both directions (10 up and 10 down, 
Table 1 - for top 50 up- and down- see Appendix C, Supplementary Table 2) we chose 6 based on 
their relevance to cell proliferation and involvement with polyamines (Thbs1, Ackr3, Tfrc, Pacrg, 
Tbc1d2 and Extl1) for RT-qPCR validation using primers listed in Supplementary Table 1 (Appendix 
C). All six genes were observed to display RQ changes on the same direction as the microarray data 
(Appendix C, Supplementary Figure 1) providing strong validation of the microarray data. The 
polyamine modulated factor 1 (PMF-1) gene, not detected in the microarray, was also included in the 
RT-qPCR analysis due its reported expression-response to high polyamine levels (Igarashi and 
Kashiwagi 2019). However, a small up-regulation of PMF-1 was observed, although a target gene 
(Sat1) and the co-transcription factor required for its function (Nrf-2) were here observed to be down-
regulated.  
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Table 1. List of the 10 most compelling up-regulated and down-regulated differentially-expressed 
genes considering fold-changes. 
Gene symbol Description Fold-
change 
FDR p-val 
Thbs1 thrombospondin 1 7.79 4.25E-05 
Ackr3 atypical chemokine receptor 3 6.97 2.06E-05 
Tfrc transferrin receptor 6.62 1.07E-05 
Chst2 carbohydrate (N-acetylglucosamine-6-O) 
sulfotransferase 2 of the Golgi network 
4.58 0.0002 
Loc103162148 uncharacterized LOC103162148 4.45 0.0002 
Znf483 zinc finger protein 483 4.24 2.13E-05 
Rnft2 ring finger protein, transmembrane 2 – E3 ubiquitin 
ligase 
3.95 1.62E-05 
Arhgef16 Rho guanine nucleotide exchange factor (GEF) 16 – 
involved in phagocytosis of apoptotic cells  
3.93 1.80E-05 
Pacrg PARK2 co-regulated 3.89 8.71E-05 
Slc17a6 solute carrier family 17 (vesicular glutamate 
transporter), member 6 
3.72 0.0021 
Cornifin-a cornifin alpha -13.85 2.37E-05 
Tbc1d2 TBC1 domain family, member 2 -7.85 2.13E-05 
Cd68 CD68 molecule -7.81 2.13E-05 
Trib3 tribbles pseudokinase 3 – mTORC2/AKT pathway 
inhibitor 
-7.54 1.07E-05 
Ypel3 yippee-like 3 (Drosophila) – apoptosis and cell cycle 
arrest inducer 
-6.84 1.62E-05 
Slc6a9 solute carrier family 6 (neurotransmitter transporter, 
glycine), member 9 
-6.84 1.62E-05 
Gtpbp2 GTP binding protein 2 -6.39 6.82E-06 
Atf3 activating transcription factor 3 – ER stress 
responsive 
-6.19 2.06E-05 
Chac1 ChaC, cation transport regulator homolog 1 (E. coli) - 
ATF3/4 activated under ER stress 
-5.7 1.07E-05 
Extl1 exostosin-like glycosyltransferase 1 -5.63 2.06E-05 
 
Thrombospondin 1 (Thbs1) was the mRNA with greatest increase in level. Increased expression of 
this gene has been already reported in DFMO-treated breast cancer cell lines (Manni et al. 2003; 
Verderame et al. 2007). Thbs1 has been described to induce cell cycle arrest and decreased growth in 
human umbilical vein endothelial cells (Yamauchi, Imajoh-Ohmi, and Shibuya 2007). Substantial up-
regulation (6.69 fold-change) of CXCR7 (Ackr3) was also observed. Several polyamine-derived 
inhibitors (such as Quinazoline‐triazole based antagonists) targeting the chemokine receptor CXCR4 
have been reported (Tsou et al. 2018) while affinity for this receptor by natural polyamines has been 
also described (Smith et al. 2017). Singh et al. (2013) reported that crosstalk can occur between the 
chemokine receptors CXCR 3,4 and 7 via CXCR 11 and 12.  
Due to the essential role of iron during DNA replication, increased expression of Tfrc during the S-
phase of the cell cycle has been reported (Neckers and Cossman 1983). Correlation between iron 
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levels and expression of polyamine metabolism enzymes has been also observed (Lane et al. 2018), 
while uptake of iron by the polyamine transport system has been also observed (Gaboriau et al. 2004). 
In our microarray data, an increase in Tfrc expression was observed, further suggesting a possible 
relationship between iron and polyamines in cell cycle progression. It is also worth noting that a 
substantial down-regulation of Tbc1d2 expression was also detected (-7.8 fold-change). Low 
expression of this gene has been related to a decrease in endocytic receptor recycling, observed with 
lack of Tfrc recycling, which might indicate possible increased Tfrc mRNA detected due to a 
dysregulation on the recycling pathway (Serva et al. 2012). 
The Parkin co-regulated gene (Pacrg), regulated by the same promoter as Parkin, was also considered 
of possible significance due to the involvement of Parkin as a tumor suppressor inducing cell cycle 
arrest (M. H. Lee et al. 2015). 
Regulation of the expression of the heparan sulphate glycosyltransferases EXT1 and EXT2 has been 
previously described to be mediated by polyamines (Imamura et al. 2016) and in our study, down-
regulation of Extl1 was similarly associated with polyamine starvation in CHO.  
All together these data indicate that polyamines cause an impact on the expression of cell membrane 
proteins and receptors involved in cell proliferation, which might contribute to activation of 
proliferating pathways or polyamine transport. 
A decrease in levels of several apoptosis-inducing mRNAs was observed with Ypel3, Trib3, ATF3, 
Chac1, Casp 8 and Bax, which correlates with the high percentage of viability maintained even after 
growth arrest (Fig. 1a). 
From the 2,171 DE transcripts list, enriched pathway analysis using the DAVID interface was 
performed, revealing five statistically significant pathways (Benjamini-Hochberg FDR-corrected p-
value ≤0.05) to be differentially-regulated following putrescine deprivation (Fig. 2). The most 
significant areas which emerged were cell proliferation, Spliceosome, p53-related pathways, 
Fanconi’s Anaemia/DNA repair and Protein Processing in Endoplasmic Reticulum (ER). 
In relation to the cell cycle, the expression of genes related to S-phase and mitosis included increased 
mRNA levels Skp2 and Tfdp1 (participating in the transition to S-phase) and Mad2l1 (part of the 
mitotic complex checkpoint). Supporting these findings, analysis of the cell cycle of the cultures in 
medium without putrescine displayed a continuous decrease on G1 population with a subsequent 
increase in S-phase populations over the three days culture. At the same time an accumulation of cells 
in the G2-phase was also observed by day 3 (Fig. 1 b,c,d). These results suggest arrest caused by 
polyamine-deprivation at possibly 3 points; the G1/S transition, mitosis and possibly also at the G2/M 
transition point. Similar to our findings, CHO cultures deprived of polyamines have been reported to 
display prolonged S-phase (Jan O. Fredlund and Oredsson 1997b; J. O. Fredlund and Oredsson 1996; 
Anehus et al. 1984). However, cell cycle effects on other mammalian cell lines have been reported to 
arrest at different stages depending on the cell line, such as G0/G1 (NIH3T3 mouse fibroblasts) 
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(Landau et al. 2012), G1/S (Hela and MALME-3M) (Yamashita et al. 2013; Kramer et al. 1999) or 
G2/M (MALME-3M) (Kramer et al. 1999). Polyamine deprivation has been reported to induce 
structural changes on microtubules, resulting in delayed cytokinesis in Hela (Yamashita et al. 2013) 
and CHO (Pohjanpelto, Virtanen, and Hölttä 1981). A peak on ODC activity is also detected at late 
stage of the cell cycle (Oredsson 2003), suggesting an involvement of polyamines for proper mitosis 
progression. 
In response to polyamine-deprivation, we observed lower levels of some mRNAs involved in ER 
stress, with the significant lower expression of Ddit3 apoptosis-inducer gene being validated by RT-
qPCR (Fig. 2, Appendix C, Supplementary Figure 1). Increased polyamine catabolism produces toxic 
by-products that can trigger ER stress and eventual apoptosis, as reported by the overexpression of 
Sat1 and SMOX in acute kidney injuries (Zahedi et al. 2017). Similarly, CCl4 treatment of liver 
increased Sat1 expression, inducing tissue damage (Zahedi et al. 2012). Consequently, decreased 
expression of genes related to ER-stress observed in our study might be associated with down-
regulation of Sat1. DFMO treated epidermal IEC-6 cells and NIH3T3 displayed lack of apoptosis 
pathway activity (Li et al. 1999) (effect also observed in our system), although increased ER-stress 
was observed in the NIH3T3 cultures (Landau et al. 2012).  
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Fig. 2 Fold-changes of DE genes from enriched pathways DAVID interface analysis. 
 
 
 
 
Ls
m
3
Sr
sf
7
M
ag
oh
Ls
m
7
Zm
at
2
Sn
rp
e
Pp
ih
R
bm
22
LO
C
10
07
69
25
1
LO
C
10
07
74
87
9
R
bm
x
Pr
pf
38
a
Sn
rp
f
Pr
pf
3
Ls
m
6
A
ly
re
f
H
nr
np
c
Sn
rp
d1
Ls
m
2
Sn
rp
b2
Sf
3a
2
Sf
3b
4
Sn
rp
d3
Pr
pf
4
Sr
sf
1
R
bm
8a
C
he
rp
LO
C
10
07
55
24
1
U
2s
ur
p
Sr
sf
3
Sn
rn
p2
00
H
nr
np
m
Tr
a2
b
W
bp
11
N
cb
p2
C
dc
40
LO
C
10
07
72
45
1
-2
-1
0
1
2
3
F
o
ld
-c
h
a
n
g
e
Spliceosome
C
as
p1
R
bx
1
B
ak
1
R
ad
23
a
Tr
af
2
C
ap
n2
M
an
1c
1
Se
c6
1g
D
na
ja
1
Sk
p1
C
ka
p4
N
gl
y1 B
ax
U
be
4b
N
fe
2l
2
Er
p2
9
Ed
em
2
Se
c3
1a
Pp
p1
r1
5a
Pd
ia
6
Sy
vn
1
H
yo
u1
D
na
jc
1
A
tf6
Se
c2
4d
H
sp
a5
Si
l1
M
bt
ps
1
X
bp
1
Pd
ia
4
Se
l1
l
D
di
t3
H
er
pu
d1
-6
-4
-2
0
2
4
F
o
ld
-c
h
an
g
e
Protein Processing - Endoplasmic Reticulum
Po
lk
R
pa
3
Em
e1
B
rip
1
Fa
nc
b
Fa
nc
i
R
ad
51
U
sp
1
R
pa
2
Po
lh
Pm
s2
A
tri
p
B
lm
B
rc
a2
R
m
i1
-2
0
2
4
F
o
ld
-c
h
a
n
g
e
Fanconi Anaemia
Sk
p2
C
cn
e2
Tf
dp
1
M
cm
3
R
bx
1
M
ad
2l
1
C
dk
n2
c
C
cn
b1
E2
f2
Pt
tg
1
O
rc
6
C
dk
2
C
dc
7
Tp
53
C
dc
25
b
B
ub
1b
C
cn
e1
C
cn
d1
M
cm
4
R
bl
1
C
dc
25
a
Y
w
ha
z
Tt
k
Y
w
ha
b
C
dc
14
b
M
cm
5
C
dc
45
C
cn
b2
Sk
p1
R
b1
O
rc
3
C
dk
n1
b
Pr
kd
c
-3
-2
-1
0
1
2
3
4
F
o
ld
-c
h
a
n
g
e
Cell Cycle
Th
bs
1
C
cn
e2
Zm
at
3
G
ts
e1
C
cn
b1
C
dk
2
Tp
53
C
cn
e1
C
cn
d1
C
cn
g1
Se
rp
in
e1
C
cn
b2
R
rm
2
C
as
p8 B
ax
Ts
c2
Se
sn
2
C
d8
2
C
cn
g2
-4
-2
0
2
4
6
8
F
o
ld
-c
h
a
n
g
e
p53
 108 
 
4. Conclusions 
The research described here is the first step in exploiting the CHO cell requirement for exogenous 
polyamine to investigate cellular roles of polyamines by nutritional depletion rather than by using 
chemical inhibitors. 
Insights have been gained into alterations in mRNA levels for specific genes and pathways, notably 
relating to cell cycle, RNA splicing, DNA homologous recombination and repair, p53-related 
pathways, membrane receptors and protein processing in ER. We realise that much remains to be 
discovered using this inhibitor-free system unique to CHO cells by examining, for example, changes 
at the proteomic and functional levels. In this paper we have demonstrated the power of the serum-
free CHO system to generate new knowledge on polyamine biology, still poorly understood, and we 
hope that the data presented supposes a first step for further investigation in the area. 
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Preface to the paper – A case study on the relevance of media formulation for transfections 
From the previous chapters, media composition has been determined to be a relevant factor to achieve 
enhanced culture performance of CHO cells (growth or productivity). However, alterations in media 
formulation have also a major impact on other bioprocess-relevant parameters, such as transfection 
efficiency. In this last chapter, to further showcase the importance of media additives, the impact of 
SFM-8 (described in Preface to the Chapters – in-house serum-free media development) in the 
transfection of CHO cells was assessed. In this case study, three different chemically-based 
transfection reagents (cationic lipid, cationic polymers and lipopolyplexes) were included to consider 
possible differences between each mechanism and how they may be differently affected by the same 
media additive. Moreover, the effects were confirmed in three CHO cell lines, accounting for possible 
cell line-specific results. Transfection efficiency was monitored using a GFP-expressing vector. The 
levels of percentage of GFP-expressing population as well as the intensity of fluorescence were 
assessed to determine the efficacy of transfection. Initial tests revealed a lack of GFP detection in all 
cell lines tested with two of the transfection reagents and very low efficiencies with lipopolyplexes. 
In order to identify the impeding additive, a step-wise removal protocol was followed revealing ferric 
ammonium citrate (FAC) as an inhibitory supplement for chemical transfection. With the removal of 
FAC, successful transfections were achieved, although viabilities were negatively impacted due to 
the vital role this additive plays in CHO cell culture. To circumvent this effect, an alternative 
transfection protocol was developed, combining transfection in FAC-depleted medium with 
replenishment prior 24h post-transfection.  
Inhibitory FAC effects were observed during the initial steps of transfection, as supplementation of 
this iron source 30 min post-transfection did not impede GFP expression. For this reason, we decided 
to characterise the DNA-delivery particles in order to gain insight into the mechanistic inhibitory 
effect of FAC by assessing their zeta potential and particle size. These parameters have become 
standard in the study of transfection efficiencies, being sensitive to changes in the pH, viscosity, 
temperature or ionic strength of the media (Mandal et al. 2018; Yu et al. 2019; Smith et al. 2017). 
Consequently, changes in the particle size of each of the three DNA-reagent complexes were 
monitored over 1 h incubation in media with and without FAC. Effects in three commercial media 
were also assessed. The results displayed increases in the particles size over the 1h incubation, 
indicating a potential FAC-mediated aggregation or destabilization. However, this effect was not 
observed with polymers transfection complexes.  
Zeta potential gives an indication of the surface charge of the particle under specific conditions (pH, 
temperature, viscosity) (Fig. 10) (Smith et al. 20017; Bhattacharjee 2016). Chemical-based 
transfection rely, in part, to the electrostatic interaction between cellular membrane and transfection-
complex (Kim and Eberwine 2010). For this reason, “negatively charged” complexes may result in 
lack of transfection. Positive zeta potentials were here detected in the absence of FAC in two of the 
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complexes, while liposomes displayed negative zeta potential values. The differences observed in 
zeta potential and particle size between the three transfection reagents indicated that investigation of 
the different mechanistic DNA uptake of each the three transfection reagents requires investigation 
to further understand the negative effects of FAC in transfection. 
 
Fig. 10 Determination of the zeta potential on a negatively charged particle. Immediately on top of 
the particle surface there is a strongly adhered layer (Stern layer) comprising of ions of opposite 
charge i.e. positive ions in this case. Beyond the Stern layer, a diffuse layer develops consisting of 
both negative and positive charges. These two layers of tightly and loosely associated ions are 
collectively referred to as the electrical double layer (EDL). During electrophoresis the particle with 
adsorbed EDL moves towards the electrodes (positive electrode in this case) with the slipping plane 
becoming the interface between the mobile particles and dispersant. The zeta potential is the 
electrokinetic potential at this slipping plane. Image and legend  (adapted) from (Bhattacharjee  2016). 
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ABSTRACT 
While reliable transfection methods are essential for Chinese Hamster Ovary (CHO) cell line 
engineering, reduced transfection efficiencies have been observed in several commercially-prepared 
media. In this study, we aimed to assess common media additives that impede efficiency mediated 
by three chemical transfection agents: liposomal-based (Lipofectamine 2000), polymer-based 
(TransIT-X2), and lipopolyplex-based (TransIT-PRO). An in-house GFP-expressing vector and 
serum-free medium (BCR-F12: developed for the purposes of this study), were used to analyse 
transient transfection efficiencies of three CHO cell lines (CHO-K1, DG44, DP12). Compared to a 
selection of commercially-available media, BCR-F12 displayed challenges associated with 
transfection in vendor-prepared formulations, with no detection when liposomal-based methods were 
used, reduced (<3 %) efficiency observed when polymer-based methods were used and only limited 
efficiency (25 %) with lipopolyplexes. Following a stepwise removal protocol, ferric ammonium 
citrate (FAC) was identified as the critical factor impeding transfection, with transfection enabled 
with the liposomal- and polymer-based methods and a 1.3- to 7-fold increased lipopolyplex efficiency 
observed in all cell lines in FAC-depleted medium (-FAC), although lower viabilities were observed. 
Subsequent early addition of FAC (0.5-5 h post-transfection) revealed 0.5 h post-transfection as the 
optimal time to supplement in order to achieve transfection efficiencies similar to -FAC medium 
while retaining optimal cellular viabilities. In conclusion, FAC was observed to interfere with DNA 
transfection acting at early stages in all transfection agents and all cell lines studied and a practical 
strategy to circumvent this problem is suggested. 
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1. Introduction  
Transfection is a core technique in molecular biology studies which is used to investigate the role of 
proteins and genes in cellular systems. In the field of biopharmaceutical manufacturing, transfection 
efficiency is a critical early step in upstream cell line development to produce complex proteins, 
typically in Chinese Hamster Ovary cells (CHO), as efficient transient gene expression offers the 
possibility of producing large amounts of recombinant protein rapidly. For this reason, optimization 
of transfection efficiency, accompanied with minimal cellular perturbation is a desirable goal of 
industry, examining the critical parameters affecting this process: cell type, cell line, expressing 
vector, transfection method and cultivation media, among others (1).  
DNA-delivery systems can be broadly classified as biological (virus-mediated), chemical (vector-
assisted) and physical (2, 3). Chemical transfection methods work on the principle of electrostatic 
interaction; forming positively charged complexes with nucleic acid, enabling interaction with the 
cellular membrane and finally releasing the genetic material into the cells (2). Chemical methods can 
be sub-classified into 3 types: (i) lipid-based (lipoplexes; cationic lipid-based), (ii) polymer-based 
(polyplexes) and (iii) lipid mixed with polymer or peptides (lipopolyplexes). Currently, a wide range 
of transfection reagents are commercially available (e. g. Lipofectamine 2000, FuGENE 6, PEI, 
TransIT-X2, TransIT-PRO, TransIT-LT1). Compared to more cost-effective reagents such as calcium 
phosphate or DEAE-Dextran, commercial agents have been advantageously applied to highly 
differentiated cell lines (such as CHO) and serum-free conditions achieving high transfection 
efficiencies (4, 5). Among polymer cationic methods, polyethylenimine (PEI) is the most common 
transfection system used for CHO and HEK293 transient transfection, offering a cost-efficient, easy-
to use and efficient methodology (6). As a result, multiple studies have focused on understanding and 
improving this transfection system (7, 8), resulting in the development of several PEI-derivate agents 
(9, 10). However, other polymer-based methods reported for successful CHO cells transfection (e.g. 
TransIT-X2 (11)) have received less investigation. Cationic lipids are comprised of hydrocarbon 
chains, neutral helpers and a cationic head group (12). Structural changes such as the type of lipid 
and composition of the complex plays a crucial role on final DNA delivery. Thus, several lipids have 
been tested, mainly to improve gene delivery, such as palmstearin, which have been reported to be 
successful in CHO cells, increasing efficiency of a commercial control lipofectamine RNAiMAX 
(13). Improvements in cell transfection have also been observed with the novel use of tomatidine, 
recently described by Rangasami et al (2019), which was reported to induce cell permeability when 
used as a helper lipid (14). Liposomes have frequently been shown to efficiently generate transiently-
expressing (15) and stably-expressing (16, 17) CHO cell lines. However, negative effects on cellular 
viabilities (18) have been described using this method, while poor endosomal escape and subsequent 
increased lysosomal degradation have also been reported (19). To overcome this hurdle, a second-
generation of DNA-delivery systems consisting of ternary structures of cationic lipids, polycations 
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(polymers or peptides) and nucleic acids have been developed, characterized by high transfection 
efficiencies due to the highly condensed DNA complexes together with the generated smaller particle 
sizes (20). Described by Caracciolo, G. et al (2011), lipopolyplexes composed by DNA/protamine 
coated by DOTAP have been observed to outperform the lipid-based DOTAP transfection 
efficiencies in mammalian cells, including CHO-K1 (21). Similarly, TransIT-PRO has been reported 
to display increased transfection efficiency, DNA expression and lower toxicity than PEI and 
Liposome 2000 in CHO-S cells (22). 
One of the key challenges that impact the efficiency of DNA delivery into mammalian cells is the 
composition of the culture media. Previous studies examining the efficiency of several transfection 
methods in combination with commercially-prepared media formulations have reported substantially 
decreased or even fully impeded DNA transfection in HEK293 and CHO cell lines, the two most 
prominent cell lines used in industry for mammalian cell production of biopharmaceuticals (23, 24). 
As the media components in these formulations are frequently not disclosed by the manufacturer due 
to commercial sensitivities, identification of medium components that may interfere with DNA-
delivery remains a challenge to optimization of transfection efficiency in mammalian culture. While 
some media additives have been identified as having a detrimental impact on transfection efficiency 
(1, 25, 26, 27), further investigation is still required to enhance the efficacy of the process. In order 
to assess the ability of media additives to support or impede transfection efficiency, we developed a 
serum-free (SFM) medium (BCR-F12) containing common media supplements and used it to test 
three different chemical-based transfection methods: (i) Lipofectamine 2000 
(liposomes/lipoplexes/cationic lipid-based), (ii) TransIT-X2 (polyplexes/polymer-based) and (iii) 
TransIT-PRO (lipopolyplex system) in three CHO cell lines (DG44, DP12, CHO-K1), measuring the 
percentage of GFP expressing cells from an in-house vector. Following the identification of a single 
media component as a transfection inhibitor, cell culture performance (viability and growth) was then 
assessed in the absence and presence of the interfering additive, in order to develop an efficient 
transfection protocol that simultaneously maintained minimal cellular perturbance. Finally, in order 
to gain insight in the mechanistic inhibitory effects observed, complexes generated with all three 
transfection reagents in each media tested were assessed for size and zeta potential changes. 
 
2. Materials and methods  
 
2.1. Cell culture 
Three CHO cell lines, CHO-DP12 (a recombinant human IgG-producer, ATCC CRL-12445 
clone#1934), an in-house DG44 derived cell line and a CHO-K1 parental (ATTC CCL-61) fully 
adapted to grow in suspension in serum-free media were cultured and maintained in three commercial 
media: a chemically-defined and animal-free medium (BalanCD CHO Growth A medium (Irvine 
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Scientific), a serum-free medium (CHO-S-SFM-II (Thermo Fisher Scientific), and a protein-free 
medium (ProCHO-5 (Lonza)). Cells were also cultured in an in-house serum-free medium (BCR-
F12). The BalanCD Growth A medium lacks hypoxanthine, thymidine, antibiotics and antimycotic 
and it was further supplemented with 8 mM L-glutamine (Gibco). The CHO-S SFM-II is a low-
protein formulation containing hypoxanthine, thymidine, L-glutamine, sodium pyruvate and sodium 
bicarbonate. The ProCHO5 medium contains 0.1 % Pluronic F-68 but lacks thymidine, hypoxanthine 
and phenol red. This medium was further supplemented with 5 mM L-glutamine (Gibco). The in-
house BCR-F12 medium was developed based on DMEM-F12 (1:1, v/v) (Sigma Aldrich, D8437) 
supplemented with sodium selenite, recombinant human insulin, ethanolamine, ferric ammonium 
citrate, poly vinyl alcohol (PVA), L-glutamine (Gibco), NEAA (Gibco), linoleic acid and putrescine 
dihydrochloride (28). The only growth factor supplement in the BCR-F12 serum-free medium is 
insulin, which has been extensively shown to be sufficient to support CHO cell growth in culture 
(29). All supplements were purchased from Sigma Aldrich unless otherwise stated. Cells were grown 
in each media for at least 3 passages, ensuring that similar VCDs were reached at each passage before 
performing transfection tests. Cells were routinely split every 3-4 days and re-seeded at 2x105 cells/ml 
in 250 ml shake flasks in 20-30 ml working volume. Cultures were maintained at 37 oC in suspension 
culture in an ISF1-X (Climo Shaker) Kuhner incubator with a speed of 170 rpm, 80 % Humidity and 
5 % CO2. Viable cell density (VCD) and viability were analysed using the ViaCount reagent (Guava 
Technologies, 4000-0041) on a Guava easyCyte 75 HT benchtop cytometer (Merck Millipore, UK). 
This reagent is a mixture of two DNA-binding dyes (propidium iodide and LDS-751) which 
distinguishes between non-viable and live cells. LDS-751 is membrane permeable dye (30) that stains 
all nucleated cells, while propidium iodide stains non-viable cells due to the lack of integrity of their 
membranes (31). The detection of viable cells is recorded when the fluorescence signal is 
accompanied by the signal of forward light scatter (FSC) in the appropriate intensity (in the 
photomultiplier tube 2, PM-2), which is related to cell size. If a lower FSC intensity is detected, the 
signal is recorded as cell debris. For this study, in order to exclude GFP detection from the VCD and 
viability fluorescence signal, the ExpressPro software was used and cell gating was performed using 
healthy cultures following the easyCyte™ System User Guide (0110-8493 Rev B). Statistical analysis 
of the VCD and viability data obtained was performed in Microsoft excel software using two‐tailed 
homoscedastic student t‐test to generate p-values. This is the form of Student's t-test which is 
appropriate to use when comparing sets of data which have similar variances - for the type of data 
presented here, it is reasonable to assume a normal distribution. 
𝑡 =
𝑥1 − 𝑥2
𝑠1
√𝑛1
+
𝑠2
√𝑛2
 
Described in (32).  
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2.2. Transfections 
An in-house GFP expressing vector (named as N44), based on CMV-d2eGFP pcDNA5 vector 
(Addgene) (modified with a functional hygromycin selection and modifications in the cloning site) 
was used for the purposes of this study due to the expression of destabilized GFP (d2GFP). Despite 
its lowered stability profile, the d2GFP vector was utilised in order to monitor minor effects on 
transfection efficiency between cell lines, transfection reagents and media – these minor effects would 
have been missed if the more stable eGFP vector and protein was used. Vector DNA was extracted 
from 5 ml Component Escherichia coli DH5α (Invitrogen) transformed cultures using the GeneJET 
Plasmid MiniprepKit (Thermo Fisher Scientific) as per the manufacturer’s instructions. Vector 
extractions were assessed for quality and quantity using the NanoDrop ND-100 (NanoDrop 
Technologies). Three transfection systems were used in this study: (i) a lipoplexes/cationic lipid-
based transfection method (Lipofectamine 2000 (Thermo Fisher Scientific)), (ii) a polymer-
based/polyplexes system (TransIT-X2 (Mirus Bio), not Polyethyleneimine (PEI)-based) and iii) a 
lipopolyplex-mediated system (TransIT-PRO (Mirus Bio)). Transfections were performed following 
manufacturer’s recommendations for CHO cells with no adaptation of the protocol per each cell line. 
Briefly, cells were counted and re-seeded at 1x106 cells/ml in fresh media 24 h prior transfection. For 
TransIT-PRO, a total of 500 ng vector was mixed with 1 µL reagent and 100 µl media and incubated 
for 10 min at room temperature. For Lipofectamine 2000, 800 ng vector was diluted in 50 µl media. 
In parallel, 1 µL Lipofectamine 2000 was mixed with 50 µl media. Both mixtures were incubated for 
5 min and then gently mixed and incubated for an additional 20 min at room temperature. For 
TransIT-X2, 500 ng vector was mixed with 50 µl media and 1 µl TransIT-X2 was mixed in 50 µl 
media. Both were then combined, gently mixed and incubated for 30 min at room temperature. All 
complexes were generated in basal DMEM-F12 medium (Sigma Aldrich, D8437). Cells were re-
suspended in fresh media without PVA at 2x106 cells/ml (TransIT-PRO) and 1x106 cells/ml (TransIT-
X2) and 900 µl were seeded per well. For Lipofectamine 2000, cells were also re-suspended in media 
without PVA at 1.6x106 cells/ml and 500 µl were seeded per well. A total of 100 µl of vector-complex 
suspension was then added to each well per each transfection reagent. Plates were parafilmed and 
incubated at 37 oC in an ISF1-X (Climo Shaker) Kuhner incubator. Media change was not performed. 
For TransIT-PRO, the PRO boost reagent was not used. A negative control for transfections was also 
prepared following the same protocols as per TransIT-X2, TransIT-PRO and Lipofectamine 2000. 
However, DNA was not added to prepare the complexes. Each transfection condition tested was 
performed in triplicate wells. For the negative control, one to two wells were used for each testing 
condition. Viable cell density (VCD) and viability were assessed 24 h post-transfection using the 
ViaCount on a Guava easyCyte HT benchtop cytometer (Merck Millipore, UK). Technical replicates 
were performed for each transfected and non-transfected well.  
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2.3. Detection of GFP expression 
The detection of GFP-expressing cells was performed 24 h post-transfection by flow cytometry using 
the Express Plus software for the Guava easyCyte benchtop cytometer (Merck Millipore, UK). To 
determine the amount of fluorescent cells, negative control cells (cells that did not express GFP 
fluorescence above autofluorescence levels) were gated by modifying the voltage in the applicable 
channel to remove autofluorescence signal - these settings were then used to identify the GFP-positive 
populations. Fluorescence of dead cells and debris were excluded to avoid false positive results. 
Technical replicates were performed for each transfected and non-transfected well. Statistical analysis 
of the transfection data obtained was performed in Microsoft excel software using two‐tailed 
homoscedastic student t‐test to generate p-values (as per VCD and viability data). 
 
2.4. Measurement of size and zeta potential 
A Malvern Zetasizer Ultra, using ZS XPLORER version 1.2, (Malvern Panalytical Ltd, UK) was used 
for measuring the size of the complexes using Dynamic light scattering (DLS) at 37 °C. Triplicate 
measurements were performed.  
Samples for zeta potential measurements were placed in a ZEN1002 dip cell cuvette and 
measurements were obtained using Phase Analysis Light Scattering at 25 °C, using the Smoluchowski 
model. Zeta potential values were obtained using monomodal mode due to the dispersant 
conductivity. Between two to five replicates were performed per sample. 
 
3. Results 
 
3.1. BCR-F12 transfection efficiencies perform similarly to commercial media preparations 
A serum-free formulation (BCR-F12) was developed and compared to a range of three commercially 
available media (BalanCD Growth A, CHO-S-SFM-II and ProCHO5) to assess whether its 
transfection efficiency profile was representative of the issues observed in commercial formulations. 
Figure 1 displays the efficiencies observed in three CHO cell lines (DG44, DP12 and CHO-K1), 
measured as percentage of GFP-expressing populations (excluding autofluorescence signal based on 
non-transfected control cells), at 24 hours post-transfection using a range of three transfection agents; 
Liposome 2000 (Liposomes), TransIT-X2 (Polymers) and TransIT-PRO (Lipopolyplexes). The N44 
vector expressing the destabilized GFP (d2GFP) was used to assist in monitoring minor changes 
between media and transfection agents. 
In BalanCD, transfection was not supported with any of the transfection agents or cell lines used, 
while in contrast, 44-60% GFP-expressing populations were detected in SFM-II with all three DNA-
delivery systems and in all cell lines (Fig 1). In ProCHO5, all 3 cell lines displayed transfection 
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efficiencies between 31 % - 65 % using polymers or lipopolyplexes agents; however, GFP expression 
was not observed in any of the 3 cell lines when liposomes were used. The GFP expression levels 
observed following transfection in the candidate BCR-F12 medium indicated that it is a suitable 
model for studying medium-related transfection disruption; only the lipopolyplex method returned 
GFP-expressing populations (25 %) in all 3 cell lines, while polymer-based transfections resulted in 
< 3 % efficiency and GFP expression was not detected with liposomes. 
 
Fig. 1 Transfection efficiency in commercial and in-house media. Percentage of GFP-expressing 
DG44 (a), DP12 (b) and CHO-K1 (c) cells 24 h post-transfection with d2GFP in three commercial 
media: BalanCD growth A (CDM), CHO-S SFM-II (SFM) and ProCHO5 (PFM) and an in-house 
SFM (BCR-F12). Three transfection systems were tested: Liposomes (Lipofectamine 2000), 
Polymer-based (TransIT-X2) and Lipopolyplexes (TransIT-PRO). Triplicate transfections were 
carried out for each media, cell line and transfection method combination. Two negative control wells 
were included for each media, cell line and transfection method, displaying between 0.0 - 1.7 % GFP 
(data not shown).  
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3.2. SIFA additives interfere with BCR-F12 transfection with all transfection systems studied 
As our in-house BCR-F12 medium formulation was observed to display transfection issues 
representative of those seen in commercial media formulations (Fig. 1), identification of the BCR-
F12 medium additives that may contribute to the decreased transfection efficiencies was attempted. 
To achieve this aim, all the additives supplemented to DMEM-F12 basal medium to develop BCR-
F12 were removed in two groups. The first group comprised lipids and polyamines - linoleic acid, 
ethanolamine and putrescine which were suspected to inhibit transfection or interfere with DNA-
complex formation (25, 26, 33, 34) – this is the “LP” formulation. The second, “SIFA” formulation 
comprised the rest of the additives - sodium selenite, insulin, ferric ammonium citrate and non-
essential amino acids supplements. Basal medium (DMEM-F12) used for the development of BCR-
F12 formulation was also included as a control in order to assess maximal transfection efficiency 
achievable without supplemental additives, while DG44 cells were used as an initial model cell line, 
as transfection efficiencies for the different methods and in the different media were observed to be 
representative for all three cell lines (except for ProCHO5 medium) (Fig 1). Compared to BCR-F12 
medium, transfection efficiencies in Basal media increased from 1 % to 16 % in liposomes and 
increased 6.3-fold (5 % to 31 %) when using polymers (Fig 2). No significant differences were 
observed between transfections performed in LP and BCR-F12 media with any of the 3 methods, 
indicating that these formulations are practically identical with regard to transfection performance. 
However, in SIFA medium, efficiencies were observed to be restored to similar levels observed in 
Basal medium (31 - 33 % GFP-expressing cells in polymer-based transfection and 15 - 16 % GFP 
positive cells in liposomes), indicating that the major impediment additive to transfection in 
liposomes and polymer-based methods was removed (Fig 2). Conversely, a small but significant 
effect was observed in lipopolyplexes-mediated transfection efficiencies, displaying slightly lower 
efficiencies in SIFA and Basal media than in BCR-F12 (19 % compared to 21 %). 
 
Fig. 2 Transfection efficiency in BCR-F12, LP, SIFA and Basal media. Percentage of GFP 
expressing DG44 cells 24 h post-transfection with d2GFP in DMEM-F12 (Basal), in-house 
formulation BCR-F12, BCR-F12 lacking linoleic acid, ethanolamine and putrescine (LP) and BCR-
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F12 lacking sodium selenite, insulin, FAC, NEAA and L-glutamine (SIFA). Three transfection 
system were used: Liposomes (Lipofectamine 2000), Polymer-based (TransIT-X2) and 
Lipopolyplexes (TransIT-PRO). Triplicate transfections were set for each media and transfection 
method combination. A negative control well was included for each media and transfection method, 
displaying between 0.1 - 1.5 % GFP (data not shown). Statistical differences between transfection 
efficiencies observed in LP and SIFA conditions compared to the ones in BCR-F12 are represented 
as: p< 0.001 (***), p<0.01 (**). 
 
3.3. FAC reduces transfection efficiency of liposomes and polymer-based agents in DG44 cells 
Individual removal of each component of the SIFA group was then performed in DG44 cells in order 
to identify whether the enhancement of transfection efficiencies observed was a result of single or 
combinatorial components. As larger effects were observed in polymer- and liposomal-mediated 
transfection (Fig. 2), we first focused on these two agents. Following this step-wise removal approach, 
ferric ammonium citrate (FAC) was identified as a key additive interfering with both systems, as its 
removal resulted in a dramatic increase in the percentage of GFP-expressing cells observed (15 % 
compared to no detection when liposomes were used and 25 % compared to 3 % when polymers were 
used) relative to transfections in BCR-F12 (Fig. 3a). By contrast, individual removal of the other four 
additives (L-glutamine, insulin, sodium selenite, NEAA) did not show any positive effect on 
transfection efficiencies when liposomes were used (Fig. 3a). Polymer-mediated transfection of the 
d2GFP-expressing vector resulted in a small but significant (p< 0.001) improvement in transfection 
efficiencies (10 %, 9 %, 4 % and 5 %) observed following the removal of insulin, sodium selenite, L-
glutamine and NEAA (respectively) relative to the transfections in BCR-F12 (Fig. 3a). In the control 
Basal medium, lower GFP-expressing populations were achieved compared to the previous 
comparison Figure 2, which was likely associated with random biological variability between 
experiments. 
As individual removal of components was anticipated to affect cell line performance, viable cell 
density (VCD) and viability assessments 24 h post-transfection were also carried out, revealing that 
supplement removal resulted in significantly decreased VCD levels in all cases except for DG44 
transfected with polymers in medium lacking NaSe, in which VCD was observed to be unaffected. 
FAC removal had a considerable impact, with VCD decreased by 1.8-fold (liposomes) and 1.5- fold 
(polymers) compared to DG44 cells in BCR-F12 medium and viabilities decreased to 84 % 
(liposomes) and 74 % (polymers) compared to 95 - 96 % in BCR-F12 (Fig. 3b). VCD and viability 
results 24 h post-transfection in Basal medium were poorer than those observed in -FAC medium 
when using the polymer-based agent (VCD decreased by 56 % and viabilities reduced to 61 %). In 
this medium, transfections mediated by liposomes displayed a significant (p< 0.05) VCD decrease of 
11 %, while viability reported similar values to that observed in -FAC medium. Viability tests showed 
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that individual removal of L-glutamine, insulin, non-essential amino acids and sodium selenite did 
not significantly impact this parameter (Fig. 3b), except for liposomes-mediated transfection, 
displaying a decrease to 91 % DG44 viability when transfected in medium without insulin. 
In a separate experiment, FAC removal was shown to have a similar effect when the lipopolyplex 
transfection method was used in the DG44 cell line, with the percentage of GFP-expressing cells 24 
h post-transfection almost doubling (from 20 % to 38 %) when transfected in medium without FAC 
(Fig. 3c); this result was also associated with a drop in viability (89 % to 74 %) and (interestingly) a 
small (9 %) increase in VCD (Fig. 3d). 
Data on the mean fluorescent intensity (MFI) (Appendix D, Supplementary Fig. 1a) revealed no 
relationship between GFP expression and transfection efficiency in BCR-F12 medium, as removal of 
FAC resulted in both increased MFI and % GFP-expressing populations in all three transfection 
reagents. 
 
Fig. 3 Transfection efficiency, viable cell density and viability obtained with individual 
supplement removal. Percentage of GFP expressing DG44 cells (a) and viable cell density (VCD, 
bars) and viability (lines) (b) 24 h post-transfection with d2GFP vector in BCR-F12 medium (Basal 
with added FAC, L-glutamine, insulin, sodium selenite and non-essential amino acids), in Basal 
medium (DMEM-F12) and in BCR-F12 medium with individual removal of: FAC (-FAC), L-
glutamine (- Glut), insulin (- Ins), sodium selenite (- NaSe) and non-essential amino acids (- NEAA). 
DMEM-F12 (Basal) and BCR-F12 were included as a control media. Two transfection systems were 
tested: liposomes (triangles) and polymers (squares). Percentage of GFP expressing DG44 cells (c) 
and VCD (bars) and viability (symbols) (d) are represented for lipopolyplexes transfection in BCR-
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F12 medium and BCR-F12 without FAC (-FAC). Triplicate transfections were set for each media 
and transfection method combination. A negative control well was included for each media and 
transfection method, displaying between 0.1 - 1.3 % GFP (data not shown) and viabilities between 
92 – 97 % for all three transfection methods (data not shown). Statistical differences between 
transfection efficiencies observed in each testing media compared to the ones in BCR-F12 are 
represented as: p< 0.001 (***), p< 0.01(**) and p< 0.05(*). 
 
3.4. FAC removal facilitates transfection in DP12 and CHO-K1 cell lines 
To confirm this FAC-depleted result on transfection efficiency was not cell line-dependent, CHO-K1 
and DP12 cells were transfected in FAC-depleted medium (-FAC) using all 3 methods. Similar to the 
results shown for DG44 (Fig. 3), transfection efficiencies were enhanced in both cell lines for all three 
transfection agents used, making the -FAC medium very similar to Basal medium in the DP12 cell 
line (Fig. 4a) and superior to Basal for the CHO-K1 cell line (Fig. 4b). In DP12, GFP-expressing 
populations were successfully generated in -FAC medium 24 h post-transfection when using 
liposomes (12 % efficiency), while an 8.5-fold increase in transfection efficiency was observed with 
polymer-mediated transfection compared to BCR-F12 medium and a small but significant (p< 0.001) 
increase (26 % to 34 %) in transfection efficiency for the lipopolyplexes system (Fig. 4a). In CHO-
K1, transfections performed in -FAC medium also resulted in higher efficiencies for all 3 methods 
(Fig. 4b). Similar to DP12, GFP-expressing populations were detected in -FAC medium when using 
liposomes (15 %), while a 5.2-fold increase in transfection efficiency was observed with polymers 
compared to BCR-F12. Similar to the results observed for DG44 but in a marked contrast to that seen 
in DP12, the largest transfection efficiency increase was observed with the lipopolyplexes system in 
CHO-K1, displaying an almost 5-fold increase in GFP-expressing populations (8 % compared to 38 
%; Fig. 4b). However, it is worth noting that the transfection efficiencies for BCR-12 medium 
presented in Figure 4b are much lower than those presented for BCR-12 medium in Figure 1. As a 
result, the possibility that these lower efficiencies adversely complicate interpretation of the 
transfection efficiency increase observed with the CHO-K1 lipopolyplexes system cannot be fully 
excluded. CHO-K1 transfections in -FAC medium displayed a higher number of GFP-expressing 
populations (1.7-fold in polymer-based transfection and 2.4-fold with liposomes) compared to Basal 
medium for all three methods (Fig. 4b), while in -FAC medium DP12 performed very similarly to the 
cells in Basal medium (Fig. 4a). 
In the absence of FAC, increased MFI levels were also observed in both cell lines with the three 
transfection agents, except for lipopolyplexes-mediated CHO-K1 transfection, which reported lower 
expression than in FAC-containing medium (Appendix D, Supplementary Fig. 1c). As expected from 
the transfection efficiencies data (Fig. 1), comparison with ProCHO5, SFM-II and BalanCD revealed 
substantially lower expression in the in-house serum-free medium. Interestingly, among the three 
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transfection reagents and media conditions tested, polymer-mediated transfection in SFM-II medium 
was observed as the only transfection condition to display high MFI levels across the three CHO cell 
lines (Appendix D, Supplementary Fig. 1a,b,c). While lipopolyplexes were observed to be optimal 
for high GFP expression in DP12 (independent of media), CHO-K1 and DG44 cell lines reported 
increased MFI levels when transfected with polymers in both ProCHO5 and SFM-II. 
As in the DG44 cell line, removal of FAC resulted in decreased viability profiles compared to BCR-
F12 in both DP12 and CHO-K1 with all 3 transfection agents tested (Fig. 4c,d), underlining the 
importance of this element to culture performance. Compared to the cells in BCR-F12, VCDs for 
DP12 in -FAC medium were lower for all three methods. CHO-K1 cells demonstrated similar VCDs 
(to BCR-F12) in -FAC medium when liposomes were used, but lower VCD for polymers and 
lipopolyplexes (Fig. 4c,d). It is important to also note that cells transfected in -FAC medium generally 
displayed unchanged or slightly improved VCD and viability profiles compared to those observed in 
Basal medium (Fig. 4d). 
 
Fig. 4 Transfection efficiency with FAC removal. Percentage of GFP expressing DP12 (a) and 
CHO-K1 (b) cells 24 h post-transfection with d2GFP vector in BCR-F12, DMEM-F12 (Basal) and 
BCR-F12 without FAC (- FAC) media. Viable cell density (VCD, bars) and viabilities (symbols) of 
DP12 (c) and CHO-K1 (d) cells 24 h post-transfection are also represented. Three transfection system 
were used: Liposomes (Lipofectamine 2000) (triangles), Polymer-based (TransIT-X2) (squares) and 
Lipopolyplexes (TransIT-PRO) (circles). Triplicate transfections were set for each cell line in each 
condition (media and transfection method combination). A negative control well was included for 
each media and transfection method, displaying between 0.0 - 0.5 % GFP (data not shown) and 
viabilities between 86 – 93 % (DP12) and 90 – 96 % (CHO-K1) for all three transfection methods 
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(data not shown). Statistical differences between transfection efficiencies observed in -FAC medium 
compared to the ones in BCR-F12 are represented as: p< 0.001 (***), p< 0.01(**) and p< 0.05(*). 
 
3.5. Ferric ammonium citrate affects zeta potential and size of some transfection reagents  
Zeta potential and particle size have become standard analytical parameters to characterise DNA-
delivery complexes and study transfection efficiency (35, 36, 37). Both of these physicochemical 
characteristics are dependent on the environment, thus being sensitive to several parameters such as 
pH, viscosity or ionic strength (38). In order to gain insight into the mechanistic inhibitory effect of 
FAC, the zeta potential and size of the three DNA-complex particles used here (liposomes, polymers 
and lipopolyplexes) were characterised in each testing medium. 
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Fig. 5. Size of liposomes, lipopolyplexes and polymers complexes in different media. Liposomes 
(a), lipopolyplexes (b) and polymers (c) were placed in BCR-F12 without FAC (NoFAC), BCR-F12 
with FAC (+FAC), ProCHO5 and BalanCD and the size (nm) was analysed every 10 min during an 
hour incubation in the Malvern Zetasizer X. Each measurement was performed in triplicate.  
 
Particle size was analysed in intervals of 10 min over an hour incubation in order to identify possible 
particle destabilization (such as aggregation) over time. For comparison, size was also analysed in 
complex formation medium (DMEM-F12). Interestingly, in DMEM-F12 all three complexes reported 
similar sizes, with 367 nm +/- 18 observed in liposomes, 377 nm +/- 11.8 in lipopolyplexes and 406 
nm +/- 51 in polymers. As the size of these complexes in DMEM-F12 was only assessed at time 0h, 
to compare with the media-effects during transfection, this data is not represented in figure 5. 
However, when diluted in some of the transfection media, increased sizes of the complexes were 
observed. Liposomes became bigger over time when diluted in BCR-F12+FAC (484 - 542 nm), 
ProCHO5 (431 - 460 nm) and BalanCD (389 - 439 nm), while in the absence of FAC complexes of 
301 to 326 nm were observed (Fig. 5a). Lipopolyplexes displayed two distinguishable behaviours 
depending on the media (Fig. 5b), as follows. In both ProCHO5 and BCR-F12 without FAC, similar 
particle sizes (to DMEM-F12) were observed at the beginning, slightly increasing over the incubation 
time. Conversely, in media containing FAC and in BalanCD, big particle sizes of 536 nm and 848 
nm were already observed at time zero. In these media, indication of particle aggregation were also 
detected due to prompt drops and increases in size observed over the incubation time, possibly as a 
consequence of the sedimentation of these big particles. Similar to that observed for liposomes and 
lipopolyplexes, polymer complexes in BalanCD were observed to increase in size to 485 nm 
compared to the particles in DMEM-F12, BCR-F12 with and without FAC and ProCHO5, which 
were observed to be 398 nm, 371 nm and 294 nm, respectively (Fig. 5c). In all four media, polyplexes 
sizes were increased over the 1 h incubation, with signs of aggregation or increased variability in 
sizes observed in both FAC and NoFAC media as well as BalanCD. 
Zeta potential does not correspond to the particle charge but gives an indication of the surface charge 
determined by the electrophoretic mobility of the complexes under specific conditions (pH, 
temperature, viscosity), thus being influenced by media composition (37, 38). Liposomes in DMEM-
F12, BCR-F12 NoFAC and BCR-F12+FAC were observed to behave similarly, with zeta potential 
values ranging from -35 to -30 mV (Fig. 6a). In contrast, the presence of FAC had a substantial effect 
on the zeta potential of polymers and lipopolyplexes, inducing negative zeta potentials of -17 mV and 
-6.9 mV, respectively, while measurements in DMEM-F12 and BCR-F12 without FAC displayed 
positive zeta potentials (11 – 17 mV, polymers and 11 – 10 mV lipopolyplexes) (Fig. 6b,c). 
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Fig. 6. Zeta potential of liposomes, lipopolyplexes and polymers complexes in different media. 
Liposomes (a), lipopolyplexes (b) and polymers (c) were placed in DMEM-F12, BCR-F12 without 
FAC (NoFAC) and BCR-F12 with FAC (+FAC) and the zeta potential was determined by Phase 
Analysis Light Scattering in the Malvern Zetasizer X. Each measurement was performed between 
two to five times (depending on the conductivity of the media). Statistical differences observed in 
zeta potential in NoFAC and +FAC media compared to the ones in DMEM-F12 are represented as: 
p< 0.001 (***) and p< 0.01(**). 
 
3.6. Ferric ammonium citrate inhibits transfection during the initial stages of the process 
Due to the importance of iron for the maintenance of cell culture performance (39), supplementation 
of FAC at early stages post-transfection was assessed in order to determine the optimal time to 
schedule FAC addition for maximal culture performance while not adversely affecting transfection 
efficiency. The manufacturer's instructions suggested that supplementation with additional additives 
should not be performed earlier than 4 h (polymers and liposomes) and 24 h post-transfection 
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(lipopolyplexes). A 4 h gap in iron supplementation was observed to have an adverse effect mainly 
on viability for all 3 cell lines (Appendix D, Supplementary Fig. 2) and for this reason, a period of 
0.5 - 5 h post-transfection was examined to determine the transfection-inhibitory effects of FAC 
supplementation. Interestingly, supplementation with 100 µM FAC at 0.5 h post-transfection was 
sufficient to restore transfection efficiencies for all three methods; dramatically increasing 
efficiencies for liposomes (from no detection to 22 %) and polymers (3 % to 28 %), while also 
increasing transfection efficacy (27 % to 38 %) for the lipopolyplexes method (Fig. 7). 
Supplementation of FAC at timepoints later than 0.5 h resulted in similar (or slightly worse) 
transfection efficiencies in almost all cases examined, reaching similar percentages of DG44 GFP-
expressing populations (Fig. 7). Following on from this comprehensive test in DG44 cells, a 
simplified protocol, examining just the 0 h, 0.5 h and 4 h timepoints, identified that 0.5 h was the 
optimal supplementation timepoint for DP12 and CHO-K1 as well; the single exception being later 
(4 h) supplementation optimal for lipopolyplexes-based efficiency in CHO-K1, increased to 38 % at 
4 h, compared to 25 % for the same method at 0.5 h (Appendix D, Supplementary Fig. 3 (b.)) 
Supplementation with FAC at 0.5 h also resulted in higher viabilities for all three cell lines and all 
methods tested (Appendix D, Supplementary Table 1), with the single exception of the lipopolyplexes 
method in DG44 cells, where viabilities increased slightly (from 83 % to 84 %) when FAC was 
supplemented at the later 4 h timepoint. 
 
Fig. 7. Effect of FAC supplementation at 0- 5 h post-transfection on the percentage of GFP 
expressing DG44 cells 24 h post-transfection. Three transfection agents were tested: liposomes, 
polymers and lipopolyplexes. Transfections were performed in BCR-F12 medium without FAC. 
Supplementation of 100 µM FAC was performed at different time points (0 h, 0.5 h, 1 h, 2 h, 3 h, 4 
h and 5 h) post-transfection. Non-supplemented media (- FAC) was added as a control. Triplicate 
transfections were carried out for each condition (timepoint and transfection method combination). A 
negative control well was included for each condition and transfection method, displaying between 
0.1 – 0.4 % (lipofectamine), 0.1 – 2.4 % (polymers) and 0.2 – 0.7 % GFP (lipopolyplexes) (data not 
shown). The 2.4 % GFP-expression detected only in polymer-transfection in -FAC medium was 
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suspected to be a consequence of cross-contamination between the transfected and non-transfected 
wells, as all other negative controls in each transfection reagents and media combinations displayed 
% GFP below 1.3 %. Transfection efficiencies observed in FAC-supplemented medium at each time 
point (0.5 – 5 h) compared to the ones at 0 h control were statistically significantly different with a 
significance of p< 0.001, represented as (***) per 0.5 h and 4 h timepoints. 
 
4. Discussion 
Due to the importance of achieving optimal transfection efficiencies for the generation of stably-
expressing clones and/or rapid recombinant protein production by transient gene expression in CHO 
cells, continued efforts to enhance the efficiency of this process are essential. Following our 
development of an in-house serum-free medium where the formulation was known, ferric ammonium 
citrate (FAC) was identified as an inhibitory supplement for all cell lines and chemical transfection 
methods used (Liposome 2000, TransIT-X2 and TransIT-PRO in CHO-K1, DG44 and DP12 cells). 
With the aim of obtaining GFP-expressing populations while maintaining healthy cultures, we 
showed that transfection in -FAC medium followed by replenishment of FAC 30 min post-
transfection (rather than 4 h or 24 h) facilitates high transfection efficiencies and delivers satisfactory 
CHO culture viabilities. 
Driven by regulatory and process concerns, the removal of serum from routine use in mammalian 
culture media has resulted in the development of a wide variety of commercially-available, 
chemically-defined serum-free formulations, optimized for high cell culture performance in terms of 
growth and volumetric productivity. However, the use of these SFM formulations has also frequently 
been associated with poor transfection efficiencies. For instance, Ye, J., et al (2009) observed media-
dependent effects in PEI-mediated transfections of CHOK1SV cells in a range of eight commercial 
protein-free and chemically-defined media, with less than 1mg/L mAb titer detected 4 days post-
transfection in ProCHO5 (also analysed in this study) but high yields obtained in ProCHO4 and 
UltraCHO media (24). Similarly, we have shown differences between the serum-free, protein-free 
and chemically-defined commercial media examined. In certain media, these differences may be 
absolute, displaying zero transfection in BalanCD but high transfection efficiencies in CHO-S-SFMII, 
with all three cell lines and transfection agents. In other media the differences are mixed - as observed 
in ProCHO5 - with zero transfection detected with liposomes, but high transfection efficiencies in 
both polymers and lipopolyplexes. In either case, the presence or absence of transfection-inhibitory 
molecules in the media formulations are likely to be the key factors contributing to this outcome. Cell 
proliferation has been suggested to play a role in transgene expression and thus, cultures displaying 
increased growth rates have been observed to achieve increased transfection efficiencies (40, 41). In 
this study, although specific growth rate (µmax) was not calculated, all three cell lines were observed 
to perform differently in each media as per VCD levels achieved on passage day (day 3) during cell 
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maintenance (data not shown), which is an indicator of different growth profiles in each media. By 
comparing VCD levels, in this study we have not observed a direct linear relationship between 
increased VCD and transfection efficiency. A similar effect has been previously reported in 
transfections mediated by cationic-lipids and PEI complexes, which were observed to achieve 
efficient transgene expression independently of cell proliferation (42, 43), indicating possible 
alternative pathways influencing efficient transgene expression. Further analysis on specific growth 
rate would provide more information to characterize this possible effect. 
Since the composition of many available media is typically not disclosed by manufacturers, we 
developed an in-house SFM formulation to study the impact on transfection efficiency following 
removal of various standard supplements. The presence of media additives such as polymers and anti-
clumping agents (dextran and heparin sulphate) have been suggested to hinder PEI mediated 
transfection, affecting the stability and uptake of the DNA complexes formed (1). In 2001, a study 
focused on the effects of serum and transfection efficiency in five mammalian cell lines (including 
CHO) revealed that the lipid part of serum (mainly cholesterol, LDL, HDL and phospholipids) caused 
inhibition of liposomal-mediated transfection. Interestingly, Son et. al (25) further reported successful 
transfection and liposomal-complex formation in delipidated-serum medium, thus demonstrating the 
critical role of lipid content in transfection media. In HEK293, a source-dependent effect of peptone 
supplementation was described to alter PEI transfection efficiencies, describing beneficial 
transfection effects with 0.5% gelatine peptones but inhibition of DNA delivery when casein-derived 
peptones were added (26). In this study, FAC has been observed as an inhibitory element for 
transfection and/or GFP expression of three CHO cell lines (DG44, DP12 and CHO-K1) and three 
chemical transfection methods (liposomal-based (Lipofectamine 2000), polymer-based (TransIT-
X2), and lipopolyplex-based (TransIT-PRO)). Ferric citrate (Iron (III) citrate) has been previously 
identified to impede PEI-mediated transfection of CHO-S and DXB11 cell lines when supplemented 
over 50 µM (27). A subsequent study (44) identified that the decreased transfection efficiencies may 
be due to a net negative zeta potential detected in the complexes formed in the presence of iron, 
leading to lower interaction of PEI:DNA complexes with CHO-S cellular membranes in ferric citrate-
supplemented CD-CHO medium. In this work, we have built on these two previously published 
studies to demonstrate that the inhibiting effect of FAC is not limited to PEI, but also affects another 
polymer-based method (TransIT-X2), as well as cationic lipid-based methods (lipofectamine 2000) 
and the mixed lipid: polymer lipopolyplexes method (TransIT-PRO). In accordance with previous 
reported data for PEI (27, 44), the zeta potential of lipopolyplexes and polymer complexes studied 
here were adversely affected in the presence of FAC, with negative zeta potentials detected. 
Interestingly, lipid-mediated complexes displayed equal negative zeta potential in all media tested, 
independent of the presence of FAC, which indicates a possible alternative inhibitory mechanism. 
Chemical agents deliver DNA to cells by hydrophobic and electrostatic interactions with the 
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negatively charged cellular membrane and thus positive zeta potential has been reported for 
successful DNA delivery (45, 46). However, the negative lipid-mediated complexes formed here were 
capable of generating GFP-expressing populations, an effect also reported by Son et al. (47, 25). The 
published literature on the influence of zeta potential on successful lipid-mediated transfection has 
shown mixed results, with some studies reporting positive zeta potentials (45, 46, 48), mainly 
measured in water, PBS or diluted media, but negative zeta potentials in lipid-mediated transfection 
have also been demonstrated, measured in culture media (47).  
We have here observed that in the absence of iron (BCR-F12 NoFAC), smaller lipopolyplexes and 
lipid-mediated complexes were obtained, relating to increased transfection efficiencies compared to 
FAC-containing medium. These results indicate a potential FAC-mediated influence on the 
encapsulation of DNA into lipopolyplexes and liposome complexes and/or an increase in the 
aggregation of the complexes, leading to a decreased transfection efficiency caused by decreased 
cellular uptake. However, this effect was not observed in polymer-DNA complexes, which displayed 
increased sizes in -FAC medium compared to medium with FAC. The influence of complex size on 
cellular uptake has been reported in the literature, but without unanimity as to its importance, with 
some studies defining this parameter as essential (49, 50) while others reporting no effect on achieving 
successful transfection (51). Several steps are involved in the generation of producer cells, which 
include successful transport through the cellular membrane, but also efficient DNA-carrier complex 
formation, cytoplasm transport, and nuclear localization (52), which could be disrupted by FAC. 
Internalisation of DNA-delivery particles has been described to be mainly mediated by endocytosis, 
with endosomal escape one of the critical steps to achieve DNA expression. Among the three 
transfection agents used here, different strategies have been proposed for successful endosomal 
release, such as the proton sponge strategy (mostly described in polyplexes), the membrane fusion 
strategy (described in liposomes) and membrane disruption and pore formation (mediated by peptide 
or/and polymer complexes) (53). Recently, an alternative random Brownian motion was described 
for intracellular trafficking of lipofectamine-containing vesicles (54), indicating that further 
investigations are still required to fully understand the mechanisms involved with each type of 
transfection agent. In our study, GFP was used as an indirect measure of traceability of efficient 
transfection (55, 56). Future work to confirm that the different conditions/additives impact the actual 
transfection efficiency and not GFP expression could be carried out by labelling the plasmid DNA 
with (e.g.) rhodamine dye (57) to follow membrane interaction and intracellular vesicles trafficking 
and could further investigate the mechanistic effect of FAC in lipoplex, polymer and liposome DNA-
delivery. 
Iron is vital for healthy growth of mammalian cells, with limited availability of this metal resulting 
in poor cell densities and eventual cellular death (39). Moreover, supplementation with iron citrate 
forms (such as FAC) has been also shown to be essential for increased mAb titers in CHO culture 
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(58). For these reasons, we aimed to identify the optimal timepoint for FAC supplementation post-
transfection in -FAC medium which would deliver satisfactory outcomes in both cellular viability 
and transfection efficiencies. Eberhardy, et al. (2009) had previously reported that FAC interference 
occurs at early stages of transfection and interestingly, FAC supplementation during the initial 4 h 
was reported to decrease PEI-mediated transfection in adherent DUXB11 cultures (27). In this study, 
supplementation as early as 30 min post-transfection has been shown to positively impact transfection 
efficiency mainly in polymers and liposomes mediated transfection, with slight enhancement in 
lipopolyplexes. Moreover, FAC supplementation at this timepoint has delivered beneficial cellular 
viability in all three cell lines and with all three transfection methods studied.  
During the course of this study, differing transfection efficiencies between cell lines (2 to 3-fold lower 
for BCR-F12 than for SFM-II and ProCHO5), transfection agents and media were observed. The in-
house serum-free medium underperformed in terms of transfection efficiency and GFP expression 
(MFI levels) compared to two of the commercial media (ProCHO5 and SFM-II), which was likely 
due to differences in media formulation additives interfering with, or impeding, efficient transfection 
(also reported previously 1, 24, 25, 26). Moreover, from in-house experimentation (data not shown), 
the BCR-F12 medium is defined as a low-producing medium, in which DP12 have been observed to 
reach up to 51 % less mAb titer than in the SFM-II commercial medium. This aspect of our in-house 
medium may have contributed to the low MFI levels detected even in -FAC medium. Interestingly, 
from the combined data of MFI and percentage of GFP expressing cells, it was revealed that high 
transfection efficiencies and expression can be achieved by using the polymer-based TransIT-X2 
transfection agent in combination with the commercial medium CHO-S SFM-II (in our conditions).  
In a recent study, transfections performed under the same conditions on a range of ten cell lines were 
observed to differently perform in terms of transfection efficacy (18), an effect that has been here 
similarly observed in the in-house -FAC medium. It is worth noting that all three CHO cell lines were 
transfected using the manufacturer’s recommendations for CHO cells but adaptation of the protocol 
was not performed per each cell line. The use of this standardised approach may explain some of the 
variability in transfection efficiencies observed between cell lines in the different media. Even though 
it is possible the transfections were performed in non-optimal conditions for each cell line, the 
inhibitory effects of FAC are not considered to be dependent on a suboptimal transfection condition, 
as removal of FAC enabled CHO transfection with all reagents tested. 
In conclusion, FAC was observed to interfere with DNA transfection mediated by the three chemical 
agents studied, acting at early stages of the process. Although previously reported to interfere with 
the interaction between DNA-complexes with the cell membrane, the effects of FAC on the zeta 
potential and complex sizes were here observed to be dependent on the transfection reagent, 
indicating that further investigation examining other essential steps of the DNA-delivery process 
(such as endosomal escape) is needed to fully understand FAC inhibition effect. To circumvent this 
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issue, a practical strategy to recover successful transfection while increasing CHO culture viabilities 
post-transfection was devised, involving transfection in -FAC medium followed by replenishment of 
FAC just 30 min post-transfection. 
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5. Summary and Conclusions 
The research work undertaken in this manuscript in preparation for a PhD. thesis by Publication aimed 
to focus on two clear elements of the 3 main strategies for improvement in CHO-based bioprocesses: 
namely (i) medium optimisation and (ii) CHO cell line engineering. With regard to (i), the impact of 
media additives on CHO performance has been comprehensively highlighted over the course of this 
research project. From the development of an in-house serum-free medium as a working tool, the 
titer-enhancing properties of the trace metal zinc were studied to better understand its potential role 
in improving CHO bioreactor performance. The research work then further built on the knowledge 
gained to investigate other important additives for CHO survival, eventually resulting in (ii), the 
design of a novel selection system to potentially rival the already well-established DHFR and GS 
selection systems. This novel innovative method offers the prospect of successful upstream cell line 
development without the use of cytotoxic drugs. As part of this invention discovery, the relevance of 
polyamines as essential components for CHO survival was established. Even though the absolute 
requirement of polyamines for CHO survival in serum-free conditions was first described in the early 
eighties, the vital role these amines play in CHO cell proliferation is still not fully understood. 
Exploiting this dependent phenotype, the effects of this multifunctional additive at transcriptomic 
level were investigated. Finally, the role media formulation additives play in a key step – transfection 
– in the generation of producer cell lines was analysed and an alternative method to optimise this 
essential process was recommended.  
Conclusions specific to each chapter are discussed below 
 
Chapter 1: Zinc supplementation increases protein titer of recombinant CHO cells 
 
▪ High zinc supplementation at 25mg/L improves the specific productivity of two producer 
CHO cell lines, increasing product titer but negatively affecting VCD profiles. 
▪ Building on previous reported work (Kim and Park 2016), our work has expanded the 
available knowledge in the field by demonstrating that the titer-enhancing effects of high zinc 
supplementation may be independent of cell line specificity (result demonstrated in two 
producer CHO cell lines: DP12 and SK15 (rCHO-K1)) and product type-specificity 
(supplementation increased titer of both IgG mAb and hEPO). 
▪ The titer-enhancing effects of zinc were attenuated by the presence of ATA in the medium 
(CDM+A). This results indicates that the positive effects of zinc may be offset by the 
presence of other additives.  
▪ At 25mg/L zinc, increased mRNA levels of both hEPO and IgG proteins were observed, 
which may be linked to higher transcriptional rates or increased mRNA stability, or a 
combination of both.  
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▪ By contrast, copper supplementation displayed cell line-specific effects at the range of 
concentrations tested. While SK15 displayed increased hEPO titers with no changes in VCD 
and viability profiles, DP12 cells growing in medium supplemented with copper were 
observed to be negatively impacted in both of these parameters. 
▪ Increased oxygen consumption rate (OCR) – indicative of oxidative respiration metabolism 
– in zinc-supplemented producing cultures was observed. Increased oxidative respiration was 
also observed to correlate with the increased titer profiles in both cell lines. 
▪ Zinc increases specific productivity but decreases cell growth. This result suggest that zinc 
supplementation strategies at stationary/production phases on the cultures might be suitable 
for enhancing CHO final titers. 
▪ The work described above was published in Cytotechnology (doi: 10.1007/s10616-019-
00334-1) 
 
Chapter 2: An arginase-based system for selection of transfected CHO cells without the use of toxic 
chemicals 
 
▪ Based on the polyamine-dependence phenotype of CHO cells and due to the limitations (lack 
of stability and toxicity of amplifying/selecting agents) in the current selection systems used 
by the biopharmaceutical industry (GS and DHFR) for the generation of stable cell lines, an 
alternative cytotoxic-free selection system was developed.  
▪ The efficacy of the newly developed auxotrophic selection system was reported. The method 
was shown to sustain the survival and growth of arginase-expressing transfected cell pools in 
a polyamine- and L-ornithine-free environment, supporting the isolation of GFP and 
recombinant therapeutic protein (hEPO) expressing single-cell derived populations. 
▪ This arginase-based system avoids the use of toxic selective agents and selection can be 
performed in low putrescine medium, such as the commercial DMEM-F12. Consequently, 
this method offers an easy-to-apply, cost-effective alternative to the GS and DHFR selection, 
with no need for customised media. 
▪ Clones generated from this system can be maintained for at least 42 generations in selecting 
media, demonstrating considerable stability in their production and growth profiles. Although 
clonal stability monitoring in industry is performed for periods over 60 generations, these 
results indicate initial evidence for stable production, which is of direct value to potential 
biopharma scientists in industry and academia.  
▪ Clones can be also maintained in putrescine-containing media and in commercial 
formulations. In both cases, productivity can be maintained for at least 27 generations. This 
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indicates that cell lines can be generated in putrescine-free media but modifications in media 
formulations for bioreactor-scale production cultures are not required.  
▪ The system may also present broader applicability than CHO, as other biopharmaceutical 
relevant cell lines displaying low arginase were identified (e.g. SP2).  
▪ Due to the lack of drug treatment and easy-to-use method designed, the system may be also 
applied to non-biopharmaceutical relevant cell lines that display low or lack of arginase 
(Capan-2, PANC-1) for the generation of recombinant cell lines. 
▪ The system may be also used in conjunction with GS or DHFR methods, offering an 
alternative to antibiotic-based selection for the generation of double transfectants. 
▪ In response to critical levels of intracellular polyamine, active transport mechanisms 
participate in the maintenance of polyamine homeostasis decreasing or increasing the 
intracellular levels by exporting/importing polyamines from the environment. This effect 
may result in a mixed population of non-transfected and transfected cells due to the 
overproduction of polyamines in high expressing clones and the uptake from non-transfected 
cells. For this reason, single-cell cloning is essential. Moreover, it has to be considered that 
the possible lack of stability of clonal-derived populations may lead to inefficient mixed 
populations.  
▪ Compared to the GS/DHFR system, the arginase-based system attempts to avoid the use of 
cytotoxic drugs. However, this may lead to the obtaining of lower producers compared to the 
amplified GS/DHFR system.  
▪ From the activity of arginase, L-ornithine and the by-products urea are generated, 
intracellular accumulation of which could lead to cytotoxic effects.  
▪ Following further investigations on the selection system, a single resistant parental CHO 
culture was obtained, displaying increased arginase activity. This effect indicated that 
arginase in CHO may be epigenetically repressed, but under high external pressure (with lack 
of polyamines) the repression may be reversed. 
▪ The work described above was published in Journal of Biological Chemistry (doi: 
10.1074/jbc.RA119.011162). 
▪ Due to the novelty, efficacy and applicability of the system designed, intellectual property 
protection has been filed for the work described under patent application number 1911023.8 
(Titled: Transfection selection and polypeptide or RNA expression; Authors: Berta Capella 
Roca, Martin Clynes, Niall Barron and Padraig Doolan). The research outlined has been the 
result of the work performed with my supervisors (Prof. Martin Clynes and Dr. Padraig 
Doolan) and with the collaborative support of Prof. Niall Barron (NIBRT). This process has 
been possible to the collaboration with DCU’s KTI (Invent) and Jonathan Myers (Barker 
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Brettell LLP) that have contributed to the preparation of the invention disclosure documents 
and novelty research.  
 
Chapter 3: Altered Gene expression in CHO cells following polyamine starvation 
 
▪ Polyamines play a central but still not fully understood role in cell proliferation and even less 
knowledge is available on the role they play in CHO. Due to the lack of arginase activity of 
these cells, CHO provide an interesting platform to study the effects at a cellular and 
molecular level of polyamine deprivation, without the need for chemical inhibitors of 
polyamine biosynthesis. An investigation of the impact of polyamine removal on gene 
expression was therefore performed. 
▪ Due to the multiple effects of polyamines at both transcription and translational levels, the 
use of an -omics platform (Affymetrix CHO whole transcriptome microarray chips) was used 
to gain insights into the vital cellular functions polyamines play in CHO.  
▪ Starving CHO-K1 cells of the essential culture additive putrescine resulted in an 
accumulation of cell populations at two stages of the cell cycle: S-phase and G2-phase. This 
effect was correspondingly observed at transcriptomic level, with the overexpression of genes 
related to S-phase transition and arrest in M/G1.  
▪ Increased expression of genes involved in DNA repair (such as RAD51, BRCA2) and RNA 
splicing (genes from the spliceosome complex) was also observed to be correlated with the 
large amount of cells observed to be found in the S-phase following putrescine starvation. 
▪ Removal of polyamines was also significantly associated with a decreased expression of 
genes related to ER stress and apoptosis pathways.  
▪ Polyamine-deprivation displayed a major impact on the increased expression of genes 
previously reported to be affected by polyamine levels or suggested to interact with these 
amines (transferrin receptor, thrombospondin 1, CXCR7, EXTL1). These genes were also 
described as cell membrane proteins and receptors involved in cell proliferation. These data 
suggest that these genes may contribute to activation of proliferating pathways or polyamine 
transport. 
 
Chapter 4: Investigation and circumvention of transfection inhibition by ferric ammonium citrate in 
serum-free media for CHO cells  
 
▪ An in-house SFM supplemented with common media additives was used to assess the 
inhibitory effects of these supplements in transfections mediated by three chemical 
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transfection agents: liposomal-based (Lipofectamine 2000), polymer-based (TransIT-X2), 
and lipopolyplex-based (TransIT-PRO) were assessed.  
▪ Removal of FAC from the medium resulted in increased/successful transfections in all three 
transfection methods but lower viabilities were observed. To circumvent this negative effect 
early addition of FAC (0.5-5 h post-transfection) was tested, revealing 0.5 h post-transfection 
as the optimal time to supplement in order to achieve transfection efficiencies similar to -
FAC medium, while retaining acceptable cellular viability profiles. 
▪ From three commercial media formulations examined, differences in the efficiency and 
support of transfection were observed between formulations and transfection reagents. 
BalanCD medium did not support transfection with any of the reagents while CHO-S-SFMII 
supported transfection with all three transfection reagents. In ProCHO5, zero transfection 
was detected with liposomes, but high transfection efficiencies in both polymers and 
lipopolyplexes. From the results observed, the presence or absence of transfection-inhibitory 
molecules in the media formulations are likely to be the key factors contributing to this 
outcome. 
▪ In BalanCD, analysis of the size of the DNA-complexes generated with the three transfection 
reagents were observed to be the biggest compared to the other media tested. However, 
transfections were not achieved with any of the agents tested in this medium. These results 
suggests a destabilization or aggregation of transfection complexes, possibly related to the 
media formulation. 
▪ FAC affects the size of the DNA-complexes generated with liposomes and lipopolyplexes, 
increasing their sizes. This result suggest that for liposomes- and lipopolyplexes-mediated 
transfections, size may matter. This effect was not observed with DNA-polymers complexes. 
▪ In medium containing FAC, the zeta potential of complexes formed with lipopolyplexes and 
polymers was affected, displaying negative potentials that could induce a lack of complex-
cell membrane interaction. In liposomes-complexes, a negative zeta potential was detected 
independent of the presence of FAC. This result indicates that liposomes might interact with 
the cell membrane with a separate system to electrostatic interactions. 
▪ Differing effects of FAC on the zeta potential and size particles observed between the three 
transfection reagents indicates that the mechanistic inhibitory effect of FAC may be different 
for each transfection reagent, most likely based on the underlying chemistry of each. 
▪ From combined data of MFI and percentage of GFP expressing cells, the polymer-based 
TransIT-X2 transfection agent in combination with the commercial medium CHO-S SFM-II 
(in our conditions) was identified to display the highest transfection efficiencies and 
expression levels.  
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6. Future work 
 
Chapter 1:. Zinc supplementation increases protein titer of recombinant CHO cells 
 
▪ As one of the implications of this research is that zinc should be considered as a beneficial 
additive in the formulation of a suitable media for CHO culture, product quality from cells 
cultured in zinc-supplemented medium should be assessed in terms of glycosylation patterns 
due to the involvement of this trace metal as a co-factor of glycosyltransferases. As per 
previously published research (Prabhu, Gadre and Gadgil, 2018), it is possible that lower 
galactosylation patterns might be a consequence of zinc supplementation - in this case, a 
double supplementation with increased manganese (strong co-factor of galactosylatses) could 
be attempted to recover galactosylation patterns  
▪ At concentrations of zinc of 25mg/L, titer was enhanced but VCD and viability were 
negatively affected. Similar to Zn-25, supplementation of 10mg/L (second highest 
concentration tested) resulted in increased titer compared to non-supplemented cultures. 
However, at this concentration, little or zero (depending on cell line) negative effects were 
observed in viability and VCD profiles. These results suggest that study of the effects of zinc 
supplementation in the range of 10-25mg/L may identify an optimised concentration to 
achieve high biomass, high specific productivity and extended viability profiles.  
▪ Zinc enhances the final titer of the cultures but decreases cell growth. The effect suggest that 
supplementation of zinc at later stages of the culture may increase final titers. To test this 
possible titer-enhancing strategy in a fed-batch operation mode, CHO cells could be cultured 
in growth media (devoid of zinc) until reaching high cell densities. At this stage, feeding with 
media containing zinc could result in increased titers.  
▪ Increased mRNA levels of both products (IgG and hEPO) were observed following high zinc 
supplementation. To investigate whether this effect was a result of increased mRNA stability, 
cultures growing in zinc-supplemented medium could be treated with actinomycin D (a 
transcription inhibitor). Samples should be then collected at several time-points post-
treatment (e.g. every 30min or 1h) to analyse the differences in mRNA levels (e.g. by RT-
qPCR) of both recombinant proteins over time. The results should be compared to a non-zinc 
supplemented control culture.  
▪ Intracellular zinc homeostasis is regulated by several systems, such as the expression of 
transporters that distribute free zinc ions among cells. Increased OCR levels (indirectly 
associated to an increased oxidative respiration metabolism) were observed following zinc-
treatment. Identifying if zinc accumulates in the mitochondria could assist in the 
understanding if a possible link between zinc and the oxidative respiration metabolism exists. 
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In order to gain insight in the mechanistic function of zinc, this study could be performed in 
two ways. One, samples of zinc-supplemented and non-supplemented cultures could be 
collected for the analysis of zinc transporters at proteomic level by using western blots. 
Alternatively, the localisation of intracellular supplemented zinc could be followed by using 
fluorescently labelled zinc (such as Zinpyr-1). After treatment with this labelled zinc, the 
mitochondria could be dyed (such as MitoFluor Red 589) and by using fluorescence 
microscopy, co-localisation of both fluorophores could be assessed. 
▪ The increased titer profiles were associated with higher OCR levels, an indication of 
increased oxidative respiration metabolism (OXPHOS) and were also correlated with high 
zinc supplementation. For this reason, there may be a potential connection between the three 
parameters (titer, OXPHOS and zinc). For example, it could be that zinc induces a switch to 
OXPHOS metabolism and this results in increased titers. A second hypothesis is that zinc 
increases recombinant protein production (e. g. increased mRNA stability) which leads to a 
switch in the metabolism to reach the energetic levels required for high production. To gain 
insight into the mechanistic effect of zinc, a metabolomic approach could be taken by 
analysing changes in the intracellular and extracellular levels of metabolites by Gas-
chromatography-mass spectrometry (GC-MS). This analysis should be performed in non-
producer and very high producer cells, to identify titer-enhanced effects or metabolism-
switch effects (or both). If changes in the oxidative respiration of non-producers are observed 
in zinc-supplemented medium, an indication that zinc can induce a switch of metabolism 
would be obtained. Similarly, if very high producers are used (in which the supplementation 
of zinc has no effect on productivity) and changes in the metabolism are observed, zinc could 
be indicative of this effect. With this approach, further insights on the mechanism and 
possible implications of zinc as titer-enhancer that could be used for optimisation of the 
culture parameters would be obtained. Moreover, information on the changes of metabolites 
would also give an indication of possible limiting metabolites to improve the process (in 
terms of VCD and/or viability), which could lead to increased titers. 
 
Chapter 2: An arginase-based system for selection of transfected CHO cells without the use of toxic 
chemicals 
 
▪ In order to isolate highly producing clones while avoiding the use of cytotoxic agents, an 
altered arginase marker displaying low activity should be used. The increased stringency of 
this selection strategy would force the cells to increase the gene copy number or integrate the 
maker (and the recombinant protein) into a chromosomal “hot spot” – highly expressed site. 
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Consequently, this strategy would ultimately result in high producer clones. The arginase 
could be modified by including random mutations or using a less efficient codon code. The 
suitable modified arginase to be used should be based on the activity levels displayed, 
prioritising low activity levels but sufficient to support growth.  
▪ The use of a different expression vector strategy could also increase the expression of 
recombinant protein and enable the isolation of high producers, following the same principle 
as per the attenuated arginase strategy described above. This strategy would consist of having 
the expression of arginase and the recombinant protein controlled by two different promoters: 
a strong promoter for the expression of recombinant protein (such as cytomegalovirus (CMV) 
or human elongation factor 1α promoter (EF1A)) and a weak promoter controlling the 
expression of arginase (such as thymidine kinase promoter (TK) or human ubiquitin C 
promoter (UbC)). Comparison of this approach with the attenuated arginase should be 
performed to determine the best strategy to achieve high production. 
▪ Arginase generates L-ornithine to be converted into putrescine by ornithine decarboxylase 
(ODC). ODC is a rate-limiting enzyme that participates in the regulation of intracellular 
polyamine content. At high arginase expression, increased production of polyamines may be 
induced, leading to the inhibition of ODC activity. This effect may then lead to the 
accumulation of L-ornithine, which can cause cytotoxic effects. At the same time, the 
conversion of arginine to L-ornithine generates the by-product urea, accumulation of which 
is also toxic for the cells. For this reason, the intracellular levels of L-ornithine should be 
assessed to determine whether accumulation is occurring (e.g. using the Ornithine Assay Kit 
(Fluorometric), Biovision). If confirmed that L-ornithine accumulation is in fact occurring as 
a consequence of using the technology, this result would highlight a possible limitation of the 
described novel system. Intracellularly, detoxification of ornithine and urea is achieved 
though the urea cycle. However, a previous study reports that there is a lack of expression of 
this pathway in CHO (Altamirano et al. 2013). Hence, to overcome the possible accumulation 
of L-ornithine and urea, the use of CHO cell lines overexpressing the urea cycle (such as the 
reported CHO-OTC1-A19 (Chung et al. 2003), expressing carbamoyl-phosphate synthase 1 
(CSP1) and ornithine transcarbamylase (OTC)) may be necessary, potentially resulting in the 
detoxification of these toxic by-products. 
▪ The system developed is not limited to just biopharmaceutical production; offering an easy-
to-apply, cost-effective and drug-free alternative to the still widely used antibiotic-based 
selection system in the academic sector. For this reason, assessment of the arginase activity 
of other mammalian cell lines and generation of arginase knock-out cell lines should be 
performed to extend the applicability of the system. Moreover, the threshold arginase activity 
tolerated for the system to successfully achieve the isolation of expressing-populations should 
 150 
 
be performed in different cell lines to determine whether knock-out are necessary. To achieve 
this, mammalian cell lines (such as the pancreatic Panc-1 and Capan-2 described in this study) 
should be placed in serum-free media lacking polyamines and L-ornithine and growth and 
survival should be assessed. Parental cells being unable to support growth would be then 
suitable for selection. Combination of the arginase activity and survival data in polyamine-
free media would then help indicate the threshold arginase activity levels needed to determine 
whether a cell line requires or not an arginase knock-out to be used with our system.  
▪ Due to the possibility to obtain resistant colonies, an arginase knock-out CHO cell line (using 
e. g. CRISPR/cas9 technology) should be developed. 
▪ Improvement of the SFM-F10 medium (completely devoid of putrescine content) should be 
performed in order to increase the stringency of the selection process, while achieving high 
VCD and viabilities of the expressing populations. This process should be performed by 
adjusting the composition of SFM-F10 (based on DMEM:F10) to a similar formulation to the 
SFM-F12, used for the development of producer cell lines during this study (based on 
DMEM-F12).  
▪ Possible mixed populations of non-transfected and transfected cells may be obtained due to 
the release of polyamines by high expressing clones and their uptake from non-transfected 
cells. For this reason, attenuation of the polyamine transport system should be performed by 
knocking out (CRISPR/cas9) some of the transporters. Knowledge on the polyamine 
transport systems is still limited, but at least three transporters have been identified 
(SLC22A16, SLC3A2, DAX). Due to the importance of polyamine homeostasis to maintain 
cell survival, individual knock-outs (instead of all three combined in a single KO) should be 
performed, which would result in an attenuation of the transport system. This process could 
ultimately result in a decrease of the non-transfected background populations.  
 
Chapter 3: Altered gene expression in CHO cells following polyamine starvation 
 
▪ From the data obtained by microarray analysis, the expression of genes involved in pathways 
related to cell proliferation (cell cycle, DNA repair, RNA synthesis, apoptosis and ER) were 
observed to be significantly affected. Due to the relevance of these pathways to explain the 
phenotype observed when removing polyamines (lack of growth), further validation of these 
results should be performed by RT-qPCR in order to confirm the results observed.  
▪ Intracellularly, polyamines are mainly found interacting with RNA, being described to 
regulate the translation of several mRNAs. For this reason, proteomic profiling by mass-
spectrometry would be interesting to further understand the involvement of polyamines in 
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CHO proliferation and, at the same time, validate the results on cell cycle observed at mRNA 
level. 
▪ The pathways identified to be affected during the microarray analysis are regulated by 
phosphorylation. This phenotype indicates that study not only of the overall proteome 
expression but focus on the changes in the phosphorylation state of the proteins should be 
assessed to correlate the changes with possible activation/deactivation of the pathways. This 
approach could be achieved by analysing the samples in mass-spectrometry using protocols 
for phosphopeptide enrichment (as described in Kaushik et al 2018).  
▪ Analysis of the changes at miRNA should be also performed (with microarrays), due to the 
regulatory role of this small RNAs on the expression of mRNAs. 
 
Chapter 4: Investigation and circumvention of transfection inhibition by ferric ammonium citrate in 
serum-free media for CHO cells 
 
▪ Although a protocol was designed to circumvent the negative effects of FAC during 
transfection, a possible further optimisation of the process could be achieved by testing 
whether alternative iron sources (such as iron sulphate) are also inhibitory of cell transfection. 
This assessment should be tested with the three transfection agents. Moreover, iron sources 
to be used have to display similar cell performance (in terms of growth and viability) to FAC 
in order to avoid media changes between cell culture and transfection processes.  
▪ To gain more insight into the inhibitory-effects of FAC, use of labelled DNA (with e.g. 
rhodamine or fluorescein) in order to follow the transfection process and determine whether 
the complexes in FAC-containing medium interact with the membrane, get into the cells, 
achieve endosomal escape and/or get into the nucleus. Combining this approach with the GFP 
results could give indications on whether FAC has an impact on the expression of the DNA.  
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Appendices 
Appendix A (Chapter 1 supplementary material) 
 
Supplementary Figure 1. Titer (a, b), VCD (c, d) and Viability (e, f) of SK15 (a, c, e) and DP12 (b, 
d, f) cells grown in suspension in in-house chemically-defined medium CDM+A supplemented with 
copper at: 1 mg/L (Cu-1), 7.5 mg/L (Cu-7.5), 13.7 mg/L (Cu-13.7) and 20 mg/L (Cu-20). Statistical 
differences in titer data compared to the control (CDM+A) are represented as: p-value <0.05 (*) and 
<0.01 (**). 
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Appendix B (Chapter 2 supplementary material)  
 
 
Fig. S1. CHO-K1 cells require concentrations over 200µg/L putrescine for healthy growth. 
Viable cell density (continuous lines) and viability (discontinuous lines) of parental CHO-K1 cells in 
SFM-F12 medium supplemented with different concentrations of putrescine: 0µg/L (Put-0), 100µg/L 
(Put-100), 150µg/L (Put-150) and 200µg/L (Put-200) compared to optimal putrescine concentration 
(control, 1mg/L). Triplicates were performed per each condition.  
 
Fig. S2. CHO-K1 cells expressing arginase recover growth profiles similar to parental cells in 
putrescine media. Viable cell density (VCD) (a) and viability (b) of CHO-K1 arginase expressing 
populations in SFM-F12 medium without putrescine (NoP) and medium with putrescine (P) 
compared to parental CHO-K1 cells in SFM-F12 medium containing putrescine (P-Neg). Triplicates 
were performed per each condition.  
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Fig. S3. hEPO-IRES-Arg Bicistronic map (generated in Vector NTI Advance10 (Invitrogen)). 
 
Fig. S4. GFP-expressing populations can be isolated in polyamine-free SFM-F10 medium. 
Viable cell density (VCD) (a), viability (b) and percentage of GFP expressing (c) CHO-K1 cells 
transfected with 500ng GFP-IRES-Arg vector (P-GFP, NoP-GFP). A negative control of cells with 
no DNA transfected (P-Neg, NoP-Neg) was included. The NoP-GFP culture was discontinued at P4 
as viabilities dropped to less than 30%. Transfected and non- transfected cells were placed in either 
SFM-F10 medium supplemented with putrescine (P) or selecting SFM-F10 medium (without 
putrescine, NoP). Triplicate wells were transfected per each condition.  
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Fig. S5. Characterisation of hEPO-expressing clones in commercial and SFM-F12 media 
containing putrescine in batch cultures. Viable cell density (VCD), viability and hEPO titer (mg/L) 
of three hEPO-expressing clones in SFM-F12 medium with putrescine (+Put), BalanCD Growth A 
supplemented with L-glutamine and CHO-S SFM-II supplemented with PVA in 5ml batch cultures 
for 7 days. Biological triplicates and duplicate (VCD, viability) or triplicate (titer) technical readings 
were performed for each phenotype.  
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Appendix C (Chapter 3 supplementary material)  
Supplementary Table 1. Primers used for qRT-PCR validation 
Gene Fwd (5’-> 3’) Rev (5’-> 3’) 
Skp2 GGTCCTTTATGGAGCAACCA CCACTGCAGATTCGGAAAAT 
Tfdp1 CCTCCCAACTCTGTCATCCA CTTCAGCAGAACAGTTCCCC 
Mad2l1 GGAAGAATCAGGACCCCAGT AGGGATTTTGTAGGCCACCA 
Ddit3 CTAGACTCCGCATCCCTAGC ACTGACCACTCTGTTTCCGT 
Thbs1 TTCCTGTTGCATGTGTGTGG GGGAATCAGGTTGGCGTTTT 
Ackr3 ATCTTGAACCTGGCCATTGC CTGGTTATGCTGCACGAGAC 
Tfrc CACTTCCTGTCACCCTACGT AAAGCCGTGAGAGTGTGAGA 
Pacrg GCATCTAGTTGTGTCAGCGG TCGCCAATGTTCTCCCTCTT 
PMF-1 TCCTGAGGTGACAAAGTGGG CCAGGGAGTTCAAGACAGCT 
Tbc1d2 CATACTGCCGGCTGAGTACT TCACTGATGAGAGAGTCGGC 
Extl1 GATGGTGGGCTTTCTGACAC AGTGGGTAAAGAGGGTGTGG 
Gapdh TGGCTACAGCAACAGAGTGG GTGAGGGAGATGATCGGTGT 
 
Supplementary Table 2. List of the 50 most compelling up-regulated and down-regulated 
differentially-expressed genes considering fold-changes. 
Gene Symbol Description Fold 
Change 
FDR P-
val 
Thbs1 thrombospondin 1 7.79 4.25E-05 
Ackr3 atypical chemokine receptor 3 6.97 2.06E-05 
Tfrc transferrin receptor 6.62 1.07E-05 
Chst2 carbohydrate (N-acetylglucosamine-6-O) 
sulfotransferase 2 
4.58 0.0002 
LOC103162148 uncharacterized LOC103162148 4.45 0.0002 
Znf483 zinc finger protein 483 4.24 2.13E-05 
Rnft2 ring finger protein, transmembrane 2 3.95 1.62E-05 
Arhgef16 Rho guanine nucleotide exchange factor (GEF) 
16 
3.93 1.80E-05 
Pacrg PARK2 co-regulated 3.89 8.71E-05 
Slc17a6 solute carrier family 17 (vesicular glutamate 
transporter), member 6 
3.72 0.0021 
E2f8 E2F transcription factor 8 3.59 2.06E-05 
LOC100757526 putative P2Y purinoceptor 10 3.55 6.54E-05 
Rab7b RAB7B, member RAS oncogene family 3.52 4.17E-05 
LOC100774651 cysteine-rich protein 1 3.47 2.06E-05 
Rab7b RAB7B, member RAS oncogene family 3.44 1.98E-05 
Immp1l IMP1 inner mitochondrial membrane 
peptidase-like (S. cerevisiae) 
3.42 2.89E-05 
Arhgef37 Rho guanine nucleotide exchange factor (GEF) 
37 
3.4 4.40E-05 
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Skp2 S-phase kinase-associated protein 2, E3 
ubiquitin protein ligase 
3.37 0.0002 
LOC100774336 von Willebrand factor A domain-containing 
protein 5A-like 
3.33 0.0001 
Serpinb1 serpin peptidase inhibitor, clade B (ovalbumin), 
member 1 
3.33 1.80E-05 
LOC100753285 uncharacterized LOC100753285 3.29 0.0001 
Col6a1 collagen, type VI, alpha 1 3.23 0.0002 
Ccne2 cyclin E2 3.2 6.25E-05 
LOC100761037 serpin B6-like 3.19 0.0013 
Pdss1 prenyl (decaprenyl) diphosphate synthase, 
subunit 1 
3.16 1.87E-05 
Mid1 midline 1 (Opitz/BBB syndrome) 3.16 5.03E-05 
Polk polymerase (DNA directed) kappa 3.14 0.0002 
Eda2r ectodysplasin A2 receptor 3.12 0.0107 
Col3a1 collagen, type III, alpha 1 3.12 4.60E-05 
Gtf2f1 general transcription factor IIF, polypeptide 1, 
74kDa 
3.1 2.06E-05 
Rgs16 regulator of G-protein signalling 16 3.08 3.79E-05 
Il6 interleukin 6 3.08 0.0001 
Col12a1 collagen, type XII, alpha 1 3.05 6.76E-05 
Atp2b4 ATPase, Ca++ transporting, plasma membrane 
4 
3.05 1.98E-05 
Apool apolipoprotein O-like 3.04 2.89E-05 
Traip TRAF interacting protein 3.04 2.13E-05 
Cdh9 cadherin 9, type 2 (T1-cadherin) 3.04 4.51E-05 
Zwint ZW10 interacting kinetochore protein 2.99 2.06E-05 
Taf9b TAF9B RNA polymerase II, TATA box 
binding protein (TBP)-associated factor, 31kDa 
2.97 0.0001 
Hspg2 heparan sulphate proteoglycan 2 2.96 5.60E-05 
Pcdh7 protocadherin 7 2.95 6.18E-05 
Crip1 cysteine-rich protein 1 (intestinal) 2.94 8.45E-05 
Fus fused in sarcoma 2.93 2.89E-05 
Rad51ap1 RAD51 associated protein 1 2.91 2.37E-05 
LOC100773941 low-density lipoprotein receptor-related protein 
1B 
2.9 2.13E-05 
Dna2 DNA replication helicase/nuclease 2 2.89 5.30E-05 
Clspn claspin 2.87 5.21E-05 
Nqo2 NAD(P)H dehydrogenase, quinone 2 2.86 3.97E-05 
Gpc6 glypican 6 2.86 2.89E-05 
Adm adrenomedullin 2.85 7.91E-05 
Cornifin-a cornifin alpha -13.85 2.37E-05 
Tbc1d2 TBC1 domain family, member 2 -7.85 2.13E-05 
Cd68 CD68 molecule -7.81 2.13E-05 
Trib3 tribbles pseudokinase 3 -7.54 1.07E-05 
Ypel3 yippee-like 3 (Drosophila) -6.84 1.62E-05 
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Slc6a9 
solute carrier family 6 (neurotransmitter 
transporter, glycine), member 9 
-6.84 1.62E-05 
Gtpbp2 GTP binding protein 2 -6.39 6.82E-06 
Atf3 activating transcription factor 3 -6.19 2.06E-05 
Chac1 
ChaC, cation transport regulator homolog 1 (E. 
coli) 
-5.7 1.07E-05 
  -5.65 1.62E-05 
Extl1 exostosin-like glycosyltransferase 1 -5.63 2.06E-05 
  -5.31 4.52E-05 
  -5.27 1.80E-05 
  -5.16 9.51E-05 
Exd1 exonuclease 3-5 domain containing 1 -5.03 1.80E-05 
LOC100750381; 
LOC103162814 
interferon-inducible protein AIM2; 
uncharacterized LOC103162814 
-4.82 2.06E-05 
LOC100762031 interferon-induced GTP-binding protein Mx2 -4.71 2.13E-05 
Abhd6 abhydrolase domain containing 6 -4.7 4.40E-05 
  -4.68 1.62E-05 
Herpud1 
homocysteine-inducible, endoplasmic 
reticulum stress-inducible, ubiquitin-like 
domain member 1 
-4.66 1.17E-05 
Rnf157 ring finger protein 157 -4.57 4.51E-05 
LOC100773612 ribosomal protein S6 kinase alpha-2 -4.48 1.80E-05 
Atf3 activating transcription factor 3 -4.45 8.05E-05 
Ccbe1 collagen and calcium binding EGF domains 1 -4.31 3.43E-05 
  -4.29 0.0003 
Abca1 
ATP-binding cassette, sub-family A (ABC1), 
member 1 
-4.25 3.43E-05 
Klf8 Kruppel-like factor 8 -4.23 1.62E-05 
LOC103161775 uncharacterized LOC103161775 -4.22 3.95E-05 
Fat4 FAT atypical cadherin 4 -4.09 6.79E-05 
Dgat2 diacylglycerol O-acyltransferase 2 -3.99 2.89E-05 
Klhl24 kelch-like family member 24 -3.98 1.98E-05 
Ddit3 DNA-damage-inducible transcript 3 -3.98 1.80E-05 
Bfar bifunctional apoptosis regulator -3.86 1.80E-05 
Uso1 USO1 vesicle transport factor -3.85 1.98E-05 
  -3.79 1.62E-05 
LOC100754734 25-hydroxycholesterol 7-alpha-hydroxylase -3.78 7.89E-05 
Tmem140 transmembrane protein 140 -3.76 1.87E-05 
Abca1 
ATP-binding cassette, sub-family A (ABC1), 
member 1 
-3.75 3.95E-05 
Mroh1 maestro heat-like repeat family member 1 -3.73 2.89E-05 
LOC103161640 NKG2D ligand 1-like -3.67 0.0002 
Rwdd3 RWD domain containing 3 -3.66 0.0001 
Elk3 
ELK3, ETS-domain protein (SRF accessory 
protein 2) 
-3.58 2.76E-05 
Amdhd2 amidohydrolase domain containing 2 -3.54 0.0001 
Pdk1 pyruvate dehydrogenase kinase, isozyme 1 -3.52 2.13E-05 
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Clybl citrate lyase beta like -3.41 2.06E-05 
Sat1 spermidine/spermine N1-acetyltransferase 1 -3.41 2.76E-05 
Gabarapl1 GABA(A) receptor-associated protein like 1 -3.39 4.51E-05 
C3ar1 complement component 3a receptor 1 -3.39 2.89E-05 
Cln3 ceroid-lipofuscinosis, neuronal 3 -3.39 1.98E-05 
 
 
 
Supplementary Figure 1. (a) RT-qPCR of DE genes chosen for validation: Skp2, Tfdp1, Mad2l1, 
Ddit3, Parcg, Ackr3, Tbc1d2, Tfrc, Thbs1, Extl1. Biological and technical triplicates were performed. 
The endogenous gene Gapdh was used. (b) Comparison between fold-changes (FC) from microarray 
data and relative quantification (RQ) data from RT-qPCR for DE genes validated. The y-axis 
represents the values for FC and RQ of DE genes. Fold-changes and relative quantification are from 
DE genes expressed in polyamine-deprived media relative to the genes expressed in polyamine-
containing conditions. 
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Appendix D (Chapter 4 supplementary material) 
Supplementary Table 1. Effect of FAC supplementation at 0, 0.5 and 4 h post-transfection on the 
viability of DG44, CHO-K1 and DP12 cells 24-hours after transfection. Three transfection agents 
were tested: liposomes, polymers and lipopolyplexes. Transfections were performed in BCR-F12 
medium without FAC. Supplementation of 100 µM FAC was added at 0 h, 0.5 h and 4 h post-
transfection. Triplicate transfections were carried out for cell line in each condition (timepoint and 
transfection method combination). The BCR-F12 medium without FAC (- FAC) was used as control. 
 
  FAC added at  
0h post-
transfection 
FAC added at  
0.5h post-
transfection 
FAC added at  
4h post-
transfection 
- FAC 
Liposomes DG44 80 ± 1.5 67 ± 2.7 49 ± 2.8 48 ± 5.7 
CHO-K1 97 ± 0.6 84 ± 1.8 77 ± 2 66 ± 3.2 
DP12 91 ± 1 54 ± 1.1 46 ± 6.4 46 ± 3.8 
Polymers DG44 86 ± 2.1 83 ± 3.8 80 ± 1.2 71 ± 1.7 
CHO-K1 93 ± 0.4 85 ± 0.9 82 ± 1 77 ± 1.5 
DP12 90 ± 3.4 85 ± 0.9 75 ± 3.8 76 ± 1.5 
Lipopolyplex 
 
DG44 88 ± 1.1 83 ± 2.5 84.1± 1.6 84 ± 0.8 
CHO-K1 95 ± 0.8 91 ± 1.3 82 ± 3.1 77 ± 1.3 
DP12 88 ± 1 79 ± 1.3 71 ± 1.4 65 ± 3.5 
 
 
 
Supplementary Fig 1. Mean fluorescent intensity (MFI) levels in different media. DG44 (a), DP12 
(b) and CHO-K1 (c) cells 24-hours after transfection. Three transfection agents were tested: 
liposomes, polymers and lipopolyplexes. Transfections were performed in BalanCD, SFM-II, 
ProCHO5 and in-house BCR-F12+FAC (with FAC) and BCR-F12 NoFAC (without FAC). Triplicate 
transfections were carried out for each cell line in each condition (media and transfection method).  
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Supplementary Fig 2. VCD and viability of CHO cells with FAC supplementation at 4 h. VCD (a) 
and viability (b) of DG44, DP12 and CHO-K1 cells in BCR-F12 supplemented with FAC at 4 h post-
seeding compared to cells in medium containing FAC (0 h). Statistical differences between VCD and 
viabilities observed at the 4 h FAC-supplemented medium compared to those in BCR-F12 with FAC 
(0 h) are represented as: p< 0.001 (***) and p< 0.05 (*). 
 
 
Supplementary Fig 3. Effect of FAC supplementation at 0, 0.5 and 4 h post-transfection on the 
percentage of GFP expressing cells. DP12 (a) and CHO-K1 (b) cells 24-hours after transfection. Three 
transfection agents were tested: liposomes, polymers and lipopolyplexes. Transfections were 
performed in BCR-F12 medium without FAC. An amount of 100 µM FAC was supplemented at 0 h, 
0.5 h and 4 h post-transfection. The BCR-F12 medium without FAC (- FAC) was used as control. 
Triplicate transfections were set for cell line for each condition (timepoint and transfection method 
combination). A negative control well was included for each condition, displaying between 0.0 - 0.2 
% GFP (data not shown). Statistical differences between transfection efficiencies observed in medium 
supplemented with FAC at 0.5 and 4 h compared to the ones supplemented at timepoint 0 h are 
represented as: p< 0.001 (***). 
 
 
